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Overview 
 
Part one of this volume is a review of the literature on the association 
between chronic pain and depression. It presents the results of 15 prospective studies, 
divided into three categories: studies investigating outcomes of chronic pain in 
patients with depression, studies investigating outcomes of depression in patients 
with chronic pain, and studies investigating variables associated with chronic pain 
and depression. The review highlights problems with the measures of depression 
used in the majority of the studies. The clinical implications are discussed, and 
suggestions for how future research can overcome methodological limitations are 
made.  
Part two presents an empirical study which investigates the influence of 
history of depression, perceived trustworthiness and gender of the patient; and 
training level of the clinician on judgements and treatment decisions in patients with 
chronic pain. The results showed that participants were affected by patient gender 
and trustworthiness in their pain judgements and management decisions. 
Implications for reducing bias in training clinicians are discussed. 
Part three is a critical appraisal of the research process as a whole. It contains 
some personal reflections on the different stages of research: designing the study, 
recruiting participants and analysing data. It also reflects further on the research 
findings.  
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Abstract 
Background Patients with chronic pain are reported to be at an increased risk for 
developing depression. 
Aim To review the current evidence for associations between chronic pain and 
depression.  
Method PsychInfo and Ovid Medline searches for prospective studies measuring 
chronic pain and depression identified 15 articles meeting criteria. 
Results Studies provided some evidence that depression in patients with chronic pain 
leads to increased pain at follow-up, and that chronic pain in patients with depression 
leads to worse outcomes in treated or untreated depression at follow-up. Studies 
investigating other variables involved in the relationship between chronic pain and 
depression found that catastrophising, self-efficacy, acceptance-related coping 
strategies and physician’s prognosis may influence outcomes in depression and 
chronic pain. The majority of studies used depression measures that include somatic 
symptoms, possibly inflating depression scores and undermining confidence in the 
results. 
Conclusions Future studies should use measures suitable for chronic pain 
populations. Interventions targeting both depression and chronic pain might improve 
outcomes, but their efficacy in patients with both chronic pain and depression awaits 
investigation. 
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Introduction 
This review provides a brief overview of the relationship between chronic 
pain and depression, a detailed review of recent findings examining this relationship 
and a discussion of the psychological implications. Additionally, this review will 
discuss how the findings fit with current theories concerning the association between 
chronic pain and depression. 
 
Chronic pain  
The International Association for the Study of Pain defines pain in humans as 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage” (Merskey,1979). Pain may be 
described as either acute or chronic, with pain that continues for more than three 
months commonly defined as chronic pain. Chronic pain affects approximately 20% 
of adult Europeans (Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006), and 
approximately 10% of adults are diagnosed with chronic pain each year worldwide 
(Goldberg & McGee, 2011). It has a significant impact on those who experience it; 
people with chronic pain are more likely to have an anxiety or depressive disorder 
and to experience significant activity limitations (Gureje, Von Korff, Simon, & 
Gater, 1998). 
 
Factors affecting onset and outcome of chronic pain 
 Pain processing is influenced by biological, psychological and social factors 
such as genetics, neurological structures, neurotransmitters, cognition, mood and the 
context in which the pain occurs and is therefore highly variable (Tracey & Mantyh, 
2007). Similarly, the development of chronic pain has been associated with a range 
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of interacting biopsychosocial risk factors including female sex (Fillingim, King, 
Ribeiro-Dasilva, Rahim-Williams, & Riley, 2009), older age (Verhaak, Kerssens, 
Dekker, Sorbi, & Bensing, 1998), health behaviours such as smoking (Shiri, 
Karppinen, Leino-Arjas, Solovieva, & Viikari-Juntura, 2010), and social factors such 
as lower levels of formal education (Dionne et al., 2001). The psychological factor of 
mood also plays a role, with depression, anxiety and anger all found to be associated 
with the development of chronic pain (Gatchel, Peng, Peters, Fuchs, & Turk, 2007; 
Kroenke et al., 2011; van der Windt, Dunn, Pincus, & McCracken, 2013). Of these, 
depression has received the most attention and will be the focus of this review. 
 
Depression and its occurrence with chronic pain 
The Diagnostic and Statistical Manual of Mental Disorders (5th ed.; American 
Psychiatric Association, 2013) describes the primary symptoms of major depression 
as either depressed mood or loss of interest or pleasure. The symptoms need to be 
present for at least two weeks, and in addition, at least five additional symptoms need 
to be present. These symptoms are: loss of energy, disturbed appetite and sleep, 
feelings of worthlessness and guilt, suicidal ideation and diminished ability to think 
or concentrate. Diagnosis of depression when chronic pain is present is a complex 
issue, as chronic pain and depression have several symptoms in common, including 
sleep disturbance, loss of energy and diminished ability to concentrate, leading to a 
risk of overdiagnosis of depression (Williams, 1998) and an inflation of prevalence 
estimates for depression in patients with chronic pain (e.g. Breivik et al., 2006; 
Miller & Cano, 2009). Despite this, depression rating scales that include somatic 
symptoms, such as the Beck Depression Inventory (Beck, Ward, Mendelson, Mock, 
& Erbaugh, 1961), are commonly used in pain populations despite only being 
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validated in psychiatric populations from which those with physical illness and 
disability had been excluded (Morley, Williams, & Black, 2002).  
Additionally, there is evidence that depression experienced by patients with 
chronic pain is different to depression experienced by patients without chronic pain. 
For example, patients with chronic pain were not found to take a particularly 
negative view of themselves (Morley et al., 2002) and cognitions relating to 
depression in patients with chronic pain differ from cognitions experienced by 
patients with depression alone, with depressed patients with chronic pain more likely 
to have negative cognitions related to health (Pincus, Pearce, McClelland, & 
Isenberg, 1995; Rusu, Pincus, & Morley, 2012). These findings imply that possible 
differences between depression in chronic pain and depression in the absence of 
chronic pain should be considered.  
 
Theories of the association between chronic pain and depression 
Several theories have attempted to explain why chronic pain and depression 
frequently occur together. Many of these theories are problematic as they view 
depression and chronic pain as two distinct disorders that are independent of one 
another, and ignore their overlapping symptoms.  
One outdated theory suggests that in the absence of tissue damage, depression 
precedes pain and the pain is the result of an underlying emotional conflict that the 
patient is unable to confront (Blumer & Heilbronn, 1982). This unhelpful view 
placed ‘blame’ on the patient for their pain, and there is ample evidence against this 
theory (Turk & Salovey, 1984). Another simplistic theory is that pain is a direct 
cause of depression (Fishbain, Cutler, Rosomoff, & Rosomoff, 1997), but evidence 
for this is mixed. 
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More recently, theories have recognised that the relationship between chronic 
pain and depression is not straightforward; these have moved away from simple 
explanations of causation and include cognitive processes as well as behaviours and 
symptoms (Pincus & Williams, 1999). A starting point for theories relating to 
chronic pain and depression is Beck’s cognitive theory, which suggests that attitudes 
and biases about the self are formed during early childhood experiences and are 
integrated cognitively in the form of schemata and core beliefs (Beck, 1967). Events 
later in life can activate the schemata, leading to automatic thoughts that affect 
emotions, biological reactions and behaviours, and distorting perceptions of the event 
(Beck, 1976). Emotional distress, including depression, occurs when individuals 
become stuck in unhelpful patterns of thinking and behaviour.  
The diathesis-stress model (Banks & Kerns, 1996) integrates Beck’s (1967) 
cognitive model, and suggests that individuals with increased sensitivity to particular 
stressors, either through genetic vulnerability or early adverse experiences, may have 
an increased risk of developing depression. Banks and Kerns (1996) suggest that 
chronic pain is one such stressor because of its persistence and the wide-ranging 
effects it can have on a person’s life, such as restriction of pleasurable activities and 
loss of roles. Vulnerable individuals who have chronic pain may experience negative 
thoughts relating to their situation and develop feelings of helplessness and 
hopelessness, which may then increase their perception of pain. A vicious cycle 
develops where increased perception of pain further activates depressive cognition 
and feelings of a loss of control, resulting in the development of depression. While 
the diathesis-stress model was helpful in moving away from more simplistic models 
of the development of chronic pain (e.g. Blumer & Heilbronn, 1982) and provides an 
explanation for why not all people with chronic pain experience depression, there is a 
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lack of studies investigating this theory (Williams, 2007). The model also does not 
take systemic and cultural differences into account. 
More recently, Linton and Bergbom (2011) presented a model that includes a 
role for catastrophising and emotional regulation in the relationship between chronic 
pain and depression. It suggests that a flare-up of pain triggers catastrophic worry in 
the patient, which in turn puts a strain on emotional regulation and leads to an 
increase in negative affect, pain and mood-related disability. Like the diathesis stress 
model above, there is a lack of inclusion of the role of the wider system and culture. 
Both models also view chronic pain and depression as two independent conditions 
and fail to take into account the overlap of symptoms between the two. Williams 
(1998) suggests that a phenomenological approach needs to be taken with regards to 
the co-occurrence of chronic pain and depression. This approach includes patients’ 
experiences and social and cultural contexts as well as interactions with health 
professionals.  
Contemporary psychodynamic perspectives have also moved away from the 
Blumer and Heilbronn’s (1982) simplistic model by developing a complex 
biopsychosocial model. They suggest that biological and environmental factors 
interact to predispose a patient to chronic pain and depression. In response to stress 
and anxiety, patients rely on attachment-deactivating and attachment-hyperactivating 
strategies that lead to impairments in their ability to mentalise (Luyten, Van 
Houdenhove, Lemma, Target, & Fonagy, 2013). Impairment in mentalising might 
lead the patient to adopt a psychic equivalence mode, where patients equate 
psychological and physical pain, and emotional and physical exhaustion. Luyten et 
al. (2013) suggest this mode might explain the high co-occurrence of pain, fatigue 
and depression. 
 15 
From a biological perspective, neurochemical and neuroanatomical 
similarities between chronic pain and depression might play a role in their common 
co-occurrence (Delgado, 2004). An individual’s perception of pain is influenced by 
the interplay of ascending and descending neural pathways. Ascending pain 
pathways transmit peripheral nociceptive signals to the brain via the spinal cord. 
Descending pathways are active in the other direction, and involve projections from 
cortical, subcortical and midbrain regions to the brain stem and on to the spinal cord, 
where the release of neurotransmitters can inhibit or amplify ascending pain signals 
(Bushnell, Ceko, & Low, 2013). Outputs from ‘higher’ regions of the brain, 
including the prefrontal cortex (Bushnell et al., 2013) and limbic areas also reach the 
midbrain, which might explain how cognitions and low mood can influence the 
experience of pain (Tracey & Mantyh, 2007). The neurotransmitters serotonin (also 
known as 5-hydroxytryptamine or 5-HT) and norepinephrine have both been linked 
to the development of depression, with lower levels of both associated with 
depression, and both also found to play a role in pain modulation by inhibiting 
ascending peripheral pain messages (Bair et al., 2003). Therefore, when there is a 
decrease in one or both of these neurotransmitters, the peripheral pain signals may be 
increased, leading to an elevation in the experience of pain. One possibility is that a 
decrease in these neurotransmitters is a common cause of both conditions. While low 
serotonergic and noradrenergic activity in the midbrain and brain stem can enhance 
ascending pain signals, depletion of these neurotransmitters in limbic areas could 
have the dual effect of inducing depressive symptoms and enhancing nociceptive 
signals further, leading to both depression and the exacerbation of pre-existing 
chronic pain conditions (Bair et al., 2003). Alternatively, a decrease in serotonin and 
norepinephrine may lead to depression and induce chronic pain, as reduced levels of 
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descending inhibition would lead to amplified pre-existing sub-perceptual 
nociceptive signals, to the extent that they become strong enough to be registered as 
painful by the person (Bair et al., 2003). 
A second possible scenario is that consistently high levels of glucocorticoid 
stress hormones, triggered by chronic pain, could damage serotonergic neurons in 
limbic areas, particularly the hippocampus, reducing their ability to produce 
serotonin (Blackburn-Munro & Blackburn-Munro, 2001). The resulting reduction in 
serotonin levels may lead to symptoms of depression (Duman, Heninger, & Nestler, 
1997). It is important to note that the situation is more complex than described here 
as these two neurotransmitters can also facilitate ascending pain signals depending 
on which receptor is activated. For instance, although the activation of 5-HT7 
receptors by serotonin can inhibit pain signals in rats, the activation of the 5-HT3 
receptor facilitates them (Dogrul, Ossipov, & Porreca, 2009). Several other 
neurotransmitters have also been associated with the development of pain and 
depression (Campbell, Clauw, & Keefe, 2003).  
Attempts at explaining a biological basis for the development of chronic pain 
and depression also neglect to mention a role for social factors in their development. 
Some pain related behaviours, such as facial expressions or verbal communication, 
are social in nature and serve to communicate pain to others (Cano & Williams, 
2010). These behaviours can be reinforced depending on different social responses 
such as validation or reassurance from others, and they might also affect a patients’ 
emotional state or experience of pain. For example, one study found that chronic 
pain patients who perceived their spouse to be critical and hostile towards their 
experience of pain were more likely to have increased pain intensity 3 hours later 
(Burns et al., 2013). Another study found that frequent hostile spousal reactions to 
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pain were associated with increased pain intensity and decreased marital satisfaction, 
which then led to increased symptoms of depression (Cano, Weisberg & Gallagher, 
2000). This evidence suggests that it is important to include social factors in models 
of the development of chronic pain and depression.   
 
Reviews on chronic pain and depression 
There have been several reviews on the association between chronic pain and 
depression. However, many reviews have tended to view chronic pain and 
depression as independent conditions and have therefore focused on questions of 
causality. By doing this, they fail to capture the complexity of the relationship 
between the two conditions and do not address the issue of common symptoms 
occurring in both. They also include epidemiological and cross-sectional studies, 
which provide limited information about the association between chronic pain and 
depression and cannot demonstrate causal relationships. They do not include 
measures of the methodological quality of the studies included in the reviews, so the 
following summary of findings from the reviews should be interpreted with caution. 
One review focused on the question of whether depression is an antecedent or 
consequence of chronic pain (Fishbain, Cutler, Rosomoff, & Rosomoff, 1997). 
Fishbain et al. (1997) found more studies providing evidence that depression is 
caused by chronic pain than studies suggesting that it is an antecedent of chronic 
pain. Bair and colleagues (2003) reviewed studies investigating the prevalence of 
comorbidity of chronic pain and depression and the consequences of comorbidity on 
diagnosis and treatment outcomes. Though there were a limited number of 
longitudinal studies, there was evidence for a reciprocal relationship between pain 
and depression, with an increase in pain severity and interference with daily 
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activities leading to an increase in symptoms of depression. To improve outcomes, 
they suggest that treatment needs to include assessment and treatment of both 
depression and pain.  
A more recent review asked whether depression triggers pain, whether 
treating one results in improvements in the other, and discussed the possible 
mechanisms by which pain and depression are linked (Linton & Bergbom, 2011). 
The review found evidence for the co-occurrence of depression and pain but limited 
evidence that depression is preceded by pain. They found evidence suggesting that in 
order to maximise improved outcomes, both depression and chronic pain need to be 
treated as opposed to targeting just one and recommended early intervention for 
depression.  
 
Aims of the current review 
This paper will review the literature examining the association between chronic 
pain and depression. It will address the following questions: 
1. Does depression affect pain and disability outcomes in patients with chronic 
pain undergoing nonspecific treatments? 
2. Does pain affect outcomes in treated or untreated depression? 
3. What variables mediate outcomes in chronic pain and depression at follow-
up? 
4. What are the psychological implications of the findings? 
 
Previous reviews include cross-sectional studies, which provide limited 
information about the association between chronic pain and depression and cannot 
demonstrate causal relationships. Further, they have included general population 
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studies rather than patient samples, the most clinically relevant group. This review 
will include studies with longitudinal designs in clinical populations only.  
 
Method 
Search strategy 
 An initial search for past reviews uncovered several review papers examining 
the link between chronic pain and depression, described above. Because of the wide-
ranging questions of Linton and Bergbom’s (2011) review, a large amount of 
literature is discussed and no individual study is reviewed in any depth. The search 
was conducted to include studies published after the review by Bair et al. (2003) to 
limit results to a manageable quantity.  
Selected databases (PsycINFO, Medline) and the reference lists of relevant 
papers were searched. An initial search included the search terms (depress*) or (low 
mood) combined with (chronic pain) or (subacute pain) or (sub-acute pain) or 
(acute to chronic pain) or (enduring pain) or (continual pain) or (sustained pain) 
(Appendix 1). Two extra papers were identified when relevant reference lists were 
examined. One of the papers did not initially come up in the search because pain was 
described as ‘back pain’ in the study. Therefore, the search was re-run to include the 
additional search terms of (back pain), (musculoskeletal pain), (neck pain) and 
(shoulder pain). In total 2370 papers were identified after removal of duplicates. The 
titles and abstracts of the resulting papers were then examined by the reviewer (see 
Figure 1 for a flowchart of the selection). Longitudinal epidemiological studies 
including participants from the general population at the beginning of the study were 
not included in the review due to the lack of good examples in the literature. 
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Eligibility criteria 
The search was limited to studies from 2003 – 2013, written in English and 
with human participants. Studies were included if they met the following criteria: 1) 
reported in a peer-reviewed journal; 2) had a longitudinal design; 3) based on a 
clinical population where the majority of participants (>50%) had sub-acute pain 
(defined as pain lasting 4 weeks or longer) or chronic pain (defined as pain lasting 3 
months or longer) and/or depression; 4) not focused on treatment outcomes; 5) pain 
and depression were both measured at baseline and follow-up; 6) the primary sample 
was adults; 7) chronic pain was not related to a specific disease process (e.g. cancer 
or rheumatoid arthritis). When there was more than one study describing the same 
sample population, the most recent paper was selected. There were no exclusion 
criteria.  
 
Data extraction 
Data pertaining to the following elements from all studies were abstracted by the 
author: 1) country of study, 2) recruitment method, 3) sample population, 4) sample 
size, 5) time from baseline to follow-up(s), 6) pain measures, and how they were 
entered into analyses, 7) depression measures, and how they were entered into 
analyses, 8) additional variables, 9) aims, 10) main findings. These data were used to 
assess the methodological quality of the studies and their findings.  
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Figure 1. Flowchart illustrating the 
selection process of papers 
 
 
 
 
 
 
 
 
 
 
 
3657 papers identified 
through database search 
 96 papers excluded.  
Reasons for exclusion (in descending 
order of frequency): 
- not based on a clinical population 
- focussed primarily on treatment 
outcomes 
- chronic pain related to a specific 
disease process 
- pain not measured at baseline 
- depression not measured at 
baseline  
- not a longitudinal study 
- pain was acute at baseline 
- same data used in previous study 
- duration of participants of pain not 
provided 
15 longitudinal studies 
selected for review 
 110 full papers accessed  
1 paper identified through 
references 
 2370 papers after removal of 
duplicates. Titles and abstracts 
examined.  
 2261 papers excluded based 
on abstracts 
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Results 
Overview of papers 
Of the 3657 initial search results, 15 studies were chosen for the review. There was 
some variation in study methodologies ranging from postal questionnaires to face-to-
face clinical interviews. There was also a wide range in time between baseline and 
follow-up points, ranging from 2 months to 5 years. Sample recruitment and data 
collection methods are shown in Table 1, below. Studies were grouped according to 
whether they 1) included patients with chronic pain at baseline, 2) included patients 
with depression at baseline, and 3) focused on identifying variables that mediated 
outcomes in chronic pain and depression. 
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Table 1. Methodologies of included studies 
 
Author 
(Year) 
Country 
Recruitment method 
 
Data collection 
method 
 
Sample population 
 
 
Mean age 
(years; SD); 
range 
Sample 
size (n 
male) 
Time from baseline 
to follow up(s) 
 
Studies with chronic pain at baseline 
     
 
Dunn et al. 
(2007) 
UK 
 
Recruited via a postal survey 
 
Self report 
questionnaire 
 
Patients with low back 
pain 
 
46.6 (8.2), 
30 - 59  
 
426 (188)  
 
12 months 
 
Hurwitz et 
al. (2003) 
USA 
 
Recruited via postal survey 
 
Self report 
questionnaire 
 
Patients with back pain  
 
 
51 (16.7), 
NP 
 
681 (327) 
 
2 weeks, 6 weeks, 6, 
12 and 18 months 
 
Kroenke et 
al. (2012) 
USA 
 
 
Recruited during a clinic visit 
 
Clinical interviews 
 
Patients with chronic 
low back, hip or knee 
pain – 127 with 
depression, 250 without  
 
55.8 (11.0), 
NP 
 
377 (187) 
 
3 months, 6 months 
and 12 months 
 
Muller et al. 
(2013) 
UK 
 
Recruited during general 
practice consultations 
 
 
Self report 
questionnaire 
 
Patients with chronic 
pain 
 
65.2 (9.5), 
>50 
 
329 (126) 
 
12 months 
 
 
Ryall et al. 
(2007) 
UK 
 
Recruited during primary 
care appointments, 
physiotherapy appointments 
and a triage clinic 
 
Self-report 
questionnaire 
Clinical assessment 
Telephone interview  
 
Patients with chronic 
arm pain 
 
 
NP, 15 - 64 
 
313 (127) 
 
1 month, 3 months, 
6 months and 12 
months 
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Von Korff 
et al. (2005) 
USA 
 
Recruited during a primary 
care clinic visit 
 
Telephone interviews 
 
Patients with chronic 
back pain 
 
 
NP, 18 - 75 
 
1213 
(600) 
 
1, 2 and 5 years 
 
Studies with depression at baseline  
     
 
Chung et al. 
(2012) 
Hong Kong 
 
Recruited during a clinic visit 
 
Clinical interview 
 
Patients with a diagnosis 
of major depressive 
disorder 
 
48.3 (9.5) 
18 – 65 
 
82 (18) 
 
3 months 
 
Gerrits et 
al. 
(2012) 
Netherlands 
 
Screening questionnaire 
posted to participants 
 
Clinical interview,  
self-report 
questionnaires 
 
Patients with depressive 
and/or anxiety disorder 
at baseline 
 
 
42.1 (12.3), 
NP 
 
1209 
(531) 
 
24 months 
 
Kroenke et 
al. (2008) 
USA 
 
Recruited during a clinic visit 
 
Clinical interviews, 
telephone interviews 
at follow-up 
 
Patients with a diagnosis 
of depression 
 
 
42.0 (NP), 
NP 
 
405 (81) 
 
3 months and 6 
months  
 
 
Studies with other variables 
     
 
Lerman et 
al. (2012) 
Israel 
 
Recruited during clinic visit 
 
 
 
Self-report 
questionnaires 
Telephone interview 
 
Patients with chronic 
pain 
 
 
56.7 (14.1), 
19 - 90 
 
163 (61) 
 
An average of 4.34 
months (range 2-8 
months) 
 
McCracken 
et al. (2005) 
UK 
 
Recruited during clinic visit 
 
Clinical assessment 
 
Patients with chronic 
pain 
 
 
44.2 (10.7), 
NP 
 
118 (NP) 
 
An average of 3.9 
months  
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McCracken 
et al.  
(2007) 
UK 
 
Recruited during clinic visit 
 
Clinical assessment 
 
Patients with chronic 
pain 
 
 
44.6 (10.7), 
NP 
 
115 (53) 
 
An average of 3.7 
months  
 
Rudich et 
al.  
(2010) 
Israel 
 
Patients approached while 
waiting for their first visit to a 
pain specialist  
 
Questionnaires and 
medical assessment 
 
Patients with chronic 
pain 
 
 
58.0 (13.0), 
24 - 81 
 
45 (19) 
 
An average of 5 
months (range 2-8 
months) 
 
Van Liew 
et al. (2013) 
USA 
 
Advertisements in 
newspapers and physician 
offices, referrals by 
physicians 
 
Questionnaires 
 
Patients with 
fibromyalgia syndrome 
(majority female) 
 
 
54 (11.1), 
NP 
 
462 (20) 
 
6 months, 12 
months 
 
Velly et al. 
(2011) 
USA 
 
Advertisements in local 
dentists 
 
 
Clinical examination 
Questionnaires 
 
Patients with chronic 
temporomandibular joint 
pain 
 
36.8 (12.2), 
NP 
 
480 (276) 
 
18 months 
NP Not provided
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Methodological quality assessment 
Assessment of methodological quality was informed by recommendations to 
assess the quality of non-randomised studies from Chapter 13 of the Cochrane 
Handbook for Systematic Reviews of Interventions (version 5.1.0; Reeves, Deeks, 
Higgins, & Wells, 2011). The Newcastle-Ottawa Scale (NOS; Wells, Shea, 
O’Connell, & Peterson, 2000) was chosen to assess the quality of studies and was 
adapted to meet the requirements of this review (Appendix 2). The reviewer assessed 
the methodological quality. 
Items on the NOS are: representativeness of the sample population, 
appropriate selection of the control cohort, reliable and valid measurement of chronic 
pain and depression at baseline and/or follow-up, control for gender and age, length 
of time between baseline and follow-up, and adequacy of follow-up of the cohort. 
Studies met the aforementioned criteria if they 1) included a sample population 
representative of typical patients with chronic pain or depression, 2) included a 
control cohort from a similar population 3) included reliable and valid measures of 
depression and chronic pain at baseline, including measures of depression that were 
valid for a pain population, 4) had a sample size of more than 50 participants, 5) 
controlled for gender and age, 6) included reliable and valid measures of depression 
and chronic pain at follow-up, 7) time from baseline to follow-up was greater than 6 
months, 8) had less than 25% participants lost to follow-up and/or controlled for 
differences in participants lost to follow-up in the analyses. A maximum of eight 
stars could be awarded for any study. Quality ratings are summarised in Tables 3, 5 
and 7.  
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Summary of findings 
1. Does depression affect pain and disability outcomes in patients with chronic 
pain undergoing nonspecific treatments? 
Six studies were identified that included patients with chronic pain at baseline 
and focused on how depression affects outcomes in chronic pain. These are 
described in Table 2, below.   
 
Methodological quality of the studies 
Overall, quality ratings for the studies in this group ranged from 6 – 7 out of a 
possible 8. All studies included patients who were representative of the chronic pain 
population, controlled for gender and age in their analyses, had a sample size of 
greater than 50 participants, had a follow-up time period of greater than 6 months, 
and where more than 25% of baseline participants were lost to follow-up, reported 
any differences between participants lost to follow-up and participants who stayed in 
the study. Some studies present problems concerning the measurement of depression 
and pain, and these will be discussed in the next two sections. 
 
Measurement of pain and inclusion of participants with chronic pain 
Participants’ reports of the length of time they had been experiencing pain 
varied between studies. One study included patients with pain for at least 3 months, 
with at least moderate pain, defined as a score of 5 out of 10 or greater on the Brief 
Pain Inventory (Keller et al., 2004; Kroenke et al., 2012). Another study included 
patients who reported pain ranging from less than 3 weeks to more than 1 year 
(Hurwitz, Morgenstern, & Yu, 2003). Four studies included patients with a range of 
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time since the first onset of pain, ranging from less than 3 months to over 3 years, 
and some patients being included in the study at their first presentation to the service 
and others after several visits (Dunn, Croft, Main, & Von Korff, 2008; Muller, 
Thomas, Dunn, & Mallen, 2013; Ryall, Coggon, Peveler, Poole, & Palmer, 2007; 
Von Korff & Miglioretti, 2005). Measurement techniques used included established 
self report instruments such as the Chronic Pain Grade Scale (Von Korff, Ormel, 
Keefe, & Dworkin, 1992) and numerical rating scales (Jensen & Karoly, 1992). 
Follow-up measurement of pain varied, with Ryall et al. (2007) using patient reports 
of whether their pain was continuing. Kroenke et al. (2012) used the Chronic Pain 
Grade Scale but did not dichotomise patients into pain vs. no pain, instead analysing 
data according to four pain grades. The Chronic Pain Grade Scale uses two scales to 
measure pain severity and pain disability. Scores on the scale can be used to classify 
patients into the following grades 1) low intensity, low disability, 2) high intensity, 
low disability, 3) high disability, moderately limiting, and 4) high disability, severely 
limiting (Von Korff et al., 1992). Dunn et al. (2008), Muller et al. (2013) and Von 
Korff et al. (2005) also used the Chronic Pain Grade Scale, and considered a grade of 
two or higher as clinically significant back pain. Hurwitz et al. (2003) classified 
participants as having clinically meaningful low back pain if they reported scores of 
2 or more out of 10 in the numerical rating scale.  
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Table 2. Studies with chronic pain at baseline 
Author 
(year) 
Pain measures, 
classification of pain 
in analyses 
 
Depression 
measures, 
classification of 
depression in 
analyses 
Other variables at baseline Aims Main findings 
 
Dunn et 
al. (2007) 
 
Chronic Pain Grade 
Scale  
 
Dichotomous 
 
Hospital Anxiety 
and Depression 
Scale* 
 
Integrated into an 
overall ‘risk 
score’ 
 
Age 
Sex 
Employment 
 
 
To investigate whether a 
prognostic approach to 
defining chronic pain 
developed in the US by 
Von Korff (2005) can be 
applied to a UK 
population  
 
The cut-off points for chronic pain 
developed in the US population 
were replicated in the UK 
population, apart from the low-
risk cut-off points 
 
Hurwitz et 
al. (2003) 
 
Numerical rating 
scales for pain 
intensity, 0 – 10. 
Frequency of pain in 
past week 
 
Dichotomous 
 
Five-item Mental 
Health Index 
from the Short 
Form Health 
Survey* 
 
Dichotomous 
 
Age 
Sex 
Employment 
Education 
Sickness Impact Profile  
 
To provide a longitudinal 
estimation of 
associations of low-back 
pain and disability with 
psychological distress 
 
Pain and disability at baseline 
significantly predicted subsequent 
depression at follow-up and 
depression at baseline predicted 
pain and disability at follow-up 
 
Kroenke 
et al. 
(2012) 
 
 
 
Brief Pain Inventory 
 
Chronic Pain Grade 
Scale  
 
Continuous 
 
PHQ-9 
 
Dichotomous 
 
Hopkins 
Symptom 
Checklist 
 
Age 
Sex 
Pain location 
Self-efficacy 
Short Form Health Survey 
(Quality of Life) 
Race 
 
To investigate whether 
comorbid depression at 
baseline is associated 
with worse pain 
outcomes at follow-up 
 
Patients with comorbid depression 
at baseline had increased pain 
severity and worse pain-related 
disability at follow-up. Only 10% 
of patients in the non-depressed 
group went on to develop 
depression at follow-up 
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Muller et 
al. (2013) 
 
Chronic Pain Grade 
Scale 
 
Dichotomous 
 
Hospital Anxiety 
and Depression 
Scale* 
 
Integrated into an 
overall ‘risk 
score’ 
 
Age 
Sex 
 
To test whether Von 
Korff’s (2005) 
prognostic approach to 
chronic pain was 
successful in predicting 
pain in older adults 
 
The cut-off points for chronic pain 
in Von Korff’s (2005) study were 
replicated, though newer cutoffs 
were needed to adjust for higher 
risk profiles for older adults 
 
Ryall et 
al. (2007) 
 
 
The Southampton 
Examination 
Schedule for Upper 
Limb Disorders 
 
Frequency of pain 
Patient reports of 
continuing pain 
 Dichotomous 
 
Hospital Anxiety 
and Depression 
Scale* 
 
Dichotomous 
 
Age 
Sex 
Somatizing tendency 
Health anxiety 
Fear-avoidance beliefs 
 
 
To investigate potential 
risk factors for the 
persistence of arm pain 
 
Depression was not found to be a 
significant predictor of continuing 
arm pain. Male sex, higher 
frequency of pain in the past 
month at baseline, chronic pain at 
other sites and current smoking 
predicted continuing pain 
 
Von Korff 
et al. 
(2005) 
 
Characteristic Pain 
Intensity (0-10 
rating) 
Pain Interference 
Score (0-10 rating) 
Pain Impact Score 
Chronic Pain Grade 
Dichotomous 
 
SCL-90 
depression scale 
 
Integrated into an 
overall ‘risk 
score’ 
 
Age  
Sex 
Number of days with back 
pain in the prior 6 months 
Number of other pain sites 
 
 
To investigate whether 
symptoms of depression, 
number of pain sites and 
number of days of pain in 
the previous 6 months 
can be used to predict the 
course of chronic pain 
 
High levels of baseline depression 
significantly raised the risk of 
severe back pain at year 1. Lower 
levels of depressive symptoms at 
baseline had a decreased risk of 
having severe back pain at year 1, 
even when participants had severe 
back pain at baseline 
* measure of depression is suitable for the pain population 
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Table 3. Assessment of the methodological quality of studies with chronic pain at baseline: results 
 
 Selection    Control Outcome    
Author 
(year) 
1.  
Selection: 
representative-
ness of the 
cohort 
2. 
Selection 
of the 
control 
cohort 
3. Reliable 
and valid 
measurement 
of pain and 
depression at 
baseline 
4.  
Sample size 
(>50 
participants) 
5. 
Control 
for 
gender 
and age 
6. Reliable 
measurement of 
pain and/or 
depression at 
follow-up  
7.  
Time from 
baseline to 
follow-up > 
6 months 
8. 
Participants 
lost to 
follow-up < 
25% 
Total 
 
Dunn et al. 
(2007) 
 
 
* 
 
n/a 
 
* 
 
* 
 
* 
 
* 
 
* 
 
* 
 
7 
Hurwitz et 
al. (2003) 
 
* n/a * * * - * * 6 
Kroenke et 
al. (2012) 
 
* * + * * * * * 7 
Muller et 
al. (2013) 
 
* n/a * * * * * * 7 
Ryall et al. 
(2007) 
 
* n/a * * * - * * 6 
Von Korff 
et al. (2005) 
* n/a + * * * * * 6 
       * criterion met  - criterion not met  + measurement of depression included somatic symptoms n/a no control cohort, not applicable 
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Measurement and classification of depression 
Studies varied not only for their chosen measures of depression, but also for 
how they integrated the scores for the measures into analyses. Three studies used the 
Hospital Anxiety and Depression Scale (Dunn et al., 2007; Muller et al., 2013; Ryall 
et al., 2007; HADS; Zigmond & Snaith, 1983) to measure depression and one study 
used the 5-item mental health index (MHI-5; Hurwitz et al., 2003; McHorney, Ware, 
& Raczek, 1993). Both the HADS and the MHI-5 exclude somatic symptoms in their 
measurement of depression, therefore avoiding score inflation by symptoms of 
chronic pain. Hurwitz et al. (2003) considered patients as depressed if their score was 
below the median of 76, and patients were divided into two groups according to 
whether their scores were above or below 76 in the analyses. Dunn et al. (2007), 
Muller et al. (2013) and Von Korff et al. (2005) integrated the depression scores into 
an overall ‘risk score’ designed to predict pain at follow-up. Ryall et al. (2007) 
classified patients as depressed if they had a HADS depression score greater than 
eight out of a total of 21, classifying patients with mild, moderate and severe 
depression in the same group (Zigmond & Snaith, 1983). This was entered into 
analysis as a risk factor for continuing pain. Kroenke et al. (2012) used the PHQ-9 to 
determine whether patients were depressed at the beginning of the study, with 
patients with a score higher than ten classified as depressed, and lower than seven as 
non-depressed. They used the 20-item Hopkins Symptom Checklist for Depression 
(HSCD) due to its sensitivity to change at follow-up (Löwe, Unützer, Callahan, 
Perkins, & Kroenke, 2004). Von Korff et al. (2005) used the Symptom Check-List to 
measure depression (SCL-90-R; Derogatis, 1986). The PHQ-9, the HSCD and the 
SCL-90-R all have significant contribution from somatic symptoms which are also 
characteristic of chronic pain and one study on a population with chronic pain did not 
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find evidence for the validity of the SCL-90-R in this population (Hardt, 
Gerbershagen, & Franke, 2000).  
   
Discussion of findings 
The studies in the review used a range of different measures, methods and 
time periods between baseline and follow-up, which makes it difficult to compare 
their results. However, five of the six studies found evidence that depression at 
baseline had adverse effects on chronic pain at follow-up. Some of these studies are 
discussed below since they used problematic tools to assess depression and chronic 
pain, which call their results into question. The findings of the studies are 
summarised in Table 2.  
One study (Ryall et al. 2007) found that depression did not predict continuing 
chronic pain, while three other studies (Hurwitz et al., 2003; Muller et al., 2013; 
Dunn et al., 2008) reported that depression at baseline predicted pain at follow-up. 
All used suitable depression scales, but Ryall used a low cut-off score and classified 
patients as depressed versus not, thus the ‘depressed sample’ very likely included 
some very mild depression. 
Von Korff et al. (2005) developed a score to predict patients’ prognosis in 
chronic pain using baseline scores of depression, pain sites and duration of pain. 
Dunn et al. (2008) and Muller et al. (2013) replicated the study but with an 
appropriate depression scale and showed that their method of prediction is also valid 
in adults and older adults in the United Kingdom, respectively. While these studies 
showed that depression can be used to predict chronic pain at follow-up, they 
included depression in total ‘prognosis’ score, calculated alongside pain sites and 
duration of pain at baseline, so the specific role of depression could not be estimated 
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from these studies. Dunn et al. (2008) and Muller et al. (2013) also used postal 
questionnaires, which may introduce bias against people with literacy or language 
difficulties.  
Von Korff et al. (2005) and Kroenke et al. (2012) both used measures of 
depression that included somatic symptoms, possibly inflating depression scores, and 
possibly accounting for their findings that depression at baseline leads to worse pain 
outcomes at follow-up. 
Another aspect that makes findings difficult to interpret is dichotomous 
classification of depression in several studies (Hurwitz et al., 2003; Kroenke et al., 
2012; Ryall et al. 2007). Information about symptom severity is thus lost, and similar 
participants whose scores fall close to the cut-offs and within the limits of the 
standard error of measurement, are classified in different groups. Where measures 
that include somatic symptoms have been used, such as by Kreonke et al. (2012), 
there is also a risk of the somatic symptoms of pain elevating patients’ scores over 
the cut-off points, erroneously classifying participants as depressed. 
While Hurwitz et al. (2003) used an appropriate measure of depression for 
patients with chronic pain, their use of 2/10 as the cut-off for clinically significant 
pain in patients compromises the validity of their results, as there is no adequate 
evidence for this (Krebs, Carey, & Weinberger, 2007). Hurwitz et al., (2003) claim 
that their study provides evidence that the relationship between chronic pain and 
depression works in both directions, with depression at baseline predicting increased 
pain and disability at follow-up, and increased pain and disability at baseline also 
predicting increased depression at follow-up, but their method of dichotomising pain 
obscures most changes in pain over that time. 
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Overall, five out of the six studies provided evidence that depression at 
baseline has a negative impact on chronic pain at follow-up, with higher levels of 
depression predicting higher levels of pain, but only two of these studies (Dunn et 
al., 2008; Muller et al., 2013) used a valid measure of depression in a pain 
population, and therefore were of high enough methodological quality to be counted 
as evidence. One study, which also used an appropriate measure of depression, did 
not find depression to predict arm pain at follow-up (Ryall et al., 2007). The findings 
suggest a very tentative conclusion that depression at baseline has a negative impact 
on chronic pain at follow-up. 
 
2. How does the presence of pain affect outcomes in patients with treated or 
untreated depression? 
Three studies were identified that included patients with depression at baseline. 
These are described in Table 4, below.    
 
Methodological quality of the studies 
Overall, quality ratings for the studies in this group ranged from 5 – 6 out of a 
possible 8 (Table 5). All studies included patients who were representative of the 
chronic pain population, controlled for gender and age in their analyses and had a 
sample size greater than 50 participants. Two studies had a follow-up time period 
greater than 6 months. All studies reported any differences between participants lost 
to follow-up and participants who stayed in the study. Again, studies presented 
problems concerning the measurement of depression and pain, and these will be 
discussed in the next two sections. 
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Measurement of pain  
 Chung, Tso, Yeung, and Li (2012) used a verbal rating scale and visual 
analogue scale to assess the severity of pain across different pain sites in each patient 
including muscle soreness, abdominal pain, heart or chest pain, lower back pain, 
joint pain and neck pain for the past week. An average score across different sites 
was then obtained. Gerrits et al. (2012) assessed pain by using the Chronic Pain 
Grade Scale (Von Korff et al., 1992), classing participants as grades 1- 4 (see above). 
They also obtained estimates of the duration of pain and number of pain locations. 
The third study (Kroenke, Shen, Oxman, Williams, & Dietrich, 2008) used the pain 
interference item from the Short Form Health Survey (Ware & Sherbourne, 1992) 
and entered both a categorical classification of pain (2 and above on the SF-36 pain 
interference classified as high interference), and the continuous score on the SF-36 in 
analyses. They did not obtain a measure of actual pain experienced.  
 
Measurement of depression 
Chung et al. (2012) included patients in their study if they had a diagnosis of 
major depressive disorder according to DSM-IV criteria. They then used the 
Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) to assess severity of 
depression. The authors acknowledged that the HRSD contains a large number of 
somatic symptoms and the depression and anxiety components of the HRSD were 
analysed separately. The HRSD also has poor content validity and poor retest and 
inter-rater reliability (Bagby, Ryder, Schuller, & Marshall, 2004). Chung et al. 
(2012) also used the HADS (Zigmond & Snaith, 1983) to evaluate symptoms from 
the patients’ perspective. Gerrits et al. (2012) screened participants using the 
Composite International Diagnostic Interview (CIDI; Wittchen, 1994) and the Life 
 37 
Chart Interview (Lyketsos, Nestadt, Cwi, & Heithoff, 1994). Participants were 
included if they had symptoms of a depressive and/or anxiety disorder in the 
previous month, using the CIDI at baseline and at follow-up. The CIDI is based on 
the DSM-IV symptoms of depression and also contains somatic symptoms in its 
measurement of depression. Kroenke et al. (2008) included participants in the study 
if they were diagnosed with depression using the PRIME-MD interview, which is 
also based on DSM-IV criteria for depression (Spitzer et al., 1995). They then used 
the 20-item Hopkins Symptom Checklist (HSCD; Derogatis, Lipman, Rickels, 
Uhlenhuth, & Covi, 1974) to assess severity of depression throughout the study. As 
mentioned above, the HSCD has a significant contribution from somatic symptoms 
characteristic of chronic pain. They used both categorical classifications of 
depression (HSCD < 0.5 classified as remission from depression at follow-up) and 
continuous scores for the HSCD in their analyses.
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Table 4. Studies with depression at baseline 
 
Author 
(year) 
Pain measures, 
classification of pain 
in analyses 
 
Depression measures, 
classification of 
depression in analyses 
Other variables 
 
Aims Main findings 
 
Chung et 
al. 
(2012) 
 
 
Verbal Rating Scale 
and Visual Analogue 
Scale for severity of 
pain in the past week 
 
Continuous 
 
Hamilton Rating Scale 
for Depression 
 
Hospital Anxiety and 
Depression Scale* 
 
Continuous 
 
Age 
Sex 
Short Form Health 
Survey (Quality of 
Life) 
Pain 
Catastrophising 
Scale 
 
To investigate whether pain 
and pain catastrophising were 
independent predictors of 
quality of life in major 
depressive disorder after 
accounting for anxiety and 
depression 
 
Pain severity, and not anxiety and 
depression were predictive of quality of life 
at 3 months, with a greater reduction in pain 
severity associated with greater 
improvement in quality of life. Pain 
catastrophising was also associated with 
quality of life after controlling for 
depression, severity of pain and anxiety. 
 
Gerrits et 
al. 
(2012) 
 
Chronic Pain Grade 
Scale (location, 
duration, use of pain 
medication and 
severity of pain) 
 
Continuous 
 
Composite 
International 
Diagnostic Interview 
Life Chart Interview 
 
Dichotomous 
 
Age 
Sex 
Education 
Fear questionnaire 
(anxiety) 
 
To examine the influence of 
pain on the course of 
depressive and/or anxiety 
disorders while controlling for 
other variables such as 
severity, duration and age of 
onset of depression 
 
More pain locations, joint pain, daily use of 
pain medication and a higher Chronic Pain 
Grade score at baseline led to worse 
outcomes of depressive and anxiety 
disorders at follow-up. These associations 
disappeared when controlling for baseline 
severity of the mental disorder. 
 
Kroenke et 
al. (2008) 
 
Short Form Health 
Survey – pain 
interference item 
 
Dichotomous and 
continuous 
 
PRIME-MD  
Hopkins Symptom 
Checklist 
 
Dichotomous and 
continuous 
 
Age 
Sex 
Chronic Disease 
Score 
 
 
To investigate whether pain 
affects treatment outcomes in 
depression 
 
The presence of pain had a significant 
negative impact on treatment outcomes in 
depression.  
* measure of depression is suitable for the pain population 
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Table 5. Assessment of the methodological quality of studies with depression at baseline: results 
 
 Selection    Control Outcome    
Author 
(year) 
1.  
Selection: 
representativeness 
of the cohort 
2. 
Selection 
of the 
control 
cohort 
3.  
Reliable and 
valid 
measurement 
of pain and 
depression at 
baseline 
4.  
Sample size 
(>50 
participants) 
5. 
Control 
for 
gender 
and age 
6. 
Reliable 
measurement 
of pain and/or 
depression at 
follow-up  
7.  
Time from 
baseline to 
follow-up > 
6 months 
8.  
Participants 
lost to 
follow-up < 
25% 
Total 
          
Chung et 
al. (2012) 
 
* n/a * * * * - * 6 
 
Gerrits et 
al. (2012) 
 
 
* 
 
n/a 
 
+ 
 
* 
 
* 
 
+ 
 
* 
 
* 
 
5 
Kroenke 
et al. 
(2008) 
* n/a + * * + * * 5 
* criterion met  - criterion not met + measurement of depression included somatic symptoms  n/a no control cohort, not applicable 
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Other variables 
Chung et al. (2012) included additional variables in their study: the Short 
Form Health Survey (McHorney et al., 1993) to measure quality of life (QOL) and 
the Pain Catastrophising Scale to measure pain-related catastrophising (Sullivan, 
Bishop, & Pivik, 1995). Both studies also assessed anxiety.  
    
Discussion of findings 
The findings of the studies are summarised in Table 4. The three studies 
included in the review that address this question had different outcome variables, 
with Chung et al. (2012) using QOL and Gerrits et al. (2012) and Kroenke et al. 
(2008) using depression as an outcome variable. Chung et al. (2012) found evidence 
suggesting that the severity of pain and pain catastrophising play more important 
roles than depression and anxiety in predicting QOL. However, the study used a 
small sample of patients, smaller than is usually required for regression analysis. The 
patients were moderately depressed and reported an average experience of pain that 
fell in the mild range; findings might have been different if more severely depressed 
patients with moderate to severe chronic pain were included in study. Their use of 
QOL as a variable is also problematic. They used the SF-36 to measure QOL, a 
questionnaire that contains multiple physical and psychosocial domains, some of 
which are relevant to pain and depression.  
 Gerrits et al. (2012) found that more severe pain at baseline was predictive of 
an increased risk for depression at two-year follow-up. However, this association 
was no longer present when controlling for baseline severity of depression and 
anxiety in all pain types except joint pain, which remained associated with worse 
outcomes independent of baseline severity. The study did not include treatment as a 
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variable since a previous study found no difference according to treatment (Penninx 
et al., 2011). Kroenke et al. (2008) found that in treated depression, the presence of 
pain at baseline has a significant negative impact on treatment outcomes at follow-
up. The study covaried the presence and severity of medical co-morbidity, 
demonstrating that the adverse effects of pain on outcomes in depression are not due 
to greater medical co-morbidity but to the severity of pain. However, Kroenke et al. 
(2008) measured pain in the study by pain interference with activities, as opposed to 
measuring actual pain experienced by patients. Using a measure of pain interference 
as a measure of pain in a population of depressed patients might have led to inflated 
scores as baseline levels of depression might have influenced patients’ ratings of the 
interference of pain. Both Kroenke et al. (2008) and Gerrits et al. (2012) used 
measures of depression that included somatic symptoms, and Gerrits et al. (2012) 
classified patients dichotomously as ‘depressed’ and ‘not depressed’ in their analyses 
according to the median score for depression. The use of these measures might have 
led to an inflated estimation of depression and also may have increased the 
likelihood that chronic pain would lead to worse outcomes in depression, since 
patients with chronic pain would have been more likely to report somatic symptoms 
of depression than patients without chronic pain. Analysing the data using a measure 
of depression that does not include somatic symptoms would have prevented this and 
given a clearer picture of the relationship between outcomes in depression and 
chronic pain.  
 Overall, the studies provide evidence that the pain patients with depression 
have worse outcomes for depression at follow-up, whether depression is treated or 
untreated. Pain and pain catastrophising might also independently predict lower QOL 
at follow-up. The use of measures of depression that include somatic symptoms in 
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two studies renders their findings impossible to interpret. Therefore, only tentative 
conclusions can be drawn regarding outcomes for depression when chronic pain is 
present.  
 
3. What variables mediate outcomes in chronic pain and depression at follow-
up? 
Six studies were identified that included other variables as well as chronic pain and 
depression in their analyses. These are described in Table 6, below.    
 
Methodological quality of the studies 
Overall, quality ratings for the studies in this group were low: 3 - 7 out of a 
possible 8 (Table 7). Nearly all studies included patients who were representative of 
the chronic pain population and controlled for gender in their analyses, apart from 
Van Liew et al. (2013), which included a large majority of female patients. All 
studies had a sample size greater than 50 participants, apart from Rudich et al. 
(2010). Only two studies had a follow-up time period greater than 6 months. All 
studies reported any differences between participants lost to follow-up and 
participants who stayed in the study. Again, problems with methodological quality 
arose in the chosen measures of pain and depression, and these will be discussed in 
the next two sections. 
 
Measurement of pain 
Inclusion criteria for studies varied, with two studies including patients who 
were receiving treatment at an interdisciplinary pain management unit (McCracken 
& Eccleston, 2005; McCracken, Vowles, & Gauntlett-Gilbert, 2007), two studies 
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including patients who were being treated at an outpatient pain clinic and who had 
pain for at least 3 months (Lerman, Shahar, & Rudich, 2012; Rudich et al., 2010) and 
other studies using as inclusion criteria a diagnosis of fibromyalgia and 
temporomandibular joint disorder (TMJD) respectively (Van Liew, Brown, Cronan, 
Bigatti, & Kothari, 2013; Velly et al., 2011). Participants’ reports of the length of 
time they had been experiencing pain also varied between studies. Patients with pain 
for at least 3 months were included in five studies (Lerman et al., 2012; McCracken 
et al., 2007; McCracken & Eccleston, 2005; Rudich et al., 2010; Velly et al., 2011). 
Van Liew et al. (2013) did not collect data on duration of pain. Again, measurement 
techniques used included established self-report instruments such as the Chronic Pain 
Grade Scale (Von Korff et al., 1992), the short-form McGill Pain Questionnaire 
(Melzack, 1987) and numerical rating scales.  
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Table 6. Studies including other variables 
 
Author 
(year) 
Pain measures, 
classification of 
pain in analyses 
 
Depression 
measures, 
classification of 
depression  
Other variables Aims Main findings 
 
Lerman et al. 
(2012) 
 
 
The Short-Form 
McGill Pain 
Questionnaire  
 
Continuous 
 
Centre for 
Epidemiological 
Studies for 
Depression Scale 
 
Continuous 
 
Age 
Sex 
Self-criticism 
 
 
To examine the role of self-
criticism in the relationship 
between chronic pain and 
depression 
 
There was a significant 3-way interaction 
between self-criticism, affective pain and 
gender – females with high affective pain 
and self-criticism at Time 1 were more 
likely to have higher levels of depression at 
Time 2. 
 
McCracken 
et al.  
(2007) 
 
 
 
 
 
 
 
 
0-10 ratings of 
present, usual, 
and highest pain 
in the past week 
 
Continuous 
 
Beck Depression 
Inventory 
 
Continuous 
 
Age 
Sex 
Chronic Pain Acceptance 
Questionnaire 
Brief Pain Coping 
Inventory 
Sickness Impact Profile 
Pain Anxiety Symptoms 
Scale 
 
To evaluate the role of 
control-oriented and 
acceptance-oriented coping 
responses in patient 
functioning 
 
Four factors within the coping data were 
identified: Pain Management, Pain Control, 
Help Seeking and Activity Persistence. 
Higher levels of Pain Management at Time 
1 were associated with less depression and 
pain at Time 2. Pain Control was associated 
with more pain and depression. Increased 
Pain Control between Time 1 and 2 was 
associated with increased depression at 
Time 2. 
   
McCracken 
et al. (2005) 
0-10 ratings of 
usual pain in the 
past week 
 
Continuous 
Beck Depression 
Inventory 
 
Continuous 
Age 
Sex 
Chronic Pain Acceptance 
Pain Anxiety Symptoms 
Scale 
Sickness Impact Profile 
To prospectively examine 
the relationship between 
acceptance of chronic pain 
and patient functioning 
Pain acceptance (composed of activity 
engagement and pain willingness) at Time 
1 significantly predicted depression at Time 
2 with increased levels of pain acceptance 
predicting lower levels of depression 
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Rudich et al.  
(2010) 
 
 
The Short-Form 
McGill Pain 
Questionnaire 
 
Continuous  
Center for 
Epidemiological 
Studies Depression 
Scale 
 
Continuous 
Age  
Sex 
Physician’s prognosis 
Self-criticism (using items 
from the Depressive 
Experiences Questionnaire) 
Pain duration 
 
To investigate whether 
physician’s prognosis 
ratings predict patient’s 
pain and depression levels 
at follow-up 
Physician's pessimistic ratings of patient 
prognosis at Time 1 uniquely predicted 
subsequent depressive symptoms and 
affective pain but not sensory pain at Time 
2 when controlling for Time 1 levels of 
these variables. Depression at Time 2 was 
not predicted by self-criticism, depression 
or pain ratings at Time 1.  
 
Van Liew et 
al. (2013) 
 
The Short-Form 
McGill Pain 
Questionnaire 
 
Continuous 
 
 
 
Center for 
Epidemiologic 
Studies for 
Depression Scale 
 
Continuous 
 
Age 
Sex  
Arthritis self-efficacy scale 
Physical functioning 
(measured using the 
Fibromyalgia Impact 
Questionnaire) 
 
 
To examine the 
longitudinal roles of self-
efficacy, depression, pain 
and functioning in the 
maintenance of pain in 
patients with fibromyalgia 
syndrome 
 
Self-efficacy significantly predicted 
depression, physical functioning and pain 
intensity ratings over time, with higher self-
efficacy predicting lower levels of 
depression, pain and higher functioning. 
Velly et al. 
(2011) 
Chronic Pain 
Grade Scale 
 
Continuous 
Beck Depression 
Inventory 
 
Continuous 
Age 
Sex 
Catastrophising (measured 
using items from the 
Coping Strategies 
Questionnaire) 
 
To investigate the role of 
depression and 
catastrophising in 
progression of pain and 
disability in patients with 
temporomandibular joint 
disorder 
There was a positive association between 
catastrophising at Time 1 and pain intensity 
and disability at Time 2. Depression at 
Time 1 was a predictor of disability, but not 
pain intensity, at Time 2. 
 
 
 
 
 
 
 
 
 
 46 
Table 7. Assessment of the methodological quality of studies including other variables: results. 
 
 Selection    Control Outcome    
Author 
(year) 
1.  
Selection: 
representativeness 
of the cohort 
2. 
Selection 
of the 
control 
cohort 
3. Reliable 
measurement 
of pain and 
depression at 
baseline 
4.  
Sample size 
( > 50 
participants) 
5. 
Control for 
gender and 
age 
6.Reliable 
measurement 
of pain and/or 
depression at 
follow-up  
7.  
Time from 
baseline to 
follow-up > 
6 months 
8. 
Participants 
lost to 
follow-up < 
25% 
Total 
          
Lerman et 
al. (2012) 
 
 
* 
 
n/a 
 
+ 
 
* 
 
* 
 
+ 
 
- 
 
 
* 
 
4 
McCracken 
et al. (2005) 
 
 
* 
 
n/a 
 
+ 
 
* 
 
* 
 
+ 
 
- 
 
* 
 
4 
McCracken 
et al. (2007) 
 
 
* 
 
n/a 
 
+ 
 
* 
 
* 
 
+ 
 
- 
 
* 
 
4 
Rudich et 
al. (2010) 
 
 
* 
 
n/a 
 
+ 
 
- 
 
* 
 
 
+ 
 
- 
 
* 
 
3 
Van Liew et 
al. (2013) 
 
 
- 
 
n/a 
 
+ 
 
* 
 
- 
 
* 
 
* 
 
* 
 
5 
Velly et al. 
(2011) 
 
 
* 
 
n/a 
 
+ 
 
* 
 
* 
 
* 
 
* 
 
* 
 
6 
      * criterion met - criterion not met  + measurement of depression included somatic symptoms n/a no control cohort, not applicable
  
 
Measurement of depression 
Three studies measured depression using the Centre for Epidemiological 
Studies Depression Scale (CES-D; Radloff, 1977), which contains items assessing 
somatic symptoms. A previous evaluation of the CES-D found the somatic items on 
the scale not to bias depression scores in patients (Foelker & Shewchuk, 1992), 
though another study recommends raising the cut-off for a diagnosis of depression in 
a chronic pain population from 16 to 19 (Turk & Okifuji, 1994). This cut-off was 
mentioned by Van Liew et al. (2013), but depression scores were entered as a 
continuous variable in analyses. Three studies used the Beck Depression Inventory 
(BDI; Beck et al., 1961). As mentioned earlier, the BDI includes somatic symptoms 
in its measurement of depression and previous studies have recommended a higher 
cut-off score for the chronic pain population (Poole, White, Blake, Murphy, & 
Bramwell, 2009).  
 
Measurement of other variables 
Two studies included acceptance of pain as a measure by using the Chronic 
Pain Acceptance Questionnaire (McCracken et al., 2007; McCracken & Eccleston, 
2005) and pain anxiety. The Chronic Pain Acceptance Questionnaire used in the 
study has two subscales – activity engagement, encompassing persistence of activity 
despite pain, and pain willingness, encompassing willingness to accept pain. 
McCracken and Eccleston (2005) also investigated control-oriented and acceptance-
oriented coping using the Brief Pain Coping Inventory. One other study included 
measures of coping and catastrophising by using the Coping Strategies Questionnaire 
(CSQ; Velly et al. 2011). One study included self-efficacy as a variable (Van Liew et 
al., 2013). Self-criticism was included as a variable in two other studies (Rudich et 
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al., 2010; Lerman et al., 2012) and Rudich et al. (2010) also included physician’s 
prognosis.   
  
Discussion of findings 
The studies included addressing this question used a wide range of variables 
statistical methods and outcomes, further complicating conclusions. The findings of 
the studies are summarised in Table 6. All studies used measures of depression that 
included somatic symptoms, and therefore may have overestimated depression scores 
in patients. However, unlike the studies in the previous questions, continuous scores 
rather than categories for depression were used in analyses.  
 One study investigated the role of catastrophising in patients with depression 
and chronic pain. Velly et al. (2011) found evidence that catastrophising at baseline 
predicted an increase in pain intensity and disability at 18 months follow-up when 
controlling for depression. They also found that depression was not a significant 
predictor of pain at follow-up when controlling for catastrophising, suggesting that 
the role of depression in the development of chronic pain is mediated by 
catastrophising.  
Two studies examined the role of acceptance in patients with chronic pain. 
McCracken et al. (2005) found that increased measures of pain acceptance at 
baseline predicted lower levels of depression at follow-up, suggesting that patients 
who show signs of willingness to accept pain and persist in activities despite pain are 
less likely to be depressed at follow-up, regardless of how much pain they were 
experiencing. McCracken et al. (2007) found that acceptance-oriented coping 
responses, including pain management responses such as changing activities, 
physical exercise, paced activity and self-encouragement at baseline were associated 
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with less depression and pain at follow-up. Coping responses that were more control-
oriented such as using painkillers, resting, or using ice or heat were associated with 
more pain and depression at follow-up. Both studies suggest that acceptance may 
play a role in decreasing chronic pain and depression at follow-up, but neither study 
could demonstrate causality due to the stability of acceptance measures and coping 
strategies at baseline and follow-up. The studies also had a short follow-up period of 
less than 4 months.  
 One study (Van Liew et al., 2013) found that high self-efficacy at baseline 
was associated with lower levels of depression, lower levels of pain and higher levels 
of physical functioning at follow-up, suggesting that patients who believed they were 
less able to manage their fibromyalgia symptoms were more likely to become 
depressed. The authors suggest that targeting self-efficacy could lead to decreases in 
depression and pain in patients with fibromyalgia. Certain features of the study limit 
the interpretation of these findings; for example the authors used a measure of 
depression that includes somatic symptoms. The observed decrease of depression 
scores in patients with higher self-efficacy at baseline could be due to a decrease in 
somatic symptoms, related to decreases in pain that were also reported. Additionally, 
they included only 21 males of 462 fibromyalgia patients in the study. While 
fibromyalgia occurs more commonly in females, this study has disproportionately 
few men (Wolfe, Ross, Anderson, Russell, & Hebert, 1995)  and findings can only 
be generalised to women with fibromyalgia.   
Lerman et al. (2011) investigated the effects of self-criticism on depression. 
The study distinguished between sensory and affective pain, with sensory pain 
referring to the intensity and location of pain, and affective pain referring to the 
unpleasantness, attributed meaning and long-term implications of pain (Lerman et 
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al., 2011). They found evidence that women with high affective pain scores and high 
self-criticism scores at baseline are more likely than females with low affective pain 
scores and low self-criticism to have higher levels of depression at follow-up. Rudich 
et al. (2010) also included self-criticism in their study but found no evidence for self-
criticism as a predictor of depression in chronic pain. It is likely that this study was 
underpowered.  
Rudich et al. (2010) was the only study to investigate a variable relating to 
factors external to the patient. They found that when physicians had a more 
pessimistic prognosis of chronic pain in a patient, the patient was more likely to have 
increased depression scores and affective pain at follow-up. They did not find a link 
between pessimistic prognosis and sensory aspects of pain at follow-up. The study 
did not find a link between physicians’ treatment decisions and outcomes in 
depression and pain, suggesting that the link between pessimistic prognosis and 
depression at follow-up is not mediated by the physician’s treatment of the patient. 
However, the study did not investigate the interactions between the physician and the 
patient that might have been affected by the physician’s pessimistic outlook, which 
could in turn have affected the patients’ wellbeing. Another possibility might be that 
the physician based their prognosis on a heuristic developed from their years of 
experience working with patients with chronic pain. The study did not investigate 
physicians’ reasoning behind their decisions, which might have provided evidence 
for this. 
The above studies, when taken together, show that a wide range of variables 
may mediate outcomes in chronic pain and depression, including catastrophising, 
acceptance, coping responses, self-efficacy, self-criticism and physician’s prognosis. 
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As with previous questions, the choice of measures of depression in patients with 
chronic pain could have significantly affected the results of these studies. 
 
Discussion 
Does depression affect outcomes in chronic pain? 
Six studies were identified in the literature search addressing this question. 
There are several differences between the studies included in the literature review 
that complicated comparisons of studies and conclusions. For example, studies 
differed according to time between follow-up, treatment received and assessment of 
depression and chronic pain. Though five of the studies found that in patients with 
chronic pain, those who are depressed at baseline are more likely to have higher 
ratings of pain at follow-up, two of the five studies used measures of depression that 
risk overdiagnosing depression in chronic pain, and one study had an unduly low 
threshold for ‘clinically significant’ chronic pain. In these cases, individuals without 
depression or clinically significant pain might have been erroneously included and 
affected the findings. Additionally, nearly all studies entered pain and depression as 
dichotomies in their studies, limiting information relating to the effects of the 
severity of pain and depression. Therefore, there were only two studies of 
appropriate methodology that found that the presence of depression in patients with 
chronic pain at baseline leads to worse outcomes of pain and disability at follow-up, 
preventing firm conclusions from being made.  
This is in contrast to the conclusions of several past reviews on the 
association between chronic pain and depression (e.g. Bair et al., 2003), which did 
not acknowledge problems with including somatic symptoms in the assessment of 
depression in their review, and were more definitive in their conclusions that the 
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presence of depression in patients with chronic pain leads to worse outcomes in 
chronic pain. 
 
Does pain affect outcomes in treated or untreated depression? 
  Three studies were identified in the literature search addressing this question. 
Two studies found that the presence of pain in depressed patients at baseline had a 
significant negative impact on treated or untreated depression (Kroenke et al., 2008; 
Gerrits et al., 2012). However, both studies used depression measures that included 
somatic symptoms, limiting the validity of their results. Chung et al. (2012) found 
that pain severity was a more important predictor of quality of life in depressed 
patients than depression or anxiety. Overall, the studies provided some evidence that 
the presence of pain in patients with depression at baseline leads to worse outcomes 
in quality of life and depression at follow-up, but there is a lack of high quality 
evidence, preventing firm conclusions from being made.   
 
What variables mediate outcomes in chronic pain and depression at follow-up? 
The six studies addressing this question reported that cognitive variables such 
as catastrophising, acceptance, self-efficacy and self-criticism, behavioural variables 
such as coping responses, and systemic variables such as physician’s prognosis, can 
all mediate outcomes in chronic pain and depression. Although all of these studies 
successfully avoided using dichotomous measures of pain and depression, they used 
measures of depression that included somatic symptoms, which means the results 
should still be interpreted with caution. Future studies should seek to replicate 
findings using a measure of depression validated in a pain population. Despite this 
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methodological issue, the results indicate that there are multiple possible mediators, 
and that several pathways lead to the development of depression in chronic pain. 
 
What are the psychological implications of the findings? 
The psychological implications of the findings of the studies in the review 
will be discussed in relation to current models, clinical implications, and issues to be 
addressed in future research.  
 
How do the findings fit with current models? 
None of the studies included in the current review explicitly set out to test 
current models of the development of chronic pain and depression, but they did 
include variables that are relevant to those models. With regards to the diathesis-
stress model, no studies investigated whether participants in their studies had genetic 
vulnerabilities or were exposed to adverse experiences in childhood, therefore this 
part of the model will not be discussed. Similarly, there were no studies identified for 
inclusion in the review that addressed biological mechanisms in the development of 
chronic pain and depression. 
One study included catastrophising, one of the variables included in the 
Linton and Bergbom (2011) model. One study found evidence that increased 
catastrophising at baseline leads to an increase in pain intensity and disability at 
follow-up when controlling for depression, providing some evidence for the model. 
However, the presence of studies that found relationships with other variables in pain 
and depression suggest that the Linton and Bergbom (2011) model is very limited in 
explaining the development of depression in pain patients. It is more likely that 
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depression in chronic pain is linked with a variety of factors, not just catastrophising, 
and that several pathways explain the development of depression in chronic pain.  
Findings that high levels of catastrophising and low levels of self-efficacy 
lead to worse outcomes for pain and depression provide support for the diathesis-
stress model. Low self-efficacy could be a pre-existing vulnerability that interacts 
with chronic pain to lead to depression, and catastrophic thoughts could contribute to 
low mood (Nezu, Nezu, & Perri, 1989). Lerman et al. (2011) suggest that their 
findings on high levels of self-criticism and of affective dimensions of pain in 
females can be used to expand the Banks and Kerns (1996) model. They suggest that 
self-criticism could be a pre-existing vulnerability, and that pain could act as a 
stressor to activate the affective dimensions of pain, leading to the development of 
depression in females with chronic pain. One mechanism they suggest for this is that 
individuals high in self-criticism might view their pain as a punishment, or that they 
are to blame for their pain. They noted that the females in the study had higher scores 
than males for depression in the study, and that males high in depression might also 
be found to have a similar pattern for self-criticism, affective pain and depression.  
Rudich et al. (2010) found that the prognosis of their physician can affect 
depression and affective pain outcomes at follow-up. The study could not identify 
the mechanism, but it is possible that the physician’s pessimistic outlook for the 
patient are conveyed to the patient, which could in turn affect the patients’ mood and 
view of their pain. Further research on how interactions with health professionals 
affect outcomes in pain patients might allow for the diathesis-stress model to be 
expanded to include the patient’s wider system. 
Two of the studies in the current review provided evidence for the role of 
acceptance in outcomes in chronic pain and depression (McCracken et al., 2005; 
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McCracken et al., 2007). Acceptance is one of the components of the psychological 
flexibility model that has been applied to both depression and chronic pain in recent 
years (McCracken & Morley, 2014). Similar to Beck’s (1976) model, psychological 
flexibility proposes that thoughts can have an influence on individual’s behaviour. 
However, the psychological flexibility model proposes that behaviour can be 
changed by bringing awareness to thoughts and emotions and bringing actions in line 
with the individual’s goals and values (McCracken & Morley, 2014). According to 
the model, suffering occurs when the individual responds in an inflexible way to 
stressors, by avoiding emotions or thoughts, and not acting in line with his/her goals. 
The model differs from Heilbronn and Blumer’s (1982) model as it does not suggest 
that an individuals’ negative emotional state leads to a physical manifestation of 
pain. It is possible that this model could also apply to people with chronic pain who 
develop depression.  
 
Implications for interventions 
Many of the studies addressing the first two questions suggested very similar 
implications for interventions, calling for both depression and chronic pain to be kept 
in mind during the assessment phase and, if deemed necessary, to intervene 
psychologically or pharmacologically in both to improve outcomes and QOL. One 
caveat that the studies do not mention is that clinicians should ensure that the 
diagnosis for clinical depression is not based on patients’ reports of somatic 
symptoms associated with chronic pain (Pincus & Williams, 1999). There is 
evidence that tricyclic antidepressants can reduce pain (Dharmshaktu, Tayal, & 
Kalra, 2012), but the dose to achieve an analgesic effect is lower than the dose 
required for the antidepressant effect. There is less evidence for the effects of 
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antidepressants specifically in patients with chronic pain and depression. One study 
found that patients with chronic pain and depression treated with closely monitored 
antidepressant therapy and attending a self-management pain programme had 
improved outcomes in depression and chronic pain at follow-up compared with 
patients who underwent usual care (Kroenke et al., 2009) of clinic visits, some of 
whom were prescribed antidepressants. 
There is a lack of studies investigating psychological interventions 
specifically for depression in patients with chronic pain. However, studies 
investigating outcomes for CBT for chronic pain commonly measure depression as 
an outcome, and a review of CBT for chronic pain found some evidence that CBT 
improves mood and catastrophising outcomes, and appears to have weak effects on 
improving pain (Williams, Eccleston, & Morley, 2012). CBT for patients with 
chronic pain aims to change unhelpful patterns of thinking and behaviour related to 
chronic pain (Williams, 2007). It contains components in common with CBT for 
depression, such as behavioural reactivation and targeting unhelpful cognitions, 
which could explain why CBT for chronic pain can improve depression. However, 
outcomes might be different for a population with both depression and chronic pain 
and this should be investigated. Studies that identified a significant role for other 
variables in outcomes in chronic pain and depression tended to suggest that these 
variables, such as catastrophising, self-efficacy and self-criticism could be targeted in 
treatments to improve outcomes. Catastrophising and self-efficacy are variables that 
commonly are associated with chronic pain, and CBT, coming from the flexible 
cognitive model, is routinely used to address these in patients with chronic pain 
(Ehde, Dillworth, & Turner, 2014). One current problem with CBT interventions for 
chronic pain is that they can vary widely in their content, and it is not known what 
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components are most effective for which patients. However, using an individualised 
psychological formulation that takes the many effects of pain on the patient’s 
emotional life, interference with activities and interpersonal relationships into 
account, could identify clear targets for treatment (Williams, 2007).  
Another target for intervention identified in the literature is control-oriented 
coping and avoidance of pain, which were linked with poorer outcomes in chronic 
pain and depression (McCracken et al., 2005). Acceptance-based strategies could be 
used to provide alternative ways of coping, and have already been integrated into 
treatment for both chronic pain and depression separately, showing small to medium 
effects on physical and mental health and have been identified as an alternative to 
CBT (Hunot et al., 2013; Veehof, Oskam, Schreurs, & Bohlmeijer, 2011). Again, 
studies have not been carried out exclusively on patients with chronic pain and 
depression, and this warrants further investigation. 
  
Implications for future research 
There are numerous methodological issues with the studies included in the 
current review. One of the most salient problems is that 10 out of the 15 studies 
selected for the review used measures of depression that risk overestimating 
depression scores in a population with chronic pain. Future studies investigating 
chronic pain and depression should ensure that their choice of measures of 
depression is suitable for patients with chronic pain and that there is no risk of 
inflation of scores.  
No studies assessed whether patients had experienced previous episodes of 
depression prior to the development of chronic pain. Distinguishing between patients 
who had previous episodes of depression, and patients who experienced a first 
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episode of depression upon the development of chronic pain could aid in the 
understanding of differences between the two sets of patients and identify processes 
in the development of depression in chronic pain, and targets for treating both 
groups. Additionally, depression and chronic pain can both fluctuate over time (Judd, 
1997; Patel, Greasley, & Watson, 2007), which could be missed when assessed only 
at fixed time points. Gerrits et al. (2012) used a life chart assessment, which 
decreased the risk of missing out on episodes of depression between baseline and 
follow-up; this or other measures that take into account such fluctuations over time 
could be used in future investigations. 
There was a lack of studies testing the theories of the development of chronic 
pain and depression, and future prospective studies could be designed to test these 
theories. In particular, the diathesis-stress model remains the most promising 
psychological model of the development of depression in patients with chronic pain 
(Banks & Kerns, 1996). Prospective studies aimed at identifying changes in 
cognition in patients who develop chronic pain and depression could also provide 
more insight into the development of depression in pain patients, and could allow for 
the development of new models, or the expansion of the diathesis-stress model.  
One problem with studies in the review, and with psychology research in 
general, is that the vast majority of studies are not pre-registered (Bishop, 2013). 
This means that it is impossible to know whether the hypotheses and corresponding 
data analyses of the studies in the current review were decided on before data 
analyses, or whether they were altered after data analyses and the significant result 
found. Most studies that used cut-off points for depression and chronic pain did not 
state whether the cut-off points were decided on before analyses were carried out. 
Additionally, research with negative findings might not have shown up in the 
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literature review due to publication bias. Pre-registering future studies would reduce 
both of these problems (Bishop, 2013).  
 
Limitations of the current review 
This review only used one reviewer to narrow down search results and assess 
the methodological quality of the studies. The lack of a second reviewer to verify 
search results and methodological quality means that relevant studies might have 
accidentally been excluded from the review, and errors made in the judgement of 
methodological quality.  
One inclusion criterion for the review was that studies included patients with 
sub-acute or chronic pain and/or depression at baseline. Some studies in the review 
included a small percentage of patients who had pain for less than 3 weeks, but 
studies were included as long as the majority of patients reported pain for at least 3 
months. Since studies controlled for duration of pain in their analyses, it is not 
possible to say whether inclusion created problems. 
The current review only included studies that included clinical populations 
who already had depression and/or chronic pain at baseline. Longitudinal 
epidemiological studies could enhance understanding of potential causal factors in 
the development of chronic pain and depression due to their inclusion of participants 
who do not have chronic pain and/or depression at baseline; these should be included 
in future literature reviews. Another issue with the review is that it included studies 
with patient populations that were receiving a range of treatments for chronic pain. 
Though most studies controlled for treatment received, their inclusion could have 
had an effect on outcomes in chronic pain and depression at follow-up.  
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 The Newcastle Ottawa Scale (NOS) was used to assess some of the 
methodological problems of the studies. However, quality assessment tools are not 
without problems (Sanderson, Tatt, & Higgins, 2007). For example, Stang (2010) 
criticises the NOS (Wells et al., 2000), for the lack of evidence for its reliability and 
validity (Stang, 2010) and for providing arbitrary criteria for whether items in the 
checklist meet criteria or not. One of the criteria included in the NOS was number of 
participants included in the study, which the current review set at 50 participants. 
Ideally, this would have been assessed using statistical power, however this was not 
provided by the studies and therefore not possible to do this. Additionally, 
assessment of the methodological quality did not include an assessment of the 
statistical analyses used in studies. This would have allowed confirmation that 
studies used the appropriate analyses and employed corrections for multiple 
comparisons. 
 
Conclusion 
Overall, the studies included in this review provide some evidence that the 
presence of depression in patients with chronic pain leads to increased pain at 
follow-up, and that the presence of chronic pain in patients with depression leads to 
worse outcomes in treated or untreated depression at follow-up. However, the 
conclusions from this review are not as strong as those of previous reviews due 
shortcomings in quality of the studies. The main issue with quality is that many 
studies included measures of depression that were not validated in a population with 
chronic pain. Future studies should seek to resolve this issue by using measures 
suitable for chronic pain populations, such as the HADS. Studies investigating other 
variables involved in the relationship between chronic pain and depression found that 
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catastrophising, self-efficacy, acceptance-related coping strategies and physician’s 
prognosis may influence outcomes in depression and chronic pain. However, the 
limited number of studies available and the wide range of variables included prevents 
firm conclusions from being drawn. Psychological interventions targeting both 
depression and chronic pain might improve patient outcomes, but research needs to 
investigate their efficacy in patients with both chronic pain and depression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  62 
References 
American Psychiatric Association. (2013). Diagnostic and statistical manual of 
mental disorders (5th ed.). Washington, DC: American Psychiatric Association. 
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004). The 
Hamilton Depression Rating Scale: has the gold standard become a lead 
weight? The American Journal of Psychiatry, 161, 2163–77. 
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003). Depression and pain 
comorbidity: a literature review. Archives of Internal Medicine, 163, 2433–45. 
Banks, S., & Kerns, R. (1996). Explaining high rates of depression in chronic pain: a 
diathesis-stress framework. Psychological Bulletin, 119, 95–110. 
Beck, A. T. (1967). Depression: Clinical, Experimental, and Theoretical Aspects. 
New York: Harper & Row. 
Beck, A. T. (1976). Cognitive therapy and emotional disorders. London: Penguin. 
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An 
inventory for measuring depression. Archives of General Psychiatry, 4, 561–71. 
Bishop, D. (2013). Why we need pre-registration. Retrieved October 13, 2014, from 
http://deevybee.blogspot.co.uk/2013/07/why-we-need-pre-registration.html 
Blackburn-Munro, G., & Blackburn-Munro, R. E. (2001). Chronic pain, chronic 
stress and depression: coincidence or consequence? Journal of 
Neuroendocrinology, 13, 1009–1023. 
Blumer, D., & Heilbronn, M. (1982). Chronic pain as a variant of depressive disease: 
the pain-prone disorder. The Journal of Nervous and Mental Disease, 170, 381–
406. 
  63 
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006). Survey 
of chronic pain in Europe: prevalence, impact on daily life, and treatment. 
European Journal of Pain, 10, 377–391. 
Bushnell, M. C., Ceko, M., & Low, L. A. (2013). Cognitive and emotional control of 
pain and its disruption in chronic pain. Nature Reviews. Neuroscience, 14, 502–
11. 
Campbell, L. C., Clauw, D. J., & Keefe, F. J. (2003). Persistent pain and depression: 
a biopsychosocial perspective. Biological Psychiatry, 54, 399–409. 
Chung, K.-F., Tso, K.-C., Yeung, W.-F., & Li, W.-H. (2012). Quality of life in major 
depressive disorder: The role of pain and pain catastrophizing cognition. 
Comprehensive Psychiatry, 53, 387–395. 
Delgado, P. L. (2004). Common pathways of depression and pain. The Journal of 
Clinical Psychiatry, 65, 16–9. 
Derogatis, L., Lipman, R., Rickels, K., Uhlenhuth, E., & Covi, L. (1974). The 
Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. 
Behavioral Science, 19, 1–15. 
Derogatis, L. R. (1986). SCL 90 R Administration, Scoring and Procedures Manual 
II for the Revised Version and Other Instruments of the Psychopathology Rating 
Scale Series. Clinical Psychometric Research. Retrieved from 
http://books.google.co.uk/books/about/SCL_90_R_Administration_Scoring_an
d_Proc.html?id=PRUBPAAACAAJ&pgis=1 
Dharmshaktu, P., Tayal, V., & Kalra, B. S. (2012). Efficacy of antidepressants as 
analgesics: a review. Journal of Clinical Pharmacology, 52, 6–17. 
  64 
Dionne, C. E., Von Korff, M., Koepsell, T. D., Deyo, R. A., Barlow, W. E., & 
Checkoway, H. (2001). Formal education and back pain: a review. Journal of 
Epidemiology & Community Health, 55, 455–468. 
Dogrul, A., Ossipov, M. H., & Porreca, F. (2009). Differential mediation of 
descending pain facilitation and inhibition by spinal 5HT-3 and 5HT-7 
receptors. Brain Research, 1280, 52–9. 
Duman, R. S., Heninger, G. R., & Nestler, E. J. (1997). A molecular and cellular 
theory of depression. Archives of General Psychiatry, 54, 597–606. 
Dunn, K. M., Croft, P. R., Main, C. J., & Von Korff, M. (2008). A prognostic 
approach to defining chronic pain: replication in a UK primary care low back 
pain population. Pain, 135, 48–54. 
Ehde, D. M., Dillworth, T. M., & Turner, J. A. (2014). Cognitive-behavioral therapy 
for individuals with chronic pain: efficacy, innovations, and directions for 
research. The American Psychologist, 69, 153–66. 
Fillingim, R. B., King, C. D., Ribeiro-Dasilva, M. C., Rahim-Williams, B., & Riley, 
J. L. (2009). Sex, gender, and pain: a review of recent clinical and experimental 
findings. The Journal of Pain, 10, 447–485. 
Fishbain, D. A., Cutler, R., Rosomoff, H. L., & Rosomoff, R. S. (1997). Chronic 
pain-associated depression: antecedent or consequence of chronic pain? A 
review. The Clinical Journal of Pain, 13, 116–37. 
Foelker, G. A., & Shewchuk, R. M. (1992). Somatic complaints and the CES-D. 
Journal of the American Geriatrics Society, 40, 259–62. 
Gatchel, R. J., Peng, Y. B., Peters, M. L., Fuchs, P. N., & Turk, D. C. (2007). The 
biopsychosocial approach to chronic pain: scientific advances and future 
directions. Psychological Bulletin, 133, 581–624. 
  65 
Gerrits, M. M. J. G., Vogelzangs, N., van Oppen, P., van Marwijk, H. W. J., van der 
Horst, H., & Penninx, B. W. J. H. (2012). Impact of pain on the course of 
depressive and anxiety disorders. Pain, 153, 429–436. 
Goldberg, D. S., & McGee, S. J. (2011). Pain as a global public health priority. BMC 
Public Health, 11, 770. 
Gureje, O., Von Korff, M., Simon, G. E., & Gater, R. (1998). Persistent pain and 
well-being: a World Health Organization Study in Primary Care. JAMA : The 
Journal of the American Medical Association, 280, 147–51. 
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, 
Neurosurgery, and Psychiatry, 23, 56–62. 
Hardt, J., Gerbershagen, H. U., & Franke, P. (2000). The symptom check-list, SCL-
90-R: its use and characteristics in chronic pain patients. European Journal of 
Pain (London, England), 4, 137–48. 
Holloway, K. L., & Zerbe, K. J. (2000). Simplified approach to somatization 
disorder. When less may prove to be more. Postgraduate Medicine, 108, 89–92, 
95. 
Hunot, V., Moore, T. H. M., Caldwell, D. M., Furukawa, T. A., Davies, P., Jones, H., 
… Churchill, R. (2013). “Third wave” cognitive and behavioural therapies 
versus other psychological therapies for depression. The Cochrane Database of 
Systematic Reviews, 10, CD008704. 
Hurwitz, E. L., Morgenstern, H., & Yu, F. (2003). Cross-sectional and longitudinal 
associations of low-back pain and related disability with psychological distress 
among patients enrolled in the UCLA Low-Back Pain Study. Journal of 
Clinical Epidemiology, 56, 463–471. 
  66 
Jensen, M. P., & Karoly, P. (1992). Self-report scales and procedures for assessing 
pain in adults. In D. C. Turk & R. Melzack (Eds.), Handbook of Pain 
Assessment (xv., pp. 135–151). New York, NY: Guildford Press. 
Judd, L. L. (1997). The clinical course of unipolar major depressive disorders. 
Archives of General Psychiatry, 54, 989–91. 
Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. 
(2004). Validity of the brief pain inventory for use in documenting the 
outcomes of patients with noncancer pain. The Clinical Journal of Pain, 20, 
309–18. 
Krebs, E. E., Carey, T. S., & Weinberger, M. (2007). Accuracy of the pain numeric 
rating scale as a screening test in primary care. Journal of General Internal 
Medicine, 22, 1453–8. 
Kroenke, K., Bair, M. J., Damush, T. M., Wu, J., Hoke, S., Sutherland, J., & Tu, W. 
(2009). Optimized antidepressant therapy and pain self-management in primary 
care patients with depression and musculoskeletal pain: a randomized controlled 
trial. JAMA : The Journal of the American Medical Association, 301, 2099–
2110. 
Kroenke, K., Shen, J., Oxman, T. E., Williams, J. W., & Dietrich, A. J. (2008). 
Impact of pain on the outcomes of depression treatment: results from the 
RESPECT trial. Pain, 134, 209–15. 
Kroenke, K., Wu, J., Bair, M. J., Damush, T. M., Krebs, E. E., & Tu, W. (2012). 
Impact of depression on 12-month outcomes in primary-care patients with 
chronic musculoskeletal pain. Journal of Musculoskeletal Pain, 20, 8–17. 
Kroenke, K., Wu, J., Bair, M. J., Krebs, E. E., Damush, T. M., & Tu, W. (2011). 
Reciprocal relationship between pain and depression: a 12-month longitudinal 
  67 
analysis in primary care. The Journal of Pain : Official Journal of the American 
Pain Society, 12, 964–973. 
Lerman, S. F., Shahar, G., & Rudich, Z. (2012). Self-criticism interacts with the 
affective component of pain to predict depressive symptoms in female patients. 
European Journal of Pain, 16, 115–122. 
Linton, S., & Bergbom, S. (2011). Understanding the link between depression and 
pain. Scandinavian Journal of Pain, 2, 47–54. 
Löwe, B., Unützer, J., Callahan, C. M., Perkins, A. J., & Kroenke, K. (2004). 
Monitoring depression treatment outcomes with the patient health 
questionnaire-9. Medical Care, 42, 1194–201. 
Luyten, P., Van Houdenhove, B., Lemma, A., Target, M., & Fonagy, P. (2013). 
Vulnerability for functional somatic disorders: A contemporary psychodynamic 
approach. Journal of Psychotherapy Integration, 23, 250 – 262. 
Lyketsos, C. G., Nestadt, G., Cwi, J., & Heithoff, K. (1994). The Life Chart 
Interview: A standardized method to describe the course of psychopathology. 
International Journal of Methods in Psychiatric Research, 4, 143 – 155. 
McCracken, L. M., & Eccleston, C. (2005). A prospective study of acceptance of 
pain and patient functioning with chronic pain. Pain, 164–169. 
McCracken, L. M., & Morley, S. (2014). The psychological flexibility model: a basis 
for integration and progress in psychological approaches to chronic pain 
management. The Journal of Pain : Official Journal of the American Pain 
Society, 15, 221–34. 
McCracken, L. M., Vowles, K. E., & Gauntlett-Gilbert, J. (2007). A prospective 
investigation of acceptance and control-oriented coping with chronic pain. 
Journal of Behavioral Medicine, 30, 339–349. 
  68 
McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-Item Short-
Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in 
measuring physical and mental health constructs. Medical Care, 31, 247–63. 
Melzack, R. (1987). The short-form McGill Pain Questionnaire. Pain, 30, 191–7. 
Merskey, H. (1979). Pain Terms: a list of definitions and notes on usage. Pain, 6, 
249–252. 
Miller, L. R., & Cano, A. (2009). Comorbid chronic pain and depression: Who is at 
risk? The Journal of Pain, 10, 619–627. 
Morley, S., Williams, A. C. de C., & Black, S. (2002). A confirmatory factor 
analysis of the Beck Depression Inventory in chronic pain. Pain, 99, 289–98. 
Muller, S., Thomas, E., Dunn, K. M., & Mallen, C. D. (2013). A prognostic approach 
to defining chronic pain across a range of musculoskeletal pain sites. The 
Clinical Journal of Pain, 29, 411–416. 
Nezu, A. M., Nezu, C. M., & Perri, M. G. (1989). Problem-solving therapy for 
depression: Theory, research, and clinical guidelines. Wiley series on 
personality processes. Oxford, England: John Wiley & Sons. 
Ohara, P. T., Vit, J.-P., & Jasmin, L. (2005). Cortical modulation of pain. Cellular 
and Molecular Life Sciences : CMLS, 62, 44–52. 
Patel, S., Greasley, K., & Watson, P. J. (2007). Barriers to rehabilitation and return to 
work for unemployed chronic pain patients: a qualitative study. European 
Journal of Pain (London, England), 11, 831–40. 
Penninx, B. W. J. H., Nolen, W. A., Lamers, F., Zitman, F. G., Smit, J. H., 
Spinhoven, P., … Beekman, A. T. F. (2011). Two-year course of depressive and 
anxiety disorders: results from the Netherlands Study of Depression and 
Anxiety (NESDA). Journal of Affective Disorders, 133, 76–85. 
  69 
Pincus, T., Pearce, S., McClelland, A., & Isenberg, D. (1995). Endorsement and 
memory bias of self-referential pain stimuli in depressed pain patients. The 
British Journal of Clinical Psychology / The British Psychological Society, 34 
(Pt 2), 267–77. 
Pincus, T., & Williams, A. (1999). Models and measurements of depression in 
chronic pain. Journal of Psychosomatic Research, 47, 211–219. 
Poole, H., White, S., Blake, C., Murphy, P., & Bramwell, R. (2009). Depression in 
chronic pain patients: prevalence and measurement. Pain Practice : The Official 
Journal of World Institute of Pain, 9, 173–80. 
Radloff, L. S. (1977). The CES-D Scale: A Self-Report Depression Scale for 
Research in the General Population. Applied Psychological Measurement, 1, 
385–401. 
Reeves, B., Deeks, J., Higgins, J., & Wells, G. (2011). Chapter 13: Including non-
randomised studies. In J. Higgins & S. Green (Eds.), Cochrane Handbook of 
Systematic Reviews of Interventions. Version 5.1.0. The Cochrane 
Collaboration. Retrieved from www.cochrane-handbook.org 
Rudich, Z., Lerman, S. F., Gurevich, B., & Shahar, G. (2010). Pain specialists’ 
evaluation of patient's prognosis during the first visit predicts subsequent 
depression and the affective dimension of pain. Pain Medicine, 11, 446–452. 
Rusu, A. C., Pincus, T., & Morley, S. (2012). Depressed pain patients differ from 
other depressed groups: Examination of cognitive content in a sentence 
completion task. Pain, 153, 1898–1904. 
Ryall, C., Coggon, D., Peveler, R., Poole, J., & Palmer, K. T. (2007). A prospective 
cohort study of arm pain in primary care and physiotherapy - prognostic 
determinants. Rheumatology (Oxford, England), 46, 508–515. 
  70 
Sanderson, S., Tatt, I. D., & Higgins, J. P. T. (2007). Tools for assessing quality and 
susceptibility to bias in observational studies in epidemiology: a systematic 
review and annotated bibliography. International Journal of Epidemiology, 36, 
666–76. 
Shiri, R., Karppinen, J., Leino-Arjas, P., Solovieva, S., & Viikari-Juntura, E. (2010). 
The association between smoking and low back pain: a meta-analysis. The 
American Journal of Medicine, 123, 87.e7–87.e35. 
Spitzer, R. L., Kroenke, K., Linzer, M., Hahn, S. R., Williams, J. B., deGruy, F. V, 
… Davies, M. (1995). Health-related quality of life in primary care patients 
with mental disorders. Results from the PRIME-MD 1000 Study. JAMA : The 
Journal of the American Medical Association, 274, 1511–7. 
Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the 
assessment of the quality of nonrandomized studies in meta-analyses. European 
Journal of Epidemiology, 25, 603–5. 
Sullivan, M. J. L., Bishop, S. R., & Pivik, J. (1995). The Pain Catastrophizing Scale: 
Development and Validation. Psychological Assessment, 7, 524–532. 
Tracey, I., & Mantyh, P. (2007). The cerebral signature for pain perception and its 
modulation. Neuron, 55, 377–391. 
Turk, D. C., & Okifuji, A. (1994). Detecting depression in chronic pain patients: 
adequacy of self-reports. Behaviour Research and Therapy, 32, 9–16. 
Turk, D. C., & Salovey, P. (1984). Chronic pain as a variant of depressive disease: a 
critical reappraisal. Journal of Nervous and Mental Disease, 398–404. 
Van der Windt, D. A. W. M., Dunn, K. M., Pincus, T., & McCracken, L. M. (2013). 
Psychological factors and treatment opportunities in low back pain. Best 
Practice & Research Clinical Rheumatology, 27, 625–635. 
  71 
Van Liew, C., Brown, K. C., Cronan, T. A., Bigatti, S. M., & Kothari, D. J. (2013). 
Predictors of pain and functioning over time in fibromyalgia syndrome: an 
autoregressive path analysis. Arthritis Care & Research, 65, 251–256. 
Veehof, M. M., Oskam, M.-J., Schreurs, K. M. G., & Bohlmeijer, E. T. (2011). 
Acceptance-based interventions for the treatment of chronic pain: a systematic 
review and meta-analysis. Pain, 152, 533–542. 
Velly, A. M., Look, J. O., Carlson, C., Lenton, P. A., Kang, W., Holcroft, C. A., & 
Fricton, J. R. (2011). The effect of catastrophizing and depression on chronic 
pain - a prospective cohort study of temporomandibular muscle and joint pain 
disorders. Pain, 152, 2377–2383. 
Verhaak, P. F. ., Kerssens, J. J., Dekker, J., Sorbi, M. J., & Bensing, J. M. (1998). 
Prevalence of chronic benign pain disorder among adults: a review of the 
literature. Pain, 77, 231–239. 
Von Korff, M., & Miglioretti, D. L. (2005). A prognostic approach to defining 
chronic pain. Pain, 117, 304–313. 
Von Korff, M., Ormel, J., Keefe, F. J., & Dworkin, S. F. (1992). Grading the severity 
of chronic pain. Pain. Netherlands: Elsevier Science. 
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey 
(SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–
83. 
Wells, G., Shea, B., O’Connell, D., & Peterson, J. (2000). The Newcastle-Ottawa 
Scale (NOS) for assessing the quality of nonrandomised studies in meta-
analyses. Retrieved from 
http://www.medicine.mcgill.ca/rtamblyn/Readings/The Newcastle - Scale for 
assessing the quality of nonrandomised studies in meta-analyses.pdf 
  72 
Williams, A. C. de C. (1998). Depression in chronic pain: mistaken models, missed 
opportunities. Behaviour Therapy, 27, 61–80. 
Williams, A. C. de C. (2007). Chronic pain: treatment. In S. Lindsay & G. Powell 
(Eds.), The handbook of clinical adult psychology (3rd ed., pp. 708 – 725). 
Hove: Routledge. 
Williams, A. C. de C., Eccleston, C., & Morley, S. (2012). Psychological therapies 
for the management of chronic pain (excluding headache) in adults. The 
Cochrane Database of Systematic Reviews, CD007407. 
Wittchen, H. U. (1994). Reliability and validity studies of the WHO--Composite 
International Diagnostic Interview (CIDI): a critical review. Journal of 
Psychiatric Research, 28, 57–84. 
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995). The prevalence 
and characteristics of fibromyalgia in the general population. Arthritis & 
Rheumatism, 38, 19–28. 
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. 
Acta Psychiatrica Scandinavica, 67, 361–70. 
 
 
 
 
 
 
 
 
 
 
 
  73 
 
 
 
 
Part 2: Empirical Paper 
 
Healthcare providers’ judgements in chronic pain: the influence of 
depression, trustworthiness and gender
  74 
Abstract 
Background: Clinicians are influenced by information immediately available about 
patients, such as gender or mental health history, and this affects their assessment 
and treatment decisions relating to the patient. Due to the subjective nature of pain, 
clinicians rely on patient reports of pain in their assessments. Therefore, perceived 
trustworthiness of the patient might also affect assessments and treatments. 
Aims: To investigate the influence of history of depression, perceived 
trustworthiness and gender of the patient; and the training level of the provider on 
judgements and treatment decisions in patients with chronic pain.  
Method: Pain clinicians and medical students (n = 63) viewed 12 videos of patients 
with chronic shoulder pain and corresponding vignettes, and made pain estimates, 
judgements and treatment decisions for each patient. Patient’s history of depression, 
perceived trustworthiness and gender were manipulated across each paired vignette 
and video. 
Results: The presence and timing of depression in chronic pain patients was not 
found have a consistent effect. Gender and trustworthiness affected pain judgements 
and management decisions, with low trustworthy females receiving the lowest 
estimates of overall pain, the highest estimates of exaggerating pain, and less likely 
to be prescribed opioids or other analgesics. Males, even those of low 
trustworthiness, received more favourable judgements. Medical students were 
particularly subject to this gender bias. 
Conclusions: These findings contribute to our understanding of what generates 
lower estimations of pain, adverse judgements about honest expression of pain, and 
the consequences of those on treatment decisions. Training programs for healthcare 
staff should include interventions in minimising implicit bias.  
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Introduction 
Pain 
The International Association for the Study of Pain describes pain in humans 
as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” (Merskey, 1979). At 
an individual level, pain processing is influenced by biological, psychological and 
social factors such as genetics, neurological structure or neurotransmitters, cognition, 
mood and the context in which the pain occurs and is therefore a highly variable and 
subjective experience (Tracey & Mantyh, 2007). Severity of pain is not correlated 
with the level of tissue damage and pain can persist after the damage resolves (Turk 
& Okifuji, 2009). Pain is normally described as either acute or chronic, with chronic 
pain defined as persisting for more than three months and not associated with on-
going injury or disease. 
Chronic pain is experienced by 7.8 million people in the UK (Donaldson, 
2008), and almost 20% of individuals in Europe have some form of chronic pain 
(Breivik, Collett, Ventafridda, Cohen, & Gallacher, 2006). It is one of the most 
common reasons why people seek medical care and is associated with more frequent 
use of health services (Elliott, Smith, Penny, Smith, & Chambers, 1999). Though the 
mechanisms behind the development of chronic pain are unclear, the development of 
chronic pain has been associated with a range of interacting biopsychosocial risk 
factors including female sex (Fillingim, King, Ribeiro-Dasilva, Rahim-Williams, & 
Riley, 2009), depression and anxiety (e.g. Gatchel, Peng, Peters, Fuchs, & Turk, 
2007; Kroenke et al., 2011; van der Windt, Dunn, Pincus, & McCracken, 2013), 
health behaviours such as smoking (Shiri, Karppinen, Leino-Arjas, Solovieva, & 
Viikari-Juntura, 2010), and social factors such as lower levels of formal education 
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(Dionne et al., 2001). Neuroimaging studies have identified various functional, 
structural and chemical changes in the brains of patients with chronic pain (Tracey & 
Bushnell, 2009). These changes lead to the amplification of pain, and suppress the 
inhibition of pain (Tracey & Bushnell, 2009). Chronic pain is treated using a wide 
range of interventions including prescription of opioids, non-steroidal anti-
inflammatory drugs, antidepressants and injection with anaesthetics, which aim to 
alleviate or eradicate pain (Turk, Wilson, & Cahana, 2011). Other interventions, such 
as pain management programmes and cognitive behavioural therapy, aim to help 
patients develop strategies to manage their pain. Evidence suggests that no one 
treatment is sufficient to eliminate pain and improve physical and emotional 
functioning in most patients (Turk et al., 2011) and both practitioners and patients 
often report dissatisfaction with treatment (Parsons et al., 2007). Treatment of 
chronic pain can therefore be a controversial area, particularly due to the prescription 
of opioid medication. Long term opioid use can produce hyperalgesia, where patients 
experience increased sensitivity to pain (Ballantyne & Mao, 2003), and other health 
problems. There are also concerns that opioid use might lead to dependence and 
offset the benefits of pain relief in some patients (Ballantyne & LaForge, 2007), 
though problematic opioid use is less prevalent in the UK than in the USA (Stannard, 
2013).   
 
Factors affecting pain judgements 
Because of pain’s subjective nature, and the fact that it can occur in the 
absence of tissue damage, healthcare professionals are faced with the challenge of 
making medical judgements and treatment choices using patient’s reports and 
behaviour, without the certainty of elicited signs commonly present in other 
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conditions (Tait, Chibnall, & Kalauokalani, 2009). healthcare professionals must use 
the patients’ reports and behaviour, and their medical knowledge, to estimate the 
amount of pain experienced by the patient, and this frequently results in 
underestimation of pain (Kappesser, Williams, & Prkachin, 2006). Additionally, 
healthcare professionals’ beliefs about individual patients or patients in general 
tending to simulate, exaggerate, minimise or hide their pain contribute to their 
assessment of the authenticity of pain and whether it warrants treatment (Kappesser 
et al., 2006). In the absence of clear symptoms and in the limited time with the 
patient, healthcare professionals may be influenced, consciously or unconsciously, 
by information immediately available about the patient in order to seek symptom 
certainty, which can then affect their assessment, estimation of pain and treatment 
decisions relating to the patient (Tait et al., 2009).  
Studies investigating factors that bias healthcare professionals’ judgements of 
pain have found that social characteristics of the patient can affect treatment 
decisions relating to pain. Factors that have been found to affect treatment include 
ethnicity, where African American and Hispanic patients consistently receive lower 
doses of pain medication than white patients across a variety of treatment settings 
(Green et al., 2003) and age, where pain in children (Alexander & Manno, 2003) and 
older adults (e.g. Fox, Raina, & Jadad, 1999) is consistently undertreated. The 
presence or absence of medical evidence has an especially important effect on 
healthcare professionals’ decisions and estimations of pain (e.g. Chibnall, Tait, & 
Ross, 1997), and this can interact with other features of the patient. For example, 
Birdwell, Herbers, and Kroenke (1993) found that doctors presented with videos of 
“histrionic” patients complaining of chest pain were less likely to attribute symptoms 
to cardiac factors than they did for “business-like” patients, unless objective medical 
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evidence supporting the patient’s symptoms was present. Another study found that 
when there is an absence of medical evidence for patients’ pain, they are more 
negatively evaluated by observers, which leads to observers providing lower ratings 
of pain and sympathy (De Ruddere, Goubert, Stevens, Williams, & Crombez, 2013).  
 
Gender 
Another factor that has been found to affect treatment decisions is gender, 
with clinical studies finding that females are more likely to have their pain 
underestimated than males (Anderson et al., 2000; Cleeland et al., 1994; Tait et al., 
2009). However, another study found that undergraduate students viewing videos of 
a participant undergoing a cold pressor task gave higher estimates of pain to females 
than males (Robinson & Wise, 2003). Biases have also been found regarding 
treatment decisions, with one study finding that women were less likely to receive 
analgesia for injuries (Michael, Sporer, & Youngblood, 2007). Another study found 
that women were less likely to receive a diagnosis of coronary heart disease when 
they presented with chest pain (Chang et al., 2007). Women are also more likely to 
have their pain attributed to emotional or psychological factors and are more likely to 
be prescribed antidepressants and non-opioid analgesics, while men are more likely 
to be prescribed opioids (Hoffmann & Tarzian, 2001). However, other studies found 
no differences in treatment between males and females by healthcare professionals 
(Safdar et al., 2009; Turk & Okifuji, 1997) and one study found that females were 
more likely than males to be prescribed opioids (Hirsh, George, & Robinson, 2009).  
 
Factors relating to healthcare professionals 
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Factors relating to healthcare professionals themselves can also influence 
pain judgement. For example, in a review of pain judgement accuracy, studies 
consistently found that increasing experience of healthcare professionals leads to an 
underestimation of pain in patients, compared to caregivers, who overestimate pain 
(Kappesser & Williams, 2010).  Another review found that nurses, physicians and 
physical and occupational therapists provide significantly lower estimates of pain 
compared to lay observers (Tait et al., 2009). 
Empathy has also been found to influence pain judgement, with higher levels 
of trait empathy in observers correlating with higher estimates of others’ pain 
(Green, Tripp, Sullivan, & Davidson, 2009; Saarela et al., 2007). Another study 
investigated the effects of empathy on physicians’ judgements by asking surgeons to 
attribute surgical outcomes in patients with back pain to physician attributes 
(reflecting skill) and patient attributes (reflecting psychological factors). Surgeons 
were more likely to link successful surgery outcomes with physician attributes, and 
less successful surgery outcomes with patient attributes. However, surgeons with 
more empathy were less likely to blame patient attributes for unsuccessful surgery 
outcomes than surgeons with less empathy (Tait, Chibnall, Luebbert, & Sutter, 
2005). 
 
Chronic pain and depression 
Depression is common in people with chronic pain, with estimates from 
epidemiological studies ranging from 20 – 50% (Bair, Robinson, Katon, & Kroenke, 
2003; Breivik et al., 2006; Miller & Cano, 2009). The presence of depression in 
patients with chronic pain can have a negative impact on treatment outcomes (Bair et 
al., 2003) and further decrease quality of life (Arnow et al., 2006). However, there is 
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a risk of overdiagnosis of depression when pain is present due to symptom overlap 
between the somatic symptoms of depression and the effects of chronic pain 
(Williams, 1998, 2007). Depression rating scales that include somatic symptoms, 
such as the Beck Depression Inventory (Beck, Ward, Mendelson, Mock, & Erbaugh, 
1961), are persistently used in pain populations despite only being validated in 
psychiatric populations from which those with physical illness and disability had 
been excluded (Morley, Williams, & Black, 2002).  
Several theories have been proposed to explain why chronic pain and 
depression frequently occur together, with some models suggesting that depression 
leads to chronic pain, and others suggesting that chronic pain leads to depression. 
One out-dated, though widespread theory suggested that pain without the presence of 
objective tissue damage was the result of an underlying emotional conflict that the 
patient was unable to confront (Holloway & Zerbe, 2000). The diathesis-stress model 
suggested that individuals who are exposed to particular stressors such as chronic 
pain may be more vulnerable to depression due to the loss of roles and restriction of 
pleasurable activities associated with chronic pain (Banks & Kerns, 1996). Other 
evidence suggests that pain and depression share common neurological pathways, 
meaning that patients with one may be vulnerable to the other (Delgado, 2004). 
Despite the common occurrence of depression in patients with chronic pain, few 
studies have examined the effects of a history of depression on treatment decisions 
and judgements in patients with chronic pain. healthcare professionals presented with 
a patient who developed chronic pain before depression might view the chronic pain 
as a cause of depression, while a patient who developed chronic pain after depression 
might be viewed as their depression causing pain. These differing views could have 
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an effect on healthcare professionals’ assessment and treatment of the patients’ 
chronic pain.   
Studies investigating the effects of psychiatric history on quality of healthcare 
received suggest that patients with psychological problems are at risk of not 
receiving preventative healthcare treatment (Druss, Rosenheck, Desai, & Perlin, 
2002; Viron & Stern, 2010). One review suggested that healthcare professionals 
might hold discriminatory beliefs against patients with psychological problems, 
viewing them as “difficult” (Viron & Stern, 2010). Another study found that 
clinicians were less likely to believe that patients had a serious illness when 
presenting with a severe headache or abdominal pain if they had a prior history of 
depression (Graber et al., 2000).  
Other evidence suggests that patients with chronic pain and depression are 
more likely to be prescribed opioids than patients without depression (Sullivan, 
Edlund, Steffick, & Unützer, 2005; Sullivan, Edlund, Zhang, Unützer, & Wells, 
2006). Hirsh et al. (2013) investigated the influence of depression, patient gender and 
race on healthcare professionals’ treatment decisions in chronic pain. They found 
that depression had the strongest influence on clinical decision-making: patients with 
depression were more likely to be prescribed opioids, antidepressants or referred to a 
mental health specialist.  
 
Trustworthiness 
People make rapid automatic judgements of others’ facial traits (Willis & 
Todorov, 2006) and these judgements have been found to influence their subsequent 
decisions. For example, Olivola and Todorov (2010) found that in a hypothetical 
political election, participants were more likely to vote for faces high in traits of 
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‘competence’. Other studies have investigated facial features associated with implicit 
judgements in trustworthiness. These studies have found high inter-rater reliability 
for trustworthiness, and there is a consistent positive correlation between the 
activation of the amygdala and increasing untrustworthiness of faces (Todorov, 
Baron, & Oosterhof, 2008). Todorov et al. (2008) suggest that face evaluation of 
neutral faces is closely linked to the detection of emotional states in others, and that 
judgements of trustworthiness reflect the detection of subtle facial features that 
resemble positive or negative emotional states in others. Features associated with 
trustworthiness include high inner eyebrows, pronounced cheekbones and wide 
chins, while features associated with untrustworthiness included low inner eyebrows, 
shallow cheekbones and thin chins (Todorov et al., 2008). Another study found that 
facial features associated with the appearance of untrustworthiness can affect 
people’s decisions in trust games and lead people to invest less money in the partner 
with the ‘untrustworthy’ facial features than the partner with the ‘trustworthy’ facial 
features (Rezlescu, Duchaine, Olivola, & Chater, 2012). This effect is reduced, but 
remains significant, even after ‘good’ reputational information is made available 
about the trustworthy or untrustworthy person. It appears that facial features 
associated with trustworthiness potentially have a strong effect on decision-making. 
Trustworthiness might be an important factor in the context of assessments and 
decision-making in chronic pain. As mentioned earlier, pain is a subjective 
experience that can be experienced without objective tissue damage (Turk & Okifuji, 
2009). Assessments involve the patient reporting their pain to their health care 
professional, requiring the health care professional to trust that the patient is being 
truthful about their experience of pain. This is particularly an issue in relation to the 
prescription of opioids, where providers are often suspicious about whether patients 
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might present a dishonest representation of their pain in order to receive opioids 
(Sullivan & Ferrell, 2005). To our knowledge, there are no studies that have 
investigated the influence of perceived trustworthiness of the patient in pain 
judgements and decision-making. 
 
The vignette model for studying healthcare professional decision making in 
chronic pain 
Many of the studies investigating the effects of patient characteristics on pain 
judgements in healthcare professionals employed vignettes to provide information 
about the patient. More recently studies have paired images of patients displaying 
expressions of pain with vignettes (e.g. Hirsh et al., 2013). Other studies have used 
actors to depict facial pain, though differences in facial expression have been found 
between actors and expressions of people experiencing genuine pain (Craig & 
Patrick, 1985). Ecological validity of these studies has been further increased by the 
use of dynamic videos depicting real patients experiencing pain (e.g. De Ruddere, 
Goubert, Vervoort, Prkachin, & Crombez, 2012), which have been shown to evoke 
distinct activation in the facial perception network in the brain (Foley, Rippon, Thai, 
Longe, & Senior, 2012). 
 
Aims of the current study 
As mentioned above, several studies have found that healthcare professionals 
make judgements of pain based on aspects of the patient. Past studies have not 
investigated the effects of a patient’s perceived trustworthiness on healthcare 
professionals’ pain judgements and treatment decisions. Only a limited number of 
studies, mentioned above, have explored the effects of a history of depression on 
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healthcare professionals’ judgements and treatment decisions in chronic pain (e.g. 
Hirsh et al., 2013), and of those, no studies have investigated whether judgements 
differ between patients who had a diagnosis of depression before or after chronic 
pain.  
The current study therefore chose to investigate the effects of the following 
variables: history of depression, patient trustworthiness and gender on clinicians’ 
judgements in pain using videos of real patients with chronic shoulder pain and 
supporting vignettes. In order to compare the effect of years of experience on 
estimates of pain and treatment decisions, participants of varying levels of training 
were included in the study. Therefore, doctors specialising in chronic pain and 
medical students in their 4th, 5th and 6th years were recruited for the study. The effects 
of empathy on pain judgements were also explored by obtaining measures of 
participants’ empathy. Participants were asked to estimate the amount of pain they 
thought each patient was experiencing, and their estimates that the patient was 
exaggerating, minimising or hiding their pain. They were also asked to rate the 
likelihood of recommending the prescription of opioids, analgesics, antidepressants 
or referral to a pain management programme or a mental health specialist, all 
orthodox methods for managing chronic pain in primary and secondary care settings 
(Turk et al., 2011). The following questions were addressed: 
 
1. Are pain clinicians’ and medical students’ estimations of pain, estimations of 
the probability that patients are exaggerating, minimising or hiding their pain, 
and their treatment decisions influenced by a patient's depression, and by the 
timing of its onset in relation to chronic pain? 
Hypotheses 
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Impact of depression on pain judgements:  
1a) Participants will give lower pain estimates for patients with a history of 
depression than for control patients. Further,  
1b) Participants will view depression developed after chronic pain as a 
consequence of the pain and therefore estimates of pain will not be affected. In 
contrast, for patients whose depression preceded chronic pain, they may view pain as 
a ‘symptom’ of depression, leading to higher estimations of exaggerating pain, and 
lower estimations of pain, and of minimising and hiding pain compared to scores for 
controls and patients whose depression developed after chronic pain.  
Impact of depression on pain management decisions:  
1c) Participants will be less likely to recommend prescribing opioids and 
other analgesics, and less likely to recommend referral to a pain management 
programme, for patients who developed depression prior to chronic pain than for 
patients without a history of depression and for patients who developed depression 
after chronic pain.  
1d) Participants will be more likely to recommend prescribing 
antidepressants to patients who developed depression prior to chronic pain and more 
likely to recommend referral to a mental health specialist than they would for 
patients in the other two groups: depression onset after chronic pain, and no 
depression.  
 
2. Are pain clinicians’ and medical students’ estimations of pain, estimations of 
the probability that patients are exaggerating, minimising or hiding their pain, 
and their treatment decisions influenced by how trustworthy the patient looks?  
Hypotheses 
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Impact of trustworthiness on pain judgements:  
2a) Participants will estimate lower pain and rate higher the probability that 
patients were exaggerating their pain in low trustworthy (LT) patients compared to 
high trustworthy (HT) patients. 
Impact of trustworthiness on pain management decisions:  
2b) Participants will be less likely to recommend prescribing opioids, 
analgesics or antidepressants for LT patients than for HT patients. There were no 
specific hypotheses regarding likelihood of recommending referral to a pain 
management programme and to a mental health specialist. 
 
3. Are pain clinicians’ and medical students’ estimations of pain, estimations of 
the probability that patients are exaggerating, minimising or hiding their pain, 
and their treatment decisions influenced by the gender of the patient?  
Hypotheses 
Impact of gender on pain judgements: 
3a) Participants will estimate lower pain and rate higher probability of 
exaggeration of pain in female patients compared to males.  
3b) Participants will rate a higher probability that patients are minimising or 
hiding their pain for male patients than female patients.  
Impact of gender on pain management decisions:  
3c) Participants will be less likely to prescribe opioids and analgesics, and 
more likely to prescribe antidepressants, for female patients than males.  There were 
no specific hypotheses regarding likelihood of referring to a pain management 
programme and mental health specialist.  
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4. Do the above variables (depression history, patient trustworthiness and 
gender) interact to affect participants’ ratings of pain and treatment decisions?  
Hypotheses 
Impact of interactions between depression history, patient trustworthiness 
and gender on pain judgements: 
4a) Perceived trustworthiness would moderate the effects of depression on 
participants’ pain ratings. Therefore, LT patients with a history of depression 
predating their pain would be given lower pain estimations and lower estimates of 
minimising or hiding their pain than HT patients with a history of depression 
predating their pain. LT patients with a history of depression predating their pain 
would also receive higher probabilities of exaggerating their pain compared to HT 
patients with a history of depression predating their pain. It was also hypothesised 
that the main effect for gender would remain across this interaction, with males given 
higher pain estimations and estimates of minimising or hiding their pain, and lower 
estimates of exaggerating their pain than females.  
 
Impact of interactions between depression history, patient trustworthiness 
and gender on pain management decisions:  
4b) Perceived trustworthiness will moderate the effects of depression on 
participants’ treatment decisions. Therefore, LT patients that have a history of 
depression predating their pain will be less likely to be recommended a prescription 
of opioids and analgesics than HT patients with a history of depression predating 
their pain. It was also hypothesised that the main effect for gender would remain 
across the interaction, with males more likely to be prescribed opioids and analgesics 
than females. 
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4c) There were no other hypotheses for interactions between depression 
history, patient trustworthiness and gender, but it was decided that significant 
interactions would be explored with post hoc tests and results interpreted with 
caution. 
 
5. Do pain clinicians’ estimations of pain, estimations of the probability that 
patients are exaggerating, minimising or hiding their pain, and their treatment 
decisions differ from those of medical students’?  
Hypotheses 
Impact of training level on pain judgements:  
5a) Pain clinicians will provide lower estimates of pain than medical 
students. There were no specific hypotheses regarding the impact of training level on 
judgements of exaggerating, minimising or hiding pain. 
Impact of training level on pain management decisions:  
5b) There were no specific hypotheses regarding the effects of training on 
likelihood of prescribing opioids, analgesics or antidepressants, or referring to a pain 
management programme to a mental health specialist. 
 
6. Are pain clinicians’ and medical students’ estimations of the probability that 
patients are exaggerating, minimising or hiding their pain, and their treatment 
decisions affected differently by history of depression, trustworthiness and 
gender of the patient?  
Hypotheses 
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There were no particular hypotheses for this research question, but it was 
decided that significant interactions would be explored with post hoc tests and results 
interpreted with caution. 
 
7. Do empathy scores of pain clinicians and medical students correspond with 
estimations of pain, estimations of the probability that patients are 
exaggerating, minimising or hiding their pain, and their treatment decisions? 
Hypotheses 
Impact of empathy on pain judgements:  
6a) Empathy will positively correlate with pain estimates and estimates of the 
probability that the patient was minimising or hiding his or her pain, and negatively 
correlate with estimates that the patient was exaggerating pain.  
Impact of empathy on pain management decisions:  
6b) There were no specific hypotheses regarding the impact of empathy on 
pain management decisions.  
 
Method 
Ethics 
Ethical approval was obtained from University College London Ethics 
Committee (Project ID Number 4714/001; Appendix 3). Informed consent was 
obtained from all participants.  
 
Participants and setting 
Participants eligible to take part in the study were doctors working in the UK, 
specialising in pain and members of the International Association for the Study of 
Pain, or a UCL medical student in their 4th, 5th or 6th year of study. Medical students 
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from their fourth year were selected due to their experience of clinical contact with 
patients.  Participants were included in the study if they had good spoken English 
and good or corrected vision. The study was set up on the survey platform Qualtrics, 
and participants accessed the study online.  
Clinicians were invited to participate in the study via email (Appendix 4) 
using the IASP members’ directory. Medical students were invited to participate in 
the study via an advertisement in the weekly medical society newsletter and by a 
verbal advertisement of the study before three lectures. Both the emails and the 
advertisements contained brief information about the study and the link to the study 
website. 
 
Design 
Participants were exposed to twelve different vignettes and corresponding 
videos. There were four vignettes for each condition: no history of depression, 
depression before chronic pain (CP) and depression after CP. There were six videos 
depicting male patients, three rated as high in trustworthiness and three rated as low 
in trustworthiness. Similarly, there were six videos depicting female patients, three 
rated as high in trustworthiness and three rated as low in trustworthiness. All 
analyses included training level (clinician, medical student) as an independent 
variable. 
A 3 (history of depression: no history of depression, depression before CP, 
depression after CP) x 2 (trustworthiness: high, low) x 2 (gender: male, female) x 2 
(training level: clinician, medical student) mixed design was used, with history of 
depression, trustworthiness and gender as within-subjects factors and training level 
as a between-subjects factor. The dependent variables were participants’ estimations 
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of pain, estimations of the probability that patients were exaggerating, minimising or 
hiding their pain, and treatment choices.  
 
Power analysis 
Power analysis for this study was informed by prior work by De Ruddere, 
Goubert, Vervoort, Prkachin, and Crombez, (2012). In this study the authors 
recruited participants from the community to estimate pain using video clips similar 
to those used in the current study and found an effect size f of 0.25 (medium). Power 
calculation on participants’ estimates of pain was carried out using the “G*Power 
3.1.5” computer program (Erdfelder, Faul, & Buchner, 1996), specifying alpha = 5% 
and desired power = 80% and estimating correlation among repeated measures to be 
0.5. The required sample size was estimated at 30 per participant group.  
 
Materials 
Videos 
Twelve videos (six male) were selected from the UNBC-McMaster Shoulder 
Pain Expression Archive Database (Lucey et al., 2011) based on ratings of high and 
low trustworthiness. Trustworthiness ratings were obtained using a method similar to 
Oosterhof and Todorov (2008). For a description of the method for obtaining 
trustworthiness ratings, see Appendix 7. The mean age of patients in the video was 
51 years and the range was 34 – 67 years (Appendix 8). Videos were already rated 
for facial pain expression intensity, using the FACS system (Ekman & Friesen, 1986) 
adapted for pain (Prkachin & Solomon, 2008). The scores can range from 0-16 and 
for the present study, patients expressing pain rated in the moderate range (5 – 9) 
were selected and FACS ratings were balanced across conditions. Videos were edited 
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so that only either neutral expressions (before the physiotherapy manoeuvre) or 
expressions of pain (during or immediately after the manoeuvre) were depicted in the 
video. Videos ranged from five to ten seconds in length. 
 
Vignettes 
Twelve corresponding vignettes were developed, taking the form of a brief 
letter from a GP asking for an opinion regarding the treatment of the patient 
(Appendix 11). Vignettes described how long the patients had suffered from pain (1 
year), how the pain was affecting their life (e.g. “She finds it difficult to drive due to 
pain”), whether they had 1) asthma, 2) depression before they developed pain, or 3) 
depression after they developed pain. For the patients with depression, the letters 
stated that they were not currently on medication or receiving psychological therapy 
for depression.  
 
Measures 
Pain estimation 
Participants’ estimates of pain were measured using a numerical scale with a 
slider bar, ranging from values 0 to 10 (Appendix 9). Participants were only able to 
select one of the 11 values. The scales were anchored at either end with the words 
“No pain” and “Extreme pain”. Participants were asked: “Please rate the amount of 
pain you think the patient in the video experienced.”  
 
Estimates of pain exaggeration, minimising or hiding 
To estimate participants’ suspicions that the person in the video was 
exaggerating, minimising or hiding his or her pain, the participant was asked: “On a 
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scale of 0 to 10, how likely do you think it is that the person in the video is 
exaggerating their pain?” The scales were anchored at either end with the words 
“Very unlikely” and “Very likely”. The question was repeated to elicit probabilities 
of ‘minimising (i.e. downplaying)’ and ‘hiding (i.e. concealing)’ their pain. 
 
Treatment options  
To investigate the treatment outcome chosen by participants, they were 
asked: “On a scale of 0 to 10, please rate the likelihood that you would 
consider/recommend management strategies listed below in the care of this patient.” 
The scales were anchored at either end with the words “Very unlikely” and “Very 
likely”. The management strategies listed were “Prescription of opioid medication”, 
“Prescription of analgesic medication”, “Prescription of antidepressant medication as 
analgesic”, “Referral to a pain management programme” and “Referral to a mental 
health specialist”. 
 
Trustworthiness ratings 
To investigate whether participants were in agreement with earlier 
trustworthiness ratings provided by trainee clinical psychologists, a rating of the 
trustworthiness of patients was also obtained. Participants were shown a picture of 
each patient with a neutral expression and asked to rate the trustworthiness of each 
patient. They were asked to rely on their ‘gut feeling’ and not to take past 
information from the vignettes and videos into account. Participants’ estimations of 
trustworthiness were measured on a scale of 1 to 9. The scales were anchored at each 
end with the words “Not trustworthy at all” and “Extremely trustworthy”. 
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Empathy 
Trait empathy of participants was measured using the Interpersonal 
Reactivity Index (IRI; Davis, 1980; 1983; Appendix 12). The IRI is a 28-item self-
report questionnaire with statements relating to different aspects of empathy. For 
each statement, the possible responses range from “does not describe me well” (0) to 
“describes me very well” (4). The IRI has four factors: perspective taking, identifying 
with the person observed (called fantasy in the original scale but referred to here as 
identification since this is a more accurate description of its content), empathic 
concern (ability to feel compassion for the other) and personal distress (experience 
of distress at the distress of another). Cronbach’s alpha coefficients for internal 
reliability of the IRI for this sample was 0.79.  
 
Guess at study purpose 
On the final page of the study, participants were asked to guess the study’s 
purpose. This was asked in order to investigate whether awareness of the study’s 
purpose affected participant responses. Responses were provided in an open field 
text box.  
 
Procedure 
Upon entering the study website, participants were presented with an 
information sheet about the study and were asked to give their consent to take part in 
the study (Appendix 5). Participants were then asked to report their level of training, 
their gender, and number of years practicing as a pain clinician or year of study. 
Subsequently, participants were shown a screen with instructions for the study and 
asked to maximise their screens and switch their phones to silent in order to 
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minimise distractions while participating in the study. Participants viewed the 
vignette before watching the corresponding video. They were asked to tick a box to 
confirm that they had both read the vignette and watched the video. They were then 
asked to estimate pain, the probability that the patient was exaggerating, minimising 
or hiding their pain and the likelihood of recommending each of the treatment 
options provided. Participants were able to re-view the pain video and re-read the 
vignette until they had submitted their responses corresponding to the particular 
video and vignette pair. Once they clicked on the ‘next’ button, they were not able to 
return to the previous page and change their answers. This procedure was repeated 
for each of the 12 vignettes and videos.  
Vignettes and their corresponding videos were shown in a random order to 
counterbalance any order effects. Participants were then asked to fill out the IRI, 
provide ratings of trustworthiness of patients and guess the study aim. The study took 
approximately 20 minutes to complete. As an incentive to complete the study, £2 
was donated to Médecins Sans Frontières/Doctors Without Borders for each 
complete study response (Appendix 6). 
 
Analysis 
Data were transferred to an SPSS 21 database. Prior to analysis, the data were 
checked for outliers using histograms, resulting in the adjustment of nine data points 
to less extreme values (Field, 2013a). All variables were checked for normality using 
measures of skewness and kurtosis and Q-Q plots of the residuals. The variables 
‘likelihood of prescribing opioids’ and ‘likelihood of referring to a mental health 
specialist’ were found to have extreme positive skews (z > 2.58). Due to a high 
number of zeros in the data, transformation did not lead to a normal distribution. 
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There is no non-parametric test available for mixed ANOVAs on SPSS 21. However, 
ANOVA has been found to be robust to deviations from normality (Field, 2013b) 
and it was decided that a mixed ANOVA could still be used to analyse the data. 
Levene’s test was used to test for homogeneity of variance and was not found to be 
violated (p > .01).  
  Pain estimations and treatment choices were tested using 3 x 2 x 2 x 2 mixed 
ANOVAs, with history of depression (no history of depression, depression before 
CP, depression after CP), trustworthiness (high vs. low), and gender of patient (male 
vs. female) as within-subjects factors and with training level (clinician vs. student) as 
a between-subjects factor. Sphericity was assessed using Mauchly’s Test of 
Sphericity. Greenhouse-Geisser corrected F-values were reported where the 
assumption of sphericity was found to be violated (p < .05). Due to the increased 
chance of significant findings in a 4-way ANOVA, interactions that were not 
previously hypothesised were given a stricter level of significance, at p < .01 
(Bishop, 2014). Therefore, interactions not previously hypothesised that did not meet 
this significance level are not reported in the main text and can be found in Appendix 
13. Interactions and main effects were further analysed with Bonferroni corrected 
post-hoc tests using the SPSS syntax Adj (Bonf) command. Effect sizes were 
calculated using partial eta squared (η𝑝
2); which is defined as the proportion of the 
variability accounted for by a variable that is not explained by other variables in the 
model (Field, 2013).  
 
Results 
Demographics 
Thirty-four doctors specialising in pain who were members of the 
International Association for the Study of Pain, and 29 medical students in their 4th, 
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5th and 6th years, took part in the study. Tables 1 and 2 present details of the two 
participant groups. The majority of pain clinicians were male (29/35: 85%) and had 
been practicing for over 20 years (65%). The majority of medical students were 
female (61%) and in their fourth year (19/29: 61%). The difference in numbers of 
males and females between groups was significant (χ2 (1, 63) = 15.15, p<0.001).  
 
Table 1. Demographic information: pain clinicians. 
 n (N=34) % 
Gender   
Female 5 15 
Male 29 85 
   
Years practicing as a 
clinician 
  
0-5 years 0 0 
6-10 years 1 3 
11-15 years 6 18 
16-20 years 5 14 
20+ years 22 65 
   
Years practicing as a pain 
clinician 
  
0-5 years 5 15 
6-10 years 7 20 
11-15 years 5 15 
16-20 years 5 15 
20+ years 12 35 
Table 2. Demographic information: medical students. 
 n (N=29) % 
Gender   
Female 18 62 
Male 11 38 
   
Year of study   
4th 18 62 
5th  8 28 
6th  3 10 
 
Trustworthiness ratings 
Clinicians’ and medical students’ mean ratings of trustworthiness were less 
extreme than ratings made by the trainee clinical psychologists (High 
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trustworthiness, male stimuli: M = 5.93, SD = 1.02, Range = 4-9; High 
trustworthiness, female stimuli: M = 5.01, SD: 1.07, Range = 3-8; Low 
trustworthiness, male stimuli: M = 4.75, SD = 0.96, Range = 2-8; Low 
trustworthiness, female stimuli: M = 4.43, SD = 1.19, Range = 1-8). This may have 
been due to 11 participants giving all patient stimuli a rating of ‘5’. Despite this, 
there was a significant difference in trustworthiness ratings between patients rated 
high vs. low in trustworthiness, F(1, 62) = 81.72, p < .001.  
 
Awareness of the study purpose 
Only three participants guessed or inferred that the aim of the study 
concerned mental health issues in patients with chronic pain. Two other participants 
mentioned perceived trustworthiness in their response. Twenty-one participants 
referred to ‘bias’, ‘first impressions’ or ‘judging by appearance’; 11 participants said 
that the study was about perception of pain; eight referred to empathy, four to 
malingering and three to decision making. Nine participants said that they were ‘not 
sure of’ or did not know the study’s purpose. Participants were therefore divided into 
groups that guessed the study concerned bias (26) and those who did not (37) and 
data analysed using these groups. There were no significant main effects or 
interactions in any of the analyses (p > 0.05), indicating that participants’ responses 
were not affected by their belief about the purpose of the study. 
 
Research question 1 
Are pain clinicians’ and medical students’ estimations of pain, estimations of the 
probability that patients are exaggerating, minimising or hiding their pain, and their 
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treatment decisions influenced by a patient's depression, and by the timing of its 
onset in relation to the onset of chronic pain? 
 
Effects of history of depression on pain estimations and judgements 
There was a main effect of history of depression on estimates of overall pain 
(Table 3). Post hoc tests indicated that patients who had depression prior to 
developing CP were estimated to have more pain than patients who developed 
depression after CP (t(62) = 2.67, p = .030). There were no differences between 
patients with no history of depression compared to patients with a history of 
depression. There was no significant main effect of history of depression on 
estimates of exaggerating, minimising, or hiding pain.  
Table 3.  Means (standard errors) for the effect of history of depression on pain 
estimates and judgements, where 0 = “No pain” or “Very unlikely”, and 10 = 
“Extreme pain” or “Very likely” 
 
No history of 
depression 
Depression 
before CP 
Depression 
after CP 
 
F 
(2, 60) 
 
p 
 
η𝑝
2  
 
Pain estimates 5.09 (0.16) 5.22 (0.14) 4.96 (0.15) 
 
3.46 
 
.035 
 
.05 
 
Exaggerating 
pain 3.59 (0.15) 3.57 (0.17) 3.52 (0.17) 
 
 
0.13 
 
 
.878 
 
 
.002 
 
Minimising 
pain 4.17 (0.20) 4.19 (0.17) 3.87 (0.19) 
 
 
7.94 
 
 
.057 
 
 
.05 
 
Hiding pain 3.96 (0.19) 4.00 (0.18) 3.95 (0.19) 
 
0.07 
 
.936 
 
<.01 
Note: Values in bold denote significance (p < .05) 
 
Effects of history of depression on pain management decisions 
In general, participants were unlikely to endorse prescription of opioids to 
patients, with scores falling at the lower end of the scale. There was no main effect 
for history of depression on likelihood of prescribing opioids (Table 4).  
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Table 4.  Means (standard errors) for the effect of history of depression on 
likelihood of indicating pain management, where 0 = “Very unlikely”, and 10 = 
“Very likely” 
 No history 
of 
depression 
Depression 
before CP 
Depression 
after CP 
 
F 
(2, 60) 
 
p 
 
η𝑝
2  
 
Opioids 2.42 (0.21) 2.52 (0.21) 2.32 (0.20) 
 
3.04 
 
.110 
 
.04 
 
Analgesics 6.59 (0.19) 6.33 (0.21) 6.41 (0.30) 
 
4.23 
 
.017 
 
.07 
 
Antidepressants 2.96 (0.25) 5.18 (0.26) 4.59 (0.27) 
 
87.30 
 
<.001 
 
.59 
 
Pain management 
programme 4.04 (0.30) 4.29 (0.28) 3.96 (0.29) 
 
 
3.63 
 
 
.029 
 
 
.06 
 
Mental health 
specialist 1.87 (0.19) 4.32 (0.28) 3.63 (0.26) 
 
 
95.91 
 
 
<.001 
 
 
.61 
Note: Values in bold denote significance (p < .05) 
 
There was a main effect of history of depression on likelihood of prescribing 
analgesics, indicating that patients without a history of depression were more likely 
to be prescribed analgesics than patients who had depression prior to developing CP 
(t(62) = 2.80, p = .021). There was no difference in likelihood of prescribing 
analgesics between patients without a history of depression and patients who 
developed depression after CP.  
There was a main effect of history of depression on likelihood of prescribing 
antidepressants. Post-hoc tests indicated that patients who developed depression 
before CP were more likely to be prescribed antidepressants than patients who 
developed depression after CP and than patients without a history of depression 
(t(62) = 4.76, p < .001; t(62) = 10.70; p < .001). Patients who developed depression 
after CP were also more likely to be prescribed antidepressants than patients without 
a history of depression, t(62) = 9.01; p < .001.  
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There was a main effect of history of depression on likelihood of referring to 
a pain management programme. Post hoc tests indicated borderline significance of 
participants rating patients who developed depression before CP as more likely to be 
referred to a pain management programme than patients with no history of 
depression (t(62) = 0.54, p = .05). There was no significant difference in likelihood 
of referral between patients who developed depression after CP and patients with no 
history of depression.  
There was a significant main effect of history of depression on likelihood of 
referring to a mental health specialist. Post-hoc tests indicated that patients who 
developed depression before CP were more likely to be referred to a mental health 
specialist than patients who developed depression after CP and patients without a 
history of depression (t(62) = 11.29, p < .001; t(62) = 4.30; p < .001). Patients who 
developed depression after CP were also more likely to be referred to a mental health 
specialist than patients without a history of depression, t(62) = 10.70; p < .001.  
 
Research question 2 
Are pain clinicians’ and medical students’ estimations of pain, estimations of the 
probability that patients are exaggerating, minimising or hiding their pain, and their 
treatment decisions influenced by how trustworthy the patient looks?  
 
Effects of trustworthiness on pain estimations 
There was no main effect of trustworthiness on estimates of pain (Table 5). 
There was a significant main effect of trustworthiness on estimations of exaggerating 
pain, indicating that participants rated LT patients as more likely to exaggerate their 
pain than HT patients. There was a main effect of trustworthiness on estimates of 
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hiding and minimising pain, indicating that participants rated HT patients as more 
likely to minimise and hide their pain than LT patients. 
 Table 5.  Means (standard errors) for the effect of perceived trustworthiness 
on pain judgements 
 High 
trustworthiness 
Low 
trustworthiness  
F 
(1, 61) 
 
p 
 
η𝑝
2  
 
Pain 
estimates 5.13 (0.14) 5.04 (0.14) 
 
 
1.18 
 
 
.282 
 
 
.02 
 
Exaggerating 
pain 3.09  (0.16) 4.03 (0.16) 
 
 
58.15 
 
 
< .001 
 
 
.49 
 
Minimising 
pain 4.46 (0.18) 3.69 (0.16) 
 
 
35.54 
 
 
< .001 
 
 
.37 
 
Hiding pain 4.37 (0.19) 3.56 (0.18) 
 
36.15 
 
< .001 
 
.37 
Note: Values in bold denote significance (p < .05) 
 
Effects of trustworthiness on pain management decisions 
There was no main effect of trustworthiness on likelihood of prescribing 
opioids (Table 6). There was a significant main effect of trustworthiness on 
likelihood of prescribing analgesics, indicating that participants were more likely to 
prescribe analgesics for HT patients than LT patients. There was no main effect of 
trustworthiness on likelihood of prescribing antidepressants, on the likelihood of  
referring to a pain management programme and to a mental health specialist. 
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Table 6.  Means (standard errors) for the effect of perceived trustworthiness on 
likelihood of indicating pain management  
 High 
trustworthiness 
Low 
trustworthiness  
F 
(1, 61) 
 
p 
 
η𝑝
2  
 
Opioids 2.49 (0.21) 2.34 (0.21) 
 
2.81 
 
.099 
 
.04 
 
Analgesics 6.57 (0.19) 6.32 (0.21) 
 
7.53 
 
.008 
 
.11 
 
Antidepressants 4.22 (0.24) 4.27 (0.25) 
 
0.18 
 
.671 
 
< .01 
 
Pain management 
programme 4.09 (0.28) 4.11 (0.29) 
 
 
0.04 
 
 
.844 
 
 
< .01 
 
Mental health 
specialist 3.25 (0.23) 3.30 (0.24) 
 
 
0.24 
 
 
.625 
 
 
< .01 
Note: Values in bold denote significance (p < .05) 
 
Research question 3 
Are pain clinicians’ and medical students’ estimations of pain, estimations of the 
probability that patients are exaggerating, minimising or hiding their pain, and their 
treatment decisions influenced by the gender of the patient?  
 
Effects of gender on pain estimations and judgements 
There was a main effect of gender on estimates of pain, indicating that 
participants estimated males as having more pain than females (Table 7). 
There was a significant main effect of gender on estimations of exaggerating pain, 
indicating that participants estimated female patients as more likely to exaggerate 
their pain than males. There was a significant main effect of gender on estimations of 
minimising and hiding pain, indicating that participants estimated males are more 
likely to minimise or hide their pain than females.  
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Table 7.  Means (standard errors) for the effect of gender on pain estimates and 
judgements 
 Female Male F(1, 61) p η𝑝
2  
 
Pain estimates 4.65 (0.15) 5.53 (0.14) 
 
69.61 
 
<.001 
 
.53 
 
Exaggerating 
pain 3.92 (0.16) 3.21 (0.16) 
 
 
26.92 
 
 
<.001 
 
 
.31 
 
Minimising pain 3.74 (0.17) 4.41 (0.18) 
 
19.37 
 
<.001 
 
.24 
 
Hiding pain 3.59 (0.18) 4.34 (0.18) 
 
23.87 
 
<.001 
 
.28 
Note: Values in bold denote significance (p < .05) 
 
Effects of patient gender on pain management decisions 
There was a main effect of gender on likelihood of prescribing opioids and 
analgesics, indicating that male patients were more likely to be prescribed opioids 
and analgesics than females (Table 8). There was no main effect of gender on 
likelihood of prescribing antidepressants. There was a main effect of gender on 
likelihood of referring to a pain management programme, indicating that male 
patients were more likely to be referred to a pain management programme than 
females. There was no main effect of gender on likelihood of referring to a mental 
health specialist.  
Table 8.  Means (standard errors) for the effect of gender on likelihood of indicating 
pain management  
 Female Male F(1, 61) p η𝑝
2  
 
Opioids 2.16 (0.19) 2.68 (0.22) 
 
31.84 
 
< .001 
 
.34 
 
Analgesics 6.12 (0.22) 6.77 (0.20) 
 
31.01 
 
< .001 
 
.34 
 
Antidepressants 4.26 (0.23) 4.23 (0.25) 
 
0.01 
 
.758 
 
< .01 
 
Pain management 
programme 3.88 (0.28) 4.31 (0.29) 
 
 
10.53 
 
 
.002 
 
 
.15 
 
Mental health specialist 3.31 (0.24) 3.24 (0.22) 
 
0.44 
 
.508 
 
< .01 
Note: Values in bold denote significance (p < .05) 
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Research question 4 
Do depression history, patient trustworthiness and gender interact?  
 
Pain estimates and judgements: interactions 
Patient trustworthiness x gender  
There was a significant interaction between patient trustworthiness and 
gender for pain estimates and all judgements of pain (Table 9). Post hoc tests 
indicated that trustworthiness had an effect on pain estimations for female, but not 
for male patients (Table 10). This indicates that participants estimated HT females as 
in more pain than LT females, but participants gave similar and higher pain estimates 
to males, regardless of their level of trustworthiness. The main effect for patient 
gender remained, with participants estimating males as in higher pain than females 
for both levels of trustworthiness (t(62) = 3.28, p = .001; t(62) = 7.69, p < .001). 
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Table 9. Interactions between history of depression, trustworthiness and gender for pain judgements 
 Trustworthiness  
x gender 
History of depression  
x trustworthiness 
History of depression x  
gender 
Trustworthiness x gender x 
history of depression 
 F 
(1,61) p  η𝑝 
2  
F 
(2,60) p η𝑝 
2  
F 
(2,60) p η𝑝 
2  
F 
(2,60) p η𝑝 
2  
 
Pain estimates 9.78 .003 .14 6.16 .003 .09 4.40 .014 .07 16.87 < .001 .22 
 
Exaggerating pain 45.71 < .001 .43 2.63 .076 .04 2.75 .068 .04 14.01 < .001 .19 
 
Minimising pain 11.99 < .001 .16 0.64 .528 .01 7.30 .001 .11 17.13 < .001 .22 
 
Hiding pain 19.44 < .001 .24 1.20 .305 .02 7.58 .001 .11 22.44 < .001 .27 
 
Opioids 13.61 <.001 .18 2.23 .112 .04 0.78 .461 .01 1.91 .153 .03 
 
Analgesics 6.50 .013 .10 0.58 .560 .01 2.19 .116 .04 4.20 .017 .06 
 
Antidepressants 3.72 .058 .06 6.42 .002 .10 7.58 .001 .11 2.70 .071 .04 
 
Pain management 
programme 0.06 .808 <.01 3.38 .037 .05 6.12 .003 .09 4.62 .015 .07 
 
Mental health 
specialist 7.67 .007 .11 0.66 .517 .01 4.10 .019 .06 2.33 .102 .04 
Note: Grey shades indicate: η𝑝 
2  ≤ .10 η𝑝 
2 ≤ .20 η𝑝 
2 >  .20         
                 Values in bold denote significance (p < .01)       
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Table 10.  Means (standard errors) and post hoc test results for the trustworthiness x 
gender interaction 
 Females Males 
 HT LT t(62) p HT LT t(62) p 
 
Pain estimates 
 
4.87 
(0.16) 
4.43 
(0.16) 
 
3.27 
 
.002 5.39 
(0.15) 
5.66 
(0.16) 
 
1.89 
 
.063 
 
Exaggerating 
pain 
 
2.95 
(0.19) 
4.89 
(0.20) 
 
8.85 
 
<.001 3.23 
(0.18) 
3.18 
(0.17) 
 
0.35 
 
.724 
 
Minimising 
pain 
4.39 
(0.22) 
3.09 
(0.18) 
 
6.72 
 
<.001 4.52 
(0.21) 
4.30  
(0.19) 
 
1.48 
 
.299 
 
Hiding pain 
 
4.32 
(0.21) 
2.86 
(0.19) 
 
7.19 
 
<.001 4.42 
(0.21) 
4.27 
(0.21) 
 
0.78 
 
.440 
Note: Values in bold denote significance (p < .05) 
 
For exaggerating, minimising and hiding pain, post hoc tests indicated that 
the previously mentioned main effects for trustworthiness only occurred in female, 
but not male patients. The main effects for patient gender also only occurred in 
patients low, and not high, in trustworthiness. Participants rated LT females as more 
likely to exaggerate, and less likely to minimise or hide their pain than HT females, 
but gave similar ratings of exaggerating, minimising and hiding to males regardless 
of their level of trustworthiness. There was no difference between participants’ 
estimates of exaggerating, minimising and hiding in HT females and HT males (t(62) 
= 1.45, p = .152; t(62) = 0.58, p = .562; t(62) = 0.44, p = .660), but participants rated 
LT females as more likely to exaggerate, and less likely to minimise or hide pain 
than LT males (t(62) = 8.30, p < .001, t(62) = 5.91, p < .001; t(62) = 6.93, p < .001).  
 
 Patient trustworthiness x history of depression 
There was a significant interaction between patient trustworthiness and 
history of depression for pain estimations, but not for pain judgements. Post hoc tests 
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indicated that the previously mentioned main effect for history of depression did not 
occur in HT patients, indicating that participants gave similar pain estimates to HT 
patients, regardless of their history of depression (p > .05). Participants estimated LT 
patients who had no history of depression as in more pain than LT patients who 
developed depression after CP (LT, no history of depression: M = 5.18, SE = 0.15; 
LT, depression after CP: M = 4.71, SE = 0.17; t(62) = 3.62, p = .002). Participants 
were also more likely to estimate LT patients who developed CP before depression 
as in more pain than patients who developed depression after CP (LT, depression 
before CP: M = 5.24, SE = 0.16; t(62) = 3.45, p = .003). HT patients who developed 
depression after CP received higher estimates than LT patients in the same group 
(t(62) = 3.45, p = .001), and there were no differences between HT and LT patients 
in the other two groups (p > .05). 
 
History of depression x gender 
There was also an interaction between patient gender and history of 
depression for minimising and hiding pain. Post hoc tests indicated that the 
previously mentioned main effect for gender only occurred in patients without a 
history of depression and patients who developed depression after CP, but not for 
patients who developed depression before CP (Table 11; minimising: t(62) = 2.72, p 
= .008; t(62) = 5.83, p < .001; t(62)=0.78, p = .440; hiding: t(62) = 3.06, p = .003; 
t(62) = 5.82, p < .001; t(62) = 0.98, p = .329). There was no difference in estimates 
of minimising or hiding between male patients, regardless of their history of 
depression (p > .05). Participants rated females who developed depression after CP 
as less likely to minimise their pain than females who developed depression before 
CP and females without a history of depression (t(62) = 5.08, p = .002; t(62) = 3.66, 
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p < .001). Females who developed depression after CP were less likely to be rated as 
hiding their pain than females who developed depression before CP (t(62) = 3.51, p 
= .003). 
Table 11.  Means (standard errors) and post hoc test results for the history of 
depression x gender interaction 
 No history of 
depression 
Depression before 
CP 
Depression  
after CP 
 Female Male Female Male Female Male 
 
Minimising pain 
 
3.89 
(0.19) 
4.44 
(0.20) 
 
4.09 
(0.21) 
 
4.29 
(0.21) 
3.23 
(0.20) 
4.51 
(0.24) 
 
Hiding pain 
3.63 
(0.21) 
4.43 
(0.21) 
3.88 
(0.21) 
4.11 
(0.23) 
3.26 
(0.21) 
4.63 
(0.24) 
Note: Values in bold denote significance between male and female patients (p < .05) 
 
Trustworthiness x gender x history of depression 
There was also a significant interaction between trustworthiness, gender and 
history of depression for pain estimates and all pain judgements, indicating that the 
trustworthiness x gender interactions differed according to the patient’s history of 
depression (Table 12). Post hoc tests for pain estimates indicated that the difference 
between HT and LT females was not consistent across depression groups, with only 
the HT female with depression before CP estimated as in higher pain than the LT 
female (t(62) = 3.99, p < .001). There was a trend for a similar pattern between the 
females with no history of depression (t(62) = 1.88, p = .065). Post hoc tests 
indicated that males were affected by trustworthiness ratings. For patients with no 
history of depression or who developed depression before CP, LT males were 
estimated as in more pain than HT males  (t(62) = 3.07, p = .003; t(62) = 3.87, p < 
.001). The opposite effect was found for males who developed depression after CP 
(t(62) = 3.71, p < .001). 
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Table 12.  Means (standard errors) for the history of depression x trustworthiness x gender interaction 
 Females Males 
 No history of 
depression 
Depression 
before CP 
Depression after 
CP 
No history of 
depression 
Depression 
before CP 
Depression after 
CP 
 HT LT HT LT HT LT HT LT HT LT HT LT 
 
Pain estimates 
 
4.92 
(0.19) 
4.56 
(0.20) 
5.05 
(0.20) 
4.20 
(0.20) 
4.65 
(0.20) 
4.51 
(0.19) 
5.06 
(0.20) 
5.81 
(0.17) 
5.36 
(0.19) 
6.27 
(0.20) 
5.75 
(0.20) 
4.91 
(0.22) 
 
Exaggerating pain 2.51 
(0.23) 
5.22 
(0.24) 
2.91 
(0.21) 
4.74 
(0.27) 
3.42 
(0.26) 
4.71 
(0.26) 
 
3.49 
(0.26) 
3.15 
(0.21) 
3.66 
(0.26) 
2.96 
(0.23) 
2.55 
(0.22) 
3.42 
(0.28) 
 
Minimising pain 
 
4.82 
(0.26) 
2.97 
(0.22) 
4.93 
(0.30) 
3.25 
(0.24) 
3.41 
(0.24) 
3.05 
(0.22) 
4.40 
(0.26) 
4.49 
(0.26) 
4.01 
(0.27) 
4.57 
(0.27) 
5.16 
(0.31) 
3.86 
(0.28) 
 
Hiding pain 
 
4.65 
(0.28) 
2.62 
(0.22) 
4.68 
(0.28) 
3.08 
(0.25) 
3.63 
(0.24) 
2.89 
(0.25) 
4.10 
(0.25) 
4.45 
(0.30) 
3.85 
(0.26) 
4.39 
(0.30) 
5.31 
(0.31) 
3.96 
(0.28) 
Note: Values in bold denote significance between high trustworthy and low trustworthy patients (p < .05) 
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Post-hoc comparisons for exaggerating and hiding pain indicated that 
participants rated all LT females as more likely to exaggerate and less likely to hide 
pain than HT females (exaggerating: t(62) = 8.39, p < .001; t(62) = 6.38; p < .001; 
t(62) = -3.70; p < .001; hiding: t(62) = 7.45; p < .001; t(62) = 4.74; p < .001; t(62) = 
2.94; p = .005). Only HT females with no history of depression (t(62) = 6.49, p < 
.001) and who developed depression before CP (t(62) = 4.89; p < .001) were rated as 
more likely to minimise their pain, while there was no difference between HT and 
LT females who developed depression after CP (p > .05). For males who developed 
depression before CP, participants rated the HT male as more likely to exaggerate his 
pain than the LT male (t(62) = 2.61, p = .010). For males who developed depression 
after CP, the LT male was rated as more likely to exaggerate pain than the HT male 
(t(62) = -3.23, p = .002), and less likely to minimise (t(62) = -8.39, p < .001) or hide 
his pain (t(62) = 3.94, p < .001). There was no difference between HT and LT males 
with no history of depression for exaggerating, minimising or hiding pain (p > .05). 
 
Pain management decisions: interactions 
There was a significant interaction between patient trustworthiness and 
gender for likelihood of prescribing opioids and analgesics. Post hoc tests indicated 
there was an effect of trustworthiness in female, but not male patients (Table 13). 
This interaction indicates that participants were more likely to prescribe opioids and 
analgesics to HT females than LT females, but participants gave similar ratings of 
prescription of opioids and analgesics to males, regardless of their level of 
trustworthiness. For prescription of opioids, the main effect for patient gender only 
occurred in LT patients, with LT males more likely to be prescribed opioids than LT 
females (t(62) = 6.15, p < .001). There was no difference for HT females compared 
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to HT males (p > .05). For prescription of analgesics, the main effect for patient 
gender remained, with males more likely to be prescribed analgesics than females for 
both levels of trustworthiness (t(62) = 2.79, p = .007; t(62) = 5.56, p < .001). 
Table 13.  Means (standard errors) and post hoc test results for the trustworthiness x 
gender interaction 
 Females Males 
 HT LT t(62) p HT LT t(62) p 
 
Opioids 
 
2.41 
(0.21 
1.90 
(0.20) 
 
4.08 
 
<.001 2.58 
(0.22) 
2.79 
(0.24) 
 
1.49 
 
.139 
 
Analgesics 
 
6.39 
(0.22) 
 
5.87 
(0.20) 
 
3.37 
 
.001 6.77 
(0.20) 
6.77 
(0.22) 
 
< .01 
 
.998 
Note:Values in bold denote significance between high and low trustworthy patients (p < .05) 
 
There was also an interaction between patient trustworthiness and gender for 
likelihood of referring to a mental health specialist. Post hoc tests showed that in LT 
patients, females were more likely than males to be referred to a mental health 
specialist (M = 3.50, SE = 0.27; M = 3.10, SE = 0.23; t(62) = 2.44, p = .018). There 
was no difference between HT males and females (M = 3.39, SE = 0.23; M = 3.11, 
SE = 0.25).  
 
Patient trustworthiness x history of depression 
There was a significant interaction between patient trustworthiness and 
history of depression for likelihood of prescribing antidepressants. The main effect 
for history of depression remained across patient trustworthiness. Post hoc tests 
indicated that for patients with no history of depression, LT patients were more likely 
to be prescribed antidepressants than HT patients (M = 3.17, SE = 0.27; M = 2.75, 
SE = 0.25; t(62) = 2.45, p = .017). There was no difference between HT and LT 
patients for patients who developed depression before CP, while for patients who 
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developed depression after CP, HT patients were more likely to be prescribed 
antidepressants than LT patients (M = 4.81; SE = 0.30; M = 4.38, SE = 0.28; t(62) = 
2.30, p = .025).  
 
History of depression x gender 
There was a significant interaction between patient gender and history of 
depression for likelihood of prescribing antidepressants and likelihood of referring to 
a pain management programme. Post hoc tests indicated that for patients without a 
history of depression, females were more likely than males to be prescribed 
antidepressants (Table 14, t(62) = 3.00, p = .004). There were no differences 
between males and females in patients who developed depression before or after CP. 
There was no difference in likelihood of referring to a pain management programme 
between males and females who had no history of depression (p > .05), but males 
who developed depression before or after CP were more likely to be referred to a 
pain management programme than females in the same conditions (t(62) = 3.05, p = 
.003; M = 4.40, t(62) = 3.78, p < .001). 
Table 14.  Means (standard errors) and post hoc test results for the history of 
depression x gender interaction 
 No history of 
depression 
Depression before 
CP 
Depression  
after CP 
 Female Male Female Male Female Male 
 
Antidepressants 
 
3.23 
(0.27) 
2.69 
(0.25) 
 
5.03  
(0.32) 
 
5.33 
 (0.29) 
4.44 
(0.32) 
4.77  
(0.31) 
 
Pain management 
programme 
 
4.01 
(0.33) 
3.92 
(0.33) 
 
3.95 
(0.34) 
 
4.63 
(0.33) 
3.37 
(0.33) 
4.40 
(0.34) 
Note: Values in bold denote significance between male and female patients (p < .05) 
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Research question 5 
Do pain clinicians’ estimations of pain, estimations of the probability that patients 
are exaggerating, minimising or hiding their pain, and their treatment decisions differ 
from those of medical students’?  
 
Effects of training level on pain estimations 
There was a main effect of training level on estimates of pain, indicating that 
pain clinicians were more likely to give patients higher pain estimates than medical 
students (Table 15). Pain clinicians provided similar estimates of pain, regardless of 
the number of years of practice (F(4, 33) = 0.28, p = .890).  
There was a significant main effect of training level on estimations of 
exaggerating, indicating that medical students were more likely rate the patient as 
exaggerating their pain than pain clinicians, and there was no main effect of training 
level on estimations of minimising or hiding pain. 
Table 15.  Means (standard errors) for the effect of training level on pain 
judgements 
 
Pain clinicians 
Medical 
students 
 
F(1, 61) 
 
p 
 
η𝑝
2  
 
Pain estimates 5.50 (0.18) 4.68 (0.19) 
 
9.85 
 
.003 
 
.14 
 
Exaggerating 
pain 3.19 (0.19) 3.93 (0.21) 
 
 
6.54 
 
 
.013 
 
 
.10 
 
Minimising pain 3.89 (0.21) 4.19 (0.17) 
 
1.41 
 
.24 
 
.02 
 
Hiding pain 3.71 (0.22) 4.23 (0.24) 
 
2.54 
 
.116 
 
.04 
Note: Values in bold denote significance (p < .05) 
 
Effects of training level on pain management decisions 
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There was a main effect of training level on likelihood of prescribing opioids 
and analgesics, indicating that medical students were more likely to prescribe opioids 
and analgesics than pain clinicians (Table 16). There was no main effect of training 
level on likelihood of prescribing antidepressants. There was a main effect of 
training level on likelihood of referring to a pain management programme and a 
mental health specialist, indicating that medical students were more likely to refer 
patients to a pain management programme and a mental health specialist than pain 
clinicians. 
Table 16.  Means (standard errors) for the effect of training level on likelihood of 
indicating pain management  
 Pain 
clinicians 
Medical 
students 
 
F(1, 61) 
 
p 
 
η𝑝
2  
 
Opioids 1.81 (0.27) 3.03 (0.27) 
 
9.19 
 
.004 
 
.13 
 
Analgesics 6.04 (0.27) 6.85 (0.29) 
 
4.13 
 
.046 
 
.06 
 
Antidepressants 4.31 (0.32) 4.18 (0.35) 
 
0.90 
 
.772 
 
<.01 
 
Pain management 
programme 3.39 (0.38) 4.81 (0.41) 
 
 
6.40 
 
 
.014 
 
 
.09 
 
Mental health 
specialist 2.24 (0.31) 4.31 (0.33) 
 
 
29.11 
 
 
<.001 
 
 
.26 
Note: Values in bold denote significance (p < .05) 
 
Research question 6 
Are pain clinicians’ and medical students’ estimations of the probability that patients 
are exaggerating, minimising or hiding their pain, and their treatment decisions 
affected differently by history of depression, trustworthiness and gender of the 
patient? 
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Interactions between training level and history of depression, trustworthiness and 
gender 
 Patient gender x training level 
There was an interaction between gender of patient and training level for pain 
estimations and all pain judgements (Table 17). Both clinicians and students were 
more likely to estimate male patients having higher pain than female patients, but 
this effect was more pronounced in students (Table 18). For exaggerating pain, post 
hoc comparisons indicated that medical students rated females as more likely to 
exaggerate their pain than males while there was no difference between males and 
females in clinicians’ ratings of exaggerating pain. For estimates of minimising and 
hiding pain, post hoc tests indicated that medical students rated females as less likely 
to minimise and hide their pain than males, while there was no difference between 
males and females in clinicians’ ratings of minimising pain. 
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Table 17.  Interactions between training level, history of depression, trustworthiness 
and gender for pain estimates, judgements and management decisions 
 Gender x training level History of depression x 
training level 
 F 
(1,61) p η𝑝 
2  
F 
(2,60) p η𝑝 
2  
 
Pain estimates 30.85 <.001 .34 0.33 .035 .05 
 
Exaggerating pain 21.65 <.001 .26 0.34 .716 .01 
 
Minimising pain 8.99 .004 .13 0.78 .380 .01 
 
Hiding pain 8.48 .005 .12 0.99 .373 .02 
 
Opioids 27.29 <.001 .31 0.86 .425 .01 
 
Analgesics 4.69 .034 .07 4.53 .017 .07 
 
Antidepressants 0.23 .631 <.01 5.87 .004 .09 
 
Pain management 
programme 3.20 .079 .05 5.10 .007 .08 
 
Mental health specialist 0.66 .420 .01 19.18 <.001 .24 
 
        Note: Grey shades indicate: η𝑝 
2  ≤ .10 η𝑝 
2 ≤ .20 η𝑝 
2 > .20   
  Values in bold denote significance (p < .05) 
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Table 18.  Means (standard errors) and post hoc test results for the gender x training 
level interaction 
 Clinicians Medical students 
 Females Males t(62) p Females Males t(62) p 
 
Pain estimates 
 
5.35 
(0.20) 
5.65 
(0.19) 
 
2.06 
 
.044 5.41 
(0.20) 
3.94 
(0.22) 
 
9.48 
 
<.001 
 
Exaggerating 
pain 
3.23 
(0.22) 
3.16 
(0.21) 
 
0.40 
 
.694 4.60 
(0.24) 
3.25 
(0.23) 
 
6.69 
 
<.001 
 
Minimising 
pain 
4.00 
(0.23) 
3.78 
(0.24) 
 
0.27 
 
.787 3.69 
(0.26) 
4.83  
(0.25) 
 
2.44 
 
.018 
 
Hiding pain 
 
3.55 
(0.24) 
3.86 
(0.25) 
 
1.45 
 
.151 3.63 
(0.26) 
4.83 
(0.27) 
 
5.31 
 
<.001 
Note: Values in bold denote significance (p < .05) 
 
 
Interactions between training level and history of depression, trustworthiness and 
gender: pain management decisions 
Patient gender x training level 
There was a significant interaction between patient gender and training level 
for likelihood of prescribing opioids. Post hoc tests indicated that students were more 
likely to prescribe opioids for males than females (M = 3.54, SE = 0.32; M = 2.52, 
SE = 0.29; t(62) = 7.37, p < .001), while there was no difference in clinicians’ 
ratings between males and females (M = 1.83, SE= 0.29  M = 1.79, SE = 0.26; t(62) 
= 0.31, p = .759).  
 History of depression x training level 
There was a significant interaction between history of depression and training 
level of participants for likelihood of prescribing analgesics, antidepressants and for 
referring to a pain management programme and to a mental health specialist. Post 
hoc tests indicated that clinicians’ likelihood of prescribing analgesics were not 
affected by the history of depression of patients (Table 19), but that medical students 
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were more likely to prescribe analgesics for patients who had no history of 
depression than patients who developed depression before CP, and patients who 
developed depression after CP. 
For antidepressants, post hoc tests indicated that for both clinicians and 
students, patients who developed depression before CP were more likely to be 
prescribed antidepressants than both patients with no history of depression and 
patients who developed depression after CP (Table 19). Patients who developed 
depression after CP were also more likely to be prescribed antidepressants than 
patients with no history of depression.  
Table 19.  Means (standard errors) and post hoc test results of the history of 
depression x training level interaction for likelihood of prescribing antidepressants 
   t p 
 No history of 
depression 
Depression 
before CP 
Depression 
after CP 
  
Analgesics      
Clinician 6.06 (0.27) 5.90 (0.29) - 1.23 .668 
 6.06 (0.27) 
- 
 
- 
5.90 (0.29) 
6.15 (0.29) 
6.15 (0.29) 
 
0.72 
1.94 
.999 
.169 
Student 7.12 (0.29) 
7.12 (0.29) 
- 
6.76 (0.31) 
- 
6.76 (0.31) 
- 
6.66 (0.31) 
6.66 (0.31) 
2.66 
3.46 
0.70 
.029 
.003 
.999 
 
Antidepressants 
     
Clinician 3.37 (0.33) 5.02 (0.35) - 5.89 <.001 
 3.37 (0.33) 
- 
 
- 
5.02 (0.35) 
4.55 (0.37) 
4.55 (0.37) 
4.77 
2.85 
<.001 
.017 
Student 2.55 (0.36) 
2.55 (0.36) 
- 
5.33 (0.38) 
- 
5.33 (0.38) 
- 
4.65 (0.40) 
4.65 (0.40) 
9.13 
7.82 
3.83 
<.001 
<.001 
.001 
 
Mental health 
specialist 
     
Clinician 1.49 (0.27) 2.88 (0.38) - 4.75 <.001 
 1.49 (0.27) 
- 
 
- 
2.88 (0.38) 
2.36 (0.36) 
2.36 (0.36) 
3.94 
2.39 
.001 
.059 
Student 2.26 (0.29) 
2.26 (0.29) 
- 
5.76 (0.41) 
- 
5.76 (0.41) 
- 
4.90 (0.39) 
4.90 (0.39) 
10.97 
10.95 
3.65 
<.001 
<.001 
.002 
Values in bold denote significance (p < .05) 
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There was an interaction between history of depression and training level. 
Students were more likely to refer the patient to pain management than clinicians in 
patients with no history of depression and patients who developed depression before 
CP (M = 4.91, SE = 0.42; M = 3.02, SE = 0.39; t(62) = 3.27, p = .002; M = 4.87, SE 
= 0.41; M = 3.71, SE = 0.38; t(62) = 2.10, p = .04). There was a trend in a similar 
direction for patients who developed depression after CP (M = 4.64, SE = 0.44; M = 
3.43, SE = 0.41; t(62) = 1.99, p = .051). 
Medical students were more likely to refer patients who developed depression 
before or after chronic pain to a mental health specialist than clinicians, (t(62) = 5.14, 
p < .001; t(62) = 4.82; p < .001) with a similar trend for patients with no history of 
depression t(62) = 1.96; p = .055. Both clinicians and students were more likely to 
refer patients with depression to a mental health specialist than the patients with no 
history of depression (Table 19), but only students were more likely to refer patients 
who developed depression before CP than patients who developed depression after 
CP. 
 
Research question 7 
Do empathy levels of pain clinicians and medical students correspond with 
estimations of pain, estimations of the probability that patients are exaggerating, 
minimising or hiding their pain, and their treatment decisions? 
 
Empathy 
Independent t-tests were used to compare total empathy scores from the IRI 
and the sub-scales between clinicians and medical students (Table 20). Clinicians 
and medical students differed for total empathy and the identification and personal 
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distress subscales, with clinicians scoring lower in empathy than medical students  
(t(61)=-4.65, p < .001; t(61)=-4.32, p < .001; t(61)=-5.06, p < .001). There was a 
significant gender difference between the two participant groups, and t-tests showed 
that there was a significant difference between males and females for total empathy 
(t(61)=-3.65, p = .001) and the subscales empathic concern (t(61)=-2.91, p = .005)  
and personal distress (t(61)=-3.14, p = .003), with females scoring higher than 
males. 
 
Table 20. Mean empathy scores of clinicians and medical students. 
 Clinicians 
M (SD) 
Medical 
students 
M (SD) 
t df p 
Total empathy 
score 
 
 
56.18 (10.50) 
 
67.86 (9.25) 
 
 
-4.65 
 
61 
 
< .001 
Perspective 18.56 (4.91) 18.14 (4.53) 
 
.352 61 .726 
Identification 12.23 (4.36) 17.38 (5.15) 
 
-4.32 61 < .001 
Empathic 
concern 
 
 
18.79 (3.52) 
 
20.34 (3.22) 
 
 
-1.81 
 
61 
 
.075 
Personal distress 6.62 (3.76) 12.00 (4.68) -5.06 61 < .001 
Values in bold denote significance (p < .05) 
 
The relationship between empathy scores, pain estimations and likelihood of 
recommending treatment was investigated using correlations (Pearson’s Product 
Coefficient or Spearman’s Rho depending on whether or not the data were normally 
distributed). For brevity, only the significant correlations are reported. Bonferroni 
corrections were applied, with p values multiplied by five to correct for the number 
of comparisons for each variable.  
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Impact of empathy on pain judgements 
Estimated pain was not correlated with empathy scores. Separately, estimated 
pain in females and males were also not correlated with empathy scores. There was 
no relationship between estimation that the patient was exaggerating, minimising or 
hiding their pain and empathy scores.  
 
Impact of empathy on pain management decisions 
There were no correlations between likelihood of prescribing opioids, 
analgesics, antidepressants or referral to a mental health specialist with any of the 
empathy scores. The subscale identification was positively correlated with referral to 
a pain management (r = .327; p = .045).  
 
Discussion  
This study aimed to investigate the effects of four variables on judgements 
and treatment decisions in patients with chronic pain. Three variables concerned the 
patient: history of depression, trustworthiness, and gender; and one concerned the 
(participant) caregiver/provider: training level. Although the main hypotheses 
concerned trustworthiness and history of depression, gender was the most influential 
factor, and consistently affected estimates, judgements and treatment decisions, 
while trustworthiness and history of depression affected them more selectively. 
Therefore, gender findings will be discussed first, followed by trustworthiness, 
history of depression and then training level and empathy. Complicating the 
interpretation of results, several interactions also occurred between trustworthiness, 
gender and depression for pain estimates and judgements, and these will be discussed 
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in further detail. For clarity and brevity, only the interactions that were hypothesised 
or that emerged consistently across different analyses, and/or that had larger effect 
sizes, will be discussed. 
 
The impact of patient gender 
The hypotheses relating to the impact of patient gender on pain estimates and 
judgements were strongly supported, and hypotheses relating to pain management 
decisions were partially supported. Males were consistently estimated to be in more 
pain than females, by nearly 0.9/10 units, by both clinicians and medical students. 
Females were judged as more likely to exaggerate pain and less likely to minimise or 
hide it than males by medical students, but not by clinicians. Trustworthiness 
interacted with gender to suggest that for judgements of exaggeration, minimising, 
and hiding, it was the LT females who were adversely judged, while HT females 
were rated similarly to HT males. The effect sizes for these were large, suggesting 
that this is a clinically significant difference. 
Consistent with understanding men’s pain as more genuine and/or serious, 
men were more likely than women to be prescribed opioids by medical students, and 
more likely to be prescribed analgesics by both pain clinicians and medical students. 
Trustworthiness interacted with gender to suggest that for opioid prescription, it was 
LT females who were less likely to be prescribed opioids than LT males, while HT 
females were just as likely to be prescribed opioids as HT males. Males with a 
history of depression were also more likely to be referred to a pain management 
programme than females in the same groups, though the effect size for this difference 
was smaller than the differences in drug prescription. There were no overall gender 
differences in likelihood of antidepressant prescription or referral to a mental health 
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specialist, but among patients with no history of depression, women were more likely 
than men to be prescribed antidepressants by both students and clinicians.  
These findings are in line with previous studies that have found that pain in 
females is taken less seriously than pain in males, and that males are more likely to 
be treated than females (Tait et al., 2009). There is evidence of real sex differences in 
the prevalence of many chronic pain problems, probably due to a combination of 
biological, psychological, and social factors (Fillingim, King, Ribeiro-Dasilva, 
Rahim-Williams, & Riley, 2009). Stereotypes of gender roles in pain experience 
mean that both males and females perceive the ‘typical’ man as less willing to report 
pain, and more tolerant of pain, than the ‘typical’ woman (Bernardes, Keogh, & 
Lima, 2008; Robinson et al., 2001). Clinicians and medical students in the current 
study provided results consistent with these stereotypes, so that females who express 
pain at a similar level to males are actually estimated to experience less pain than 
males because of their decreased tolerance and increased willingness to express their 
pain. Thus men are estimated to have more pain than women, to be less likely to 
exaggerate pain and more likely to minimise or hide it, and as a consequence, are 
more eligible for opioids and analgesics. The stereotype that females are less tolerant 
of and more likely to report pain might also lead to providers providing a higher 
burden of proof on their reports, and therefore less likely to prescribe analgesics and 
opioids (Hoffmann & Tarzian, 2001). They could possibly view males as more able 
to handle the effects of a ‘stronger’ drug such as an opioid, and females as less 
tolerant of the side effects. The results are also consistent with reported experiences 
of female patients that their health problems are not taken seriously (Werner & 
Malterud, 2003). In one study, females with medically unexplained symptoms 
reported spending time before their appointments thinking about how their 
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appearance and description of their symptoms during the appointment might affect 
their credibility as patients (Werner & Malterud, 2003). However, the lack of gender 
differences in the current study for antidepressant prescription and referral to a 
mental health specialist contrast with another study which found that females were 
more likely to be prescribed antidepressants or referred to a mental health specialist 
(Hirsh, Hollingshead, Matthias, Bair, & Kroenke, 2014). 
 
The impact of perceived trustworthiness 
It was hypothesised that participants would estimate lower pain in LT 
patients compared to HT patients, but this effect emerged only for female patients, 
with LT females estimated to experience about 1/10 units less pain than HT females. 
This is consistent with the notion that women are prone to report more pain. 
Findings on exaggerating pain were complex, with partial support for the 
hypothesis that participants would rate LT patients as more likely to exaggerate their 
pain. Low trustworthiness overall, but only in women, was associated with a higher 
likelihood of exaggeration; for men, low trustworthiness was associated with higher 
expectation of exaggeration for those with depression onset after CP. For HT men, 
those with depression onset before CP were judged more likely to exaggerate pain. 
This is hard to interpret. 
Findings on minimising and hiding pain also interacted with trustworthiness, 
gender and depression history. Overall, HT patients were judged more likely to 
minimise or hide their pain, but for HT females compared to LT females minimising 
was only judged more likely for those with no depression or depression onset after 
CP, with no difference for those with depression onset before CP, while hiding pain 
was more likely for HT females in either depression group. The effects for males 
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were also complex but consistent, with HT males with depression onset after CP 
judged as particularly likely to minimise or hide their pain compared to the LT male 
in the same category.  
Hypotheses relating to the effects of trustworthiness on recommending 
treatment were partially supported. Trustworthiness interacted with gender for 
opioids and analgesics, with HT females more likely to be prescribed opioids and 
analgesics than LT females. Patients at both trustworthiness levels were just as likely 
to be prescribed antidepressants, or referred to a pain management programme or 
mental health specialist. 
Perceived trustworthiness affects investment decisions in trust games 
(Rezlescu et al., 2012; Wout & Sanfey, 2008); our results suggest that it also affects 
clinical decisions which purport to be free of such biases. Previous studies in 
trustworthiness do not appear to have tested for differences in judgements of males 
and females according to trustworthiness (Olivola, Funk, & Todorov, 2014; van  ’t 
Wout & Sanfey, 2008). This appears to be the first finding that gender interacts with 
perceived trustworthiness to influence judgements in the context of assessment of 
chronic pain. In the context of pain assessment, it is possible that clinicians and 
medical students view LT females as more likely to ‘manipulate’ clinicians by 
exaggerating their pain, leading to compensatory discounting of pain in their 
estimates; their treatment decisions are consistent with this in being less inclined to 
prescribe analgesics or opioids. In contrast, LT males might be seen as ‘tough’, and 
in line with gender role expectations, less likely to exaggerate their pain, and more 
likely to minimise or hide their pain, leading to higher pain estimations.  
Due to the differences within the three-way interactions, there is no clear 
explanation for why males of different levels of trustworthiness with different 
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histories of depression might receive different estimations of pain and judgements of 
how they expressed pain. One possibility is that information in the vignettes about 
the patient’s social situation influenced participants’ estimates of pain. For example, 
the LT male who developed depression before CP was described as a ‘carer’ in the 
vignette, as was the HT male who developed depression after CP. Both received 
higher estimates of pain, and were judged as less likely to exaggerate than the 
respective HT and LT males in the same groups. Participants could have a 
stereotypical view of a carer as being trustworthy, which could have over-ridden the 
effects of facial cues of perceived trustworthiness. One study found that perceived 
trustworthiness can be altered by priming participants with the word ‘partner’ instead 
of ‘opponent’ (Burnham, McCabe, & Smith, 2000). Therefore, it is possible that the 
social description could have influenced the effects of perceived trustworthiness on 
participants.    
 
The impact of depression 
It was hypothesised that participants would conceptualise pain developed 
after depression as a ‘symptom’ or ‘presentation’ of depression or at least amplified 
by it (Holloway & Zerbe, 2000), and therefore estimate less pain in patients with a 
history of depression before CP than in patients with no history of depression and 
patients who developed depression after CP. The hypothesis also stated that 
participants would rate patients with a history of depression as more likely to 
exaggerate and less likely to minimise or hide their pain. Results did not support 
these hypotheses: participants rated more pain in patients who developed depression 
prior to CP than in patients who developed depression after CP. The effect size was 
small, so it would be unlikely to have clinical impact, and this effect only occurred in 
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LT patients. There was no overall difference in pain estimates between patients with 
and without a history of depression, suggesting that the presence of depression 
whenever it developed in relation to CP did not affect pain estimates in a consistent 
way. An unexpected interaction with trustworthiness and gender suggested that LT 
males with no depression or depression before CP were given higher pain estimates 
than HT males in those groups, while for males who developed depression after CP, 
HT males were given higher pain estimates than LT males. For females, only LT 
females with depression before CP were given lower estimates of pain than HT 
females. History of depression did not affect participants’ judgements on the 
likelihood that the patient was exaggerating, minimising or hiding their pain, but 
interacted with gender such that while judgements of male patients were unaffected 
by depression history, female patients who developed depression after CP were rated 
as less likely to minimise or hide their pain than the other two groups. 
It was also hypothesised that participants would be less likely to prescribe 
opioids and analgesics, less likely to recommend a pain management programme, 
and more likely to prescribe antidepressants and to refer to a mental health specialist 
for patients with a history of depression (consistent with Hirsh et al. 2013). 
Depression history did not have the expected effect on the likelihood of being 
prescribed opioids; participants were reluctant in general to endorse prescription of 
opioids, and that may have obscured small effects of variable manipulations. The 
hypothesis was partially supported for prescription of analgesics and referral to a 
pain management programme, with patients with no history of depression more 
likely to be prescribed analgesics or referred to a pain management programme than 
patients who developed depression before CP. However, the effect sizes were small 
and unlikely to be of clinical significance.  
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History of depression was, as hypothesised, associated with the likelihood of 
prescribing antidepressants even though they were specified as analgesics, so not at 
an antidepressant dose, most strongly for patients who developed depression before 
CP, followed by those who developed depression after CP. History of depression 
also had a large effect on likelihood of referring to a mental health specialist, with no 
differentiation according to time of onset. These findings are consistent with those of 
Hirsh et al. (2013), and for mental health treatment (Teh, Zaslavsky, Reynolds, & 
Cleary, 2010) and to an extent for tricyclic antidepressants. The issue of different 
dose of antidepressants for pain and for depression (Mico, Ardid, Berrocoso, & 
Eschalier, 2006) seems to have been overlooked by both experienced (clinician) and 
inexperienced (medial student) participants, as were the analgesic benefits of 
antidepressants available to patients without depression (Mico et al., 2006). It was 
hypothesised that perceived trustworthiness would moderate the effects of depression 
on participants’ pain estimates, but we found no such interaction.  
The current study is the first to investigate differences in participants’ 
judgements according to the timing of depression in patients with chronic pain. The 
lack of any consistent effects does not necessarily imply that pain clinicians and 
medical students are unaffected by history of depression, but that they are not simple. 
One study found that treatment decisions of medical students and physicians for 
patients with depression and chronic pain varied according to their attitudes about 
patients with depression (Botega & Silveira, 1996; Hirsh, Hollingshead, Bair, 
Matthias, & Kroenke, 2014). We did not measure this variable, although participants 
with more negative attitudes about patients with depression would be expected to 
estimate the pain of depressed patients as lower than of non-depressed patients, while 
participants with more positive attitudes about patients with depression might have 
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provided higher estimations of pain. Such an effect, if strong, could easily obscure 
any effects of history of depression on pain estimation. Another reason for the 
unexpected effects of history of depression could be that participants interpreted the 
information about the patient’s history of depression in the referral letter incorrectly, 
interpreting depression onset before pain to mean not currently depressed, which 
would produce the same effects for that group as for the non-depressed group, but it 
is not possible to ascertain if this is the case.  
 
The impact of training level 
It was hypothesised that pain clinicians would give lower estimates of pain 
than medical students, consistent with many findings on the effects of years of 
experience (Tait et al., 2009), but results indicated the opposite, with pain clinicians 
giving patients higher pain estimates than medical students. In both groups, the 
gender effect of estimating men’s pain higher than females held, though the effect 
was more pronounced in medical students. It could be that the specialist nature of 
pain clinicians’ experience, unlike a range of clinician experience in published 
studies, moderates the tendency towards lower estimates with years of experience; 
differences between specialisms were found in a study by Kappesser et al. (2006). 
Medical students were more likely than clinicians to rate patients as exaggerating 
their pain, particularly female patients, and while there were no differences between 
clinicians and students on overall estimates of minimising and hiding pain, medical 
students rated females as less likely to minimise or hide their pain than males.  
Medical students were more likely to endorse prescription of opioids 
especially for males, consistent with their greater confidence in male presentation of 
pain. A similar pattern for the prescription of opioids was found in a study of medical 
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records at a general medical practice, with newly qualified clinicians more likely to 
prescribe opioids to patients than more senior clinicians (Colburn, Jasinski, & 
Rastegar). Medical students were also more likely than clinicians to prescribe 
analgesics, particularly for females with no history of depression compared to those 
with a history of depression, though this effect was small. Both training levels were 
equally likely to endorse prescription of antidepressants, especially to those with a 
history of depression before pain. Medical students were more likely to endorse 
referral to a pain management programme and to a mental health specialist. It is 
possible that medical students’ greater readiness to refer to pain management and to 
a mental health specialist is due to a self-selection bias. Medical students with an 
interest in psychology could have been more likely to take part in the study than 
medical students without an interest. As a result, they might be more likely to 
endorse referrals to pain management, which includes psychological elements, and a 
mental health specialist. Both clinicians and students were more likely to refer 
patients with depression to a mental health specialist than patients with no history of 
depression but only students were more likely to refer patients who developed 
depression before CP than patients who developed depression after CP. This suggests 
that medical students, though generally giving lower pain estimates, were more 
inclined to offer a range of treatments than were pain clinicians; this differs from the 
study by Hirsh et al. (2014), which found no difference between medical students 
and qualified clinicians. These differences could be due to differences in the training 
of medical students in the US, where the study was conducted, and the UK, and the 
inclusion of qualified clinicians of differing specialities as opposed to exclusively 
including pain clinicians. Perhaps in our study the pain clinicians’ desire to treat was 
modified by greater scepticism about the strength of evidence of efficacy, or because 
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they would have preferred other treatment options not included in the study, or 
because without it being preceded by a full assessment they found it hard to 
recommend particular treatments.  
 
The impact of empathy 
Clinicians had lower empathy scores than medical students, particularly for 
the subscale ‘personal distress’, and male participants also scored lower than female 
participants. Based on previous literature, it was hypothesised that empathy would 
predict pain estimates and judgements of likelihood of exaggerating, minimising or 
hiding pain, but no significant correlations emerged. Similarly, there were no 
correlations of note with pain management decisions. This is in contrast to other 
studies that have found empathy linked with estimations of pain (Green, Tripp, 
Sullivan, & Davidson, 2009; Saarela et al., 2007; Williams et al., 2013).  
 
Limitations 
This study has several limitations that may have influenced the accuracy of 
the results. First, the study did not control for whether participants had paid attention 
to all information in each vignette, specifically whether they had taken in the 
information about each patient’s history of depression, and its timing. As mentioned 
above, medical students and clinicians could have mistaken the information in the 
vignette about onset of depression before pain, producing inconsistent findings for 
history of depression. It can be difficult to include such checks without making the 
study hypotheses transparent. It may also be that the reference to depression in the 
vignette may have been too weak to trigger biases in judgement, and that an enriched 
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description, or behaviour indicative of depression in the video, would have had more 
impact.  
Using videos of patients, expressing real pain, was superior to using still 
images or actors, but a genuine pain presentation entails many other variables that 
may influence clinician judgements and treatment decisions, including the patient’s 
own report of pain, and his or her behaviours during the assessment. Some of these 
variables would interact with those we investigated here. Additionally, each video 
was paired with the same vignette, so that unidentified peculiarities of particular 
patient videos could have created systematic biases in participant responses. 
Although we did balance pain intensity as quantified by FACs ratings across 
conditions, differences in dynamics of pain expression could not be controlled and 
could have influenced findings.  
Including additional measures in the study, such as measures of gender role 
expectations (Bernardes et al., 2008), or stigma in depression (Hirsh et al., 2014), 
might have helped with the understanding of the pain judgements and treatment 
decisions of medical students and pain clinicians, as might an exploration with 
clinicians and medical students about how patients’ trustworthiness affects their 
evaluation and treatment decisions.  
 
Clinical and research implications 
Although history of depression and timing of depression onset did not have 
the expected impact on pain judgements and management decisions in this study, it is 
sufficiently important an issue not to abandon on this basis, particularly given the 
findings of Hirsh et al. (2014) who found an effect on pain management decisions of 
clinicians and medical students presented with patients with depression and chronic 
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pain. Future studies could investigate whether timing of onset of depression in 
relation to pain is thought by clinicians to be relevant information in understanding 
pain and deciding on treatment options; our assumptions might have been incorrect.   
Perceived trustworthiness was found to have an effect on pain judgements, 
particularly in females. Trustworthiness is an automatic and very rapid judgement 
made on first meeting someone (Willis & Todorov, 2006) and the clinician may not 
be sufficiently aware of this to try to exclude it from his or her clinical decisions 
(Chapman, Kaatz, & Carnes, 2013). In particular, females who are judged to be low 
in trustworthiness may have their pain discounted and not be offered treatment to 
which they are entitled; it is clear that such decisions are made on the basis of gender 
and ethnicity (Anderson et al., 2000; Green et al., 2003; Michael et al., 2007).   
If the results of the current study are taken to show implicit bias and 
stereotyping among medical students and clinicians about people with chronic pain, 
there are several implications. Professional training alone may not bring about a 
change in bias, as found by Drwecki, Moore, Ward, and Prkachin (2011) in relation 
to ethnicity; nurses were found to be as biased in their treatment decision making as 
undergraduate psychology students. In their review of implicit bias in clinicians, 
Chapman et al. (2013) discuss studies where implicit bias was successfully reduced. 
They suggest that reminding clinicians of their potential susceptibility to bias is one 
way of targeting implicit bias, citing a study on racial bias in clinicians which found 
that clinicians who were aware of the study’s purpose were more likely to treat white 
and black patients similarly than unaware clinicians (Green et al., 2007). However, 
this effect may have been due in part to participants giving a socially desirable 
response, and may not be as effective if clinicians are not being observed by others 
(Furnham, 1986). At a minimum, regular feedback regarding potential biases in their 
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treatment decisions might enable clinicians to correct implicit biases in their practice 
(Green et al., 2007). While gender and race are more obvious biases, clinicians may 
not be aware of other cues, such as perceived trustworthiness, that can affect their 
responses. Interventions to reduce bias by increasing awareness of the bias would not 
be able to target sources of bias that are currently unknown. There is evidence that 
bias can be reduced without requiring awareness of the particular bias. For example, 
when people are asked to focus on the unique qualities of individuals and look past 
the social categories to which they belong, automatically activated stereotypes can be 
inhibited (Chapman et al., 2013). Even just increasing the amount of information 
available about a patient can reduce bias, with initial gender bias in physicians’ 
diagnosis of COPD in patients with chest pain successfully reduced after physicians 
were provided with spirometry data consistent with COPD (Chapman, 2001). 
Although empathy was not found to be a predictor of pain judgements in the current 
study, there is evidence that encouraging nurses to take on the perspective of the 
patient reduced racial bias in prescribing pain medication (Drwecki et al., 2011). 
Future studies should investigate whether ‘individuating’ or perspective taking will 
reduce bias in pain judgements of patients of different genders and perceived 
trustworthiness, and if so, what is most effective.  
Additionally, timing of interventions in bias might be important. First of all, 
medical students were more biased in their pain judgements and decisions, making it 
important to take steps to reduce their bias. Teaching medical students techniques in 
reducing implicit bias while they are still learning about patient assessments might 
make them less susceptible to implicit bias later on in their careers. Medical schools 
have already implemented diversity training with the aim of reducing bias into the 
curriculum (Dogra, Reitmanova, & Carter-Pokras, 2010), but there is a lack of 
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published research on what techniques are employed to reduce bias, and whether 
these interventions are effective and translate to decreasing bias in patient care. 
Additionally, there is evidence that medical students are influenced by the behaviour 
of senior clinicians, which can counteract the effects of training (Neumann et al., 
2011). Therefore, courses should incorporate methods to specifically decrease non-
conscious bias in their diversity training (e.g. Stone & Moskowitz, 2011) and 
consistently evaluate the effectiveness of these interventions. Successful early 
interventions in implicit bias could also decrease the cognitive load that is required to 
reduce implicit bias over the longer term (Burgess, van Ryn, Dovidio, & Saha, 
2007).  
At a higher level, healthcare policies could potentially play a role in reducing 
bias in treatment. There is limited evidence that policies already introduced to 
promote gender equality in healthcare are effective (Payne, 2014). Policies fail to 
address healthcare professionals’ susceptibility to implicit bias in medical treatment, 
and place more of an emphasis on differences between males and females, while 
ignoring their similarities. Future policies should include evidence based ways of 
addressing implicit bias. 
 
Conclusion 
This study provides evidence of effects of history of depression, gender, and 
perceived trustworthiness on pain clinicians’ and medical students’ judgements and 
pain management decisions in patients with chronic pain. These findings contribute 
to our understanding of what generates lower estimations of pain, adverse 
judgements about honest expression of pain, and the consequences of those on 
treatment decisions. The presence and timing of depression in chronic patients was 
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not found have a consistent effect. However, gender and trustworthiness was found 
to consistently bias pain judgements and management decisions, with LT females 
particularly subject to adverse judgements, receiving the lowest estimates of overall 
pain, the highest estimates of exaggerating pain, and less likely to be prescribed 
opioids or other analgesics. Males, even those of low trustworthiness, received more 
favourable judgements. Medical students, male and female, were particularly subject 
to this gender bias. Implications both for treatment of patients and for training of 
healthcare staff to minimise bias, are obvious.  
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Introduction 
 
 This appraisal considers some of the conceptual and practical issues 
encountered during the steps in designing the empirical study and collecting, 
analysing and interpreting the data. It aims to shed light on the different decision 
making processes involved at each step, and lessons learned, to aid researchers 
carrying out similar studies. The appraisal ends with reflections on the study findings 
and the research process as a whole. 
 
Designing the study 
 The study aimed to investigate whether the perceived trustworthiness and 
history of depression of the patient affected pain judgements and clinical decision 
making in pain clinicians and medical students. When designing the study and 
putting together the study stimuli, I noticed the constant interplay between internal 
and external validity in the study design, and how difficult it can be to increase 
external validity while making sure that the study remains as internally valid as 
possible. Studies eliciting judgements and decision making can be difficult to design, 
and methodologies incorporating questionnaires and interviews have been criticised 
in the past due to vague questions and misleading results (Poulou, 2001). 
Researchers address this problem by using vignettes, which provide brief accounts of 
hypothetical persons or situations, containing concrete details necessary for 
participants to base their judgements upon. They provide a method to easily 
manipulate information in the vignette according to the variables being studied, and 
are commonly used in research eliciting judgements and decision making. For those 
reasons, I decided that information relating to history of depression would be 
conveyed using vignettes. However, vignettes on their own provide only limited 
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information (Hughes & Huby, 2002), so to test perceived trustworthiness, my 
supervisor and I decided to supplement vignettes with videos of real patients with 
chronic shoulder pain. The inclusion of videos had the advantage of increasing 
external validity of the study, but it meant that variables relating to the patients, such 
as facial expressions, could possibly affect study responses. In order to decrease this 
risk, I edited the videos so that patients were not shown with facial expressions other 
than a neutral or pain expression.  
 Past studies investigating judgements and decision-making in health care 
professionals use either independent groups designs, where participants are exposed 
to one condition, or repeated measures designs, where participants are exposed to all 
conditions. I decided to use a repeated measures design due to its advantage of 
increased statistical power, and therefore a need for fewer participants. One 
disadvantage of the repeated measures design is that participants, when viewing all 
conditions, might be able to notice differences between the conditions and therefore 
guess the aim of the study. As a consequence, they might change their responses to 
what they would see as socially desirable. I mitigated this possibility by first piloting 
the study on colleagues who had completed medical school, and eliciting their 
feedback. I also decided to ask participants to guess the aim of the study as an extra 
precaution. Another disadvantage of using a repeated measures design is that 
participants’ responses might have been affected by being exposed to twelve 
different vignettes of patients. This might have decreased participants’ concentration 
as the task went on, and they might have paid less attention to the content of the 
vignettes. The study was counterbalanced to avoid this potential effect on results 
(Field, 2013), but the repetition in the study might have led to participants choosing 
to drop out before completion. The use of a repeated measures design also meant that 
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12 different videos were used in the study, as opposed to just four videos that would 
have been needed if using an independent groups design. This could have led to 
more variation between the different conditions in the repeated measures design, and 
made the results more difficult to interpret. The advantages and disadvantages of the 
two research designs is something that should be carefully considered by future 
researchers.   
 
Recruiting participants 
 Before the study started, my supervisor and I decided that medical students in 
their 5th and 6th years and qualified pain clinicians would be most suitable to recruit 
for the study. Medical students at UCL have contact with patients from their 4th year. 
Therefore both groups have regular contact with patients and are responsible for 
clinical decision-making, which made them a sample of participants, representative 
of those likely to be involved in decision making in chronic pain. However, this 
population of participants is particularly in demand, making them more difficult to 
recruit than a less representative sample. Medical students in their 5th and 6th years 
have a heavy workload, regular assessments and are frequently asked to provide 
feedback on various aspects of their course. These circumstances are likely to make 
them less willing to volunteer their time to others’ studies. Survey responses from 
health professionals has also decreased through the years, likely due to their work 
demands (Cho et al., 2013). Therefore, the study was designed to be online so that 
participants could take part in the study in their own time, and without needing to 
arrange a face-to-face meeting, which would have been difficult given the different 
locations of the pain clinicians and medical students. 
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Although an online study was more convenient, it also has its disadvantages 
that might affect both internal and external validity. If the study were to take place in 
a laboratory, the experimenter is able to control the environment, limiting the amount 
of intrusive visual, auditory or social stimuli (Kraut et al., 2003). The online study 
included instructions designed to decrease this risk by asking participants to switch 
their computer and mobile phones to silent. Online studies have the additional 
advantage of eliminating incomplete responses in data, and a study comparing an 
online study with questionnaires in clinicians found minimal differences between the 
two methods and that the online study produced higher quality data (Matteson et al., 
2011). 
 Given the budget for the study and the differing financial positions that 
medical students and pain clinicians are likely to be in, we decided that a £2 donation 
to Médecins Sans Frontières for each study response would be an appropriate 
incentive to encourage both groups of participants to take part in the study. Pain 
clinicians in the UK were invited to participate in the study using the mailing list of 
the International Association for the Study of Pain (IASP), and recruitment, while 
slow, was steady and attracted the required number of participants to meet the power 
recommendations for the study.  
There was a similar plan for recruiting medical students, but I soon found out 
that it would not be possible to email all medical students at once. This is because the 
medical school is the holder of the mailing list and has a policy of not emailing 
students for two reasons: 1) medical students already receive a lot of emails and 2) 
they were concerned that students would feel pressured to take part in the study due 
to the email coming from the medical school. Therefore, the study could only be 
advertised through a weekly mailing list sent to medical students, which featured 
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several other advertisements, meaning that students were less likely to see the study. 
Despite advertising the study on the mailing list for several months, there was a very 
low response rate to the study. For this reason, we decided to expand recruitment to 
4th year medical students, who also have clinical experience, to increase the available 
subject pool, and also to invite students to participate in the study by talking to them 
about the study at the beginning of a lecture, at the discretion of the lecturer. This led 
to a better response rate and meant that enough students were recruited to meet the 
power recommendations for the study.  
 Given the number of medical students that attend UCL, and the efforts in 
recruitment, the study had a low response rate. Recruiting health care professionals 
for studies is particularly challenging, and there have been several studies 
investigated the best techniques to improve recruitment (e.g. Cho, Johnson, & 
Vangeest, 2013). Posting surveys is more successful than sending emails, but this 
would not have been possible given the stimuli used in the study. One of the reasons 
for low recruitment in the current study is likely to be due to the barrier of not being 
able to contact medical students directly. It is also possible that the incentive was not 
enough to interest medical students in the study, and using a different incentive, such 
as a chance to win a prize or a small financial incentive, might have recruited more 
participants. In fact, previous studies have found that charity donations are not 
successful in increasing recruitment rates (Gendall & Healey, 2008). However, since 
the type of incentive can affect participants’ performance in studies (Brase, 2008), 
then pain clinicians would also require the same incentive, and they might not have 
been motivated by a chance at winning a modest prize or small financial incentive 
(Cho et al., 2013). Medical students also differ from pain clinicians in their 
experience of psychology. Pain clinicians frequently work alongside psychologists in 
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multidisciplinary teams, and might be more willing to take part in psychology 
studies. Interest in the study area is also known to improve recruitment rates, and 
given pain clinicians’ choice of field, they might also be more interested in studies 
relating to chronic pain and therefore be more likely to take part in the study 
(Groves, Presser, & Dipko, 2004).  
 The low response rates in the study for medical students could also have led 
to a sample bias, potentially affecting results. As mentioned in the discussion, 
medical students with a specific interest in psychology might have decided to take 
part in the study, and their results might not be typical of other medical students who 
chose not to take part. Before taking part, students were told that the study involved 
decision making in chronic pain. Therefore, students who were more confident in 
their assessment and decision-making skills might have been more likely to take part, 
and their responses could be less representative of the general population of medical 
students.  
 
Statistical analyses 
Although the field of statistics purports to be an objective way of testing data, 
I was aware that statistical techniques can be manipulated by researchers to provide 
misleading results (Bishop, 2013), and wanted to make sure that my statistical 
analyses would be of high quality. However, I was often stalled in my progress when 
finding conflicting advice from statistics texts, and I was surprised to see that choices 
were not always straightforward. I noticed that the choice of statistical technique 
described in books is often due to the personal preference of the author, or due to 
practical limitations. For example, when it came to reporting the effect size of my 
results, I had several choices for my estimate of effect size, including partial eta 
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squared and omega squared. Of these effect size estimates, SPSS only calculates 
partial eta squared. The use of partial eta squared is problematic, as it can 
overestimate and provide a misleading effect size (Bakeman, 2005). However, due to 
time constraints, and Andy Field’s description of calculating omega squared as ‘the 
road to madness’ (Field, 2013), I chose to go with partial eta squared for my effect 
size measure. I also became aware of issues that are not often talked about in 
statistical texts, for example, how the use of 4-way ANOVAs can increase the risk of 
false positive results (Bishop, 2014), so my supervisor and I decided that it would be 
better to use a stricter p value when reporting results. The use of mixed ANOVAs is 
seen as out-dated by some statisticians, and techniques such as multilevel modelling 
are advised instead (Institute of Psychiatry, 2014). One of the main issues with 
mixed ANOVAs appears to be their exclusion of whole cases due to missing data 
points, which was not an issue in my study. However, it is an example of how the 
statistics field is constantly evolving, and that it is important to keep up to date with 
changes. 
I would advise future researchers to be cautious when deciding on the number 
of variables to include in studies. My curiosity about the effects of multiple variables 
when designing the study turned into confusion during my statistical analyses, when 
my data produced several 3-way interactions. This meant that my results, though 
interesting, were difficult to interpret. I sought guidance from statistical books, my 
supervisor, and statistics advisor, only to find that there are several options for 
carrying out post-hoc tests and ways of interpreting the interactions, and the only 
consensus seemed to be about the difficulty of their interpretation. It also meant that 
the use of videos and vignettes to make the study more externally valid might have 
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introduced unknown variables relating to the patients in the videos that affected the 
results, and therefore played a role in the 3-way interaction.   
 
Reflections on the research findings 
Generalisability of the results 
 Due to the need for internal validity, only a limited amount of information 
about the patient’s history was available to participants. As a result, participants 
might have had difficulty with providing responses to the study, and could have 
provided different responses if more information was available about the patient’s 
history. Additionally, a face-to-face consultation provides a much richer experience 
with patients, and patient communication styles can also influence decision making 
(Birdwell, Herbers, & Kroenke, 1993). Future studies could enhance the design of 
the current study by including videos of chronic pain patients responding to 
questions typically asked in a pain consultation. This format has been successfully 
implemented in previous studies using actors (e.g. Birdwell, Herbers, & Kroenke, 
1993), though admittedly would be more difficult to implement using chronic pain 
patients. 
Similarly, only a limited amount of demographic information about the 
patient was available to participants. In reality several categories might activate bias 
in a consultation, such as race, social class and sexual orientation of the patient; and 
these categories occur in patients simultaneously, an issue known as intersectionality 
(Cole, 2009). Testing the effects of all of these categories would have been beyond 
the scope of the study. It would also be very difficult to design a study with all 
variables, since the introduction of more variables would lengthen the study and 
make statistical results difficult to interpret. Nevertheless, when designing future 
  158 
studies, researchers should keep issues of intersectionality in mind. Additionally, 
programmes aiming to reduce bias are often targeted at single biases (e.g. Stone & 
Moskowitz, 2011), which might not reduce biases in other categories, so 
intersectionality should also be kept in mind when designing these programmes. 
Due to differences in training programmes, the results from the study might 
not be applicable to clinicians in other specialities. Conducting the study with 
clinicians of other specialities is important, given that other specialities are regularly 
involved in the treatment of pain. In particular, general practitioners might be an 
important group to target, given their role in referring patients to other specialists and 
that they would often be the first clinical contact when patients develop chronic pain. 
 
The concept of trustworthiness 
 There are some issues with the inclusion of perceived trustworthiness as a 
variable in the study that has not yet been discussed. Facial features of 
trustworthiness are highly positively correlated with attractiveness and intelligence 
and negatively correlated with aggressiveness (0.75, 0.63, and -0.76 respectively; 
Todorov, Baron, & Oosterhof, 2008). Therefore, it is not possible for experimental 
stimuli to have a face high in trustworthiness, without also having other facial traits 
implied. Because of this, factors such as attractiveness and aggressiveness might 
have also played a role in differences in participants’ judgements. Additionally, 
chronic pain patients in the videos were from a region in Northern Canada, and 
might have had different facial features to patients in the UK. Todorov (2008) 
proposes that the evaluation of traits from facial features is similar to how emotional 
expressions can be used to evaluate the behavioural intentions of a person. For 
example, expressions of anger might communicate that the person should not be 
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approached. Todorov (2008) suggests that people infer traits about others based on 
the similarity of their neutral faces to active facial expressions. Similar to how people 
make decisions to approach or avoid others based on their emotional expressions, 
they also can make similar decisions based on a person’s resting facial features. To 
my knowledge, there have been no studies investigating whether there is an 
interaction with facial trait trustworthiness and emotional expressions. The additional 
use of pain expressions in the study could also have had an effect on participants’ 
perceived trustworthiness of the patient. 
 
Reflections on the research process 
One major aspect of conducting research that I noticed is that there is a 
difference between how a study is designed and executed, and how the resulting 
findings are communicated. A typical scientific paper will present a hypothesis, 
describe how the hypothesis was tested and the subsequent findings, and come to a 
conclusion that is in line with the findings (Howitt & Wilson, 2014). The 
presentation of research in this way makes sense, as it communicates the findings as 
clearly as possible. However, it also conveys the impression that there were no 
roadblocks during the research process and that the researcher was confident at all 
stages that they were making the correct decisions. The scientific method is also 
frequently conveyed as a series of clearly defined steps that will lead to answers as 
long as they are followed (Howitt & Wilson, 2014). In reality, I encountered several 
crossroads, such as in my statistical analyses, where I had to make informed, but 
sometimes subjective, decisions. From discussions with my colleagues, I began to 
realise that getting stuck and encountering obstacles is part of the process, and that 
one of the most important lessons of research is how I dealt with the obstacles and 
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learnt from them, and to seek guidance from my supervisor if I couldn’t solve the 
problem myself. Researchers embarking on their first projects might find it helpful to 
keep in mind that obstacles are normal and part of the process.  
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Appendices 
Appendix 1: Search terms 
 
Database: Ovid MEDLINE(R) <1946 to October Week 3 2013>, PsycINFO <1806 
to October Week 3 2013> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     depress*.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (615054) 
2     low mood.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (694) 
3     chronic pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (33223) 
4     neck pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (7909) 
5     musculoskeletal pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (4203) 
6     shoulder pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (5353) 
7     back pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (43343) 
8     subacute pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (47) 
9     sub-acute pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (7) 
10     acute to chronic pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (1653) 
11     enduring pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (44) 
12     continual pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (13) 
13     sustained pain.mp. [mp=ti, ab, ot, nm, hw, kf, ps, rs, ui, tc, id, tm] (444) 
14     1 or 2 (615277) 
15     3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (86562) 
16     14 and 15 (8525) 
17     ((depress* or low mood) and (chronic pain or neck pain or musculoskeletal 
pain or shoulder pain or back pain or 
subacute pain or sub-acute pain or acute to chronic pain or enduring pain or continual 
pain or sustained pain)).ab,ti. 
(6926) 
18     limit 17 to "300  adulthood <age 18 yrs and older>" [Limit not valid in Ovid 
MEDLINE(R); records were retained] 
(6044) 
19     limit 18 to humans [Limit not valid in PsycINFO; records were retained] 
(5931) 
20     limit 19 to human (5929) 
21     limit 20 to humans [Limit not valid in PsycINFO; records were retained] 
(5929) 
22     limit 21 to human (5929) 
23     limit 22 to yr="2003 -Current" (3954) 
24     limit 23 to humans [Limit not valid in PsycINFO; records were retained] 
(3954) 
25     limit 24 to english language (3727) 
26     limit 25 to peer reviewed journal [Limit not valid in Ovid MEDLINE(R); 
records were retained] (3657) 
27     remove duplicates from 26 (2370) 
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Appendix 2: Quality Assessment Scale 
ADAPTED FROM NEWCASTLE-OTTAWA QUALITY ASSESSMENT 
SCALE (COHORT STUDIES) 
Italics represent changes from original assessment scale 
 
Note: A study can be awarded a maximum of one star for each numbered item within 
the Selection and Outcome categories. A maximum of two stars can be given for 
Comparability. 
 
Selection (Max 5*) 
1) Representativeness of the exposed cohort (initial sample) 
a. Truly representative of the average patient with chronic pain or 
depression* 
b. Somewhat representative of the average patient with chronic pain or 
depression * 
c. Selected group of users 
d. No description of the derivation of the cohort 
 
2) Selection of the non-exposed cohort 
a. drawn from the same community as the exposed cohort* 
b. drawn from a different source 
c. no description of the derivation of the non exposed cohort 
 
3) Ascertainment of chronic pain or depression diagnosis 
a. Diagnosis confirmed with validated measures, measures of depression  
    suitable for the pain population* 
b. Evidence of assessment by a health professional* 
c. Written self report 
d. No description 
 
4) Criterion 4 (Demonstration that the outcome of interest was not present at 
start of study) removed as not applicable to current review 
 
5) Sample size 
a. Fifty or more adults included* 
b. Less than fifty adults included 
 
Control (Max 1*) 
1) Appropriate control for other variables 
a. study controls for sex and age* 
 
 
Outcome (Max 3*) 
1) Assessment of outcome 
a. Diagnosis confirmed with validated measures, measures of depression  
    suitable for the pain population* 
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b. No description or inappropriate measures 
 
2) Was follow-up long enough for outcomes to occur 
a. 6 months or more between baseline and follow-up* 
b. No 
 
3) Adequacy of follow-up of cohorts  
a. Complete follow-up – all subjects accounted for * 
b. Subjects lost to follow up unlikely to introduce bias – small number lost 
<25% or description provided of those lost* 
c. Follow-up rate <75% and no description of those lost 
d. No statement 
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Appendix 3: Ethical approval letters 
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Appendix 4: Recruitment emails 
4th, 5th and 6th year medical students needed for short online study. 
 
We are inviting 4th, 5th and 6th year UCL medical students to participate in a short 
online study which aims to improve our understanding of medical students' decisions 
about chronic pain. 
 
A £2 donation will be made to Medecins san Frontieres (Doctors Without Borders) 
on your behalf for your participation. 
 
The study is an online experiment which takes no more than 20 minutes to complete. 
If you are interested in taking part in the study or would like further information, 
please click on the following link: 
https://uclpsych.eu.qualtrics.com/SE/?SID=SV_8dnHU8SoCQtgDpr 
 
This study is being completed as part of my Doctorate in Clinical Psychology at 
University College London and has been approved by the UCL Ethics Committee 
(project ID: 4714/001). Your responses will be confidential and data will be handled 
in accordance with the Data Protection Act 1998. 
 
If you have any further questions, please email Grainne Schafer at [email] or Dr 
Amanda C de C Williams at [email] 
 
Dear Dr    
 
You are invited by Dr Amanda Williams and Grainne Schafer to participate in a 
short online study which aims to increase our understanding of doctors’ decisions 
about chronic pain. We are also sampling medical students using the same materials.  
 
A £2 donation will be made to Médecins san Frontières (Doctors Without Borders) 
on your behalf if you decide to take part in the study.  If you are interested in taking 
part in the study or would like further information, please click on the following 
link:  https://uclpsych.eu.qualtrics.com/SE/?SID=SV_8dnHU8SoCQtgDpr    The 
study requires you to take part in an online experiment which should take no more 
than 20 minutes. Your responses will be confidential and data will be handled in 
accordance with the Data Protection Act 1998.  This study is being completed as 
part of Grainne’s Doctorate in Clinical Psychology at University College London 
and has been approved by the UCL Ethics Committee (project ID: 4714/001). Your 
participation in this study is entirely on a voluntary basis and you are free to 
withdraw from the study at any time. The findings from the study may be published 
in peer-reviewed journals.  Please note: sometimes organisations block the survey 
site. If this happens to you, we would be very grateful if you still completed the 
survey from your home computer. If you have any further questions, please email 
Grainne Schafer at [email]or Dr Amanda Williams at [email] .     
 
Many thanks 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Appendix 5: Volunteer Information Sheet and Consent form 
 
Treatment decisions in Chronic Pain 
  
Volunteer Information Sheet 
 
This study has been approved by the Ethics Chair of the UCL Research Ethics 
Committee as Project ID Number 4714/001 
  
Investigators: 
  
Dr. Amanda C de C Williams 
Research Department of Clinical, 
Educational and Health Psychology 
UCL Gower Street    
London WC1E 6BT      
[email] 
Gráinne Schafer 
Research Department of Clinical, 
Educational and Health Psychology 
UCL Gower Street    
London WC1E 6BT      
 [email] 
                                                                                                                                                                         
                   
You are invited to participate in a research study. This study aims to increase our 
understanding of factors affecting the decisions of doctors and medical students 
relating to CP. 
  
This study is being conducted by researchers from the Research Department of Clinical, 
Educational and Health Psychology at University College London. Before we describe 
the study and its purpose to you we would like to make it clear that it is up to you to 
decide whether or not to take part. If you choose not to participate, you won't incur any 
penalties or lose any benefits to which you might have been entitled. Even after 
agreeing to take part, you can still withdraw at any time and without giving a reason. 
  
Who can participate in this study? 
We are inviting medical doctors who are specialists in CP and  th and 6th year UCL 
medical students to take part in the study. All volunteers must have good spoken 
English and good or corrected vision. 
  
What is involved? 
Before taking part in the study, you will be asked to give your consent by signing a 
computerised consent form. Testing will take place in a single session, lasting 
approximately 20 minutes. You will be shown 12 vignettes paired with short (<10 
seconds) video clips featuring patients with pain. After each vignette and its 
accompanying video, you will be asked questions relating to the patient’s experience of 
CP and possible treatment decisions. You will also be asked to provide demographic 
information about yourself and fill out an additional questionnaire. 
  
What are the risks of taking part in this study? 
No risks are envisaged from taking part in this study and the videos and vignettes are 
not anticipated to be distressing. 
  
What are the benefits to me? 
You will leave with the knowledge that you have contributed to our understanding of 
treatment decisions in CP and have helped in pain research. 
 
Will I receive compensation for giving my time? 
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A donation of £2 to Médecins Sans Frontières/Doctors Without Borders will be made on 
your behalf. 
  
How will my data be kept? 
Your data from this study will be stored electronically using a numbered code. Your 
email address will be taken in order for us to be able to send you a full debrief of the 
study and the results when the data collection process is complete. Your email address 
will be stored in a separate password protected file and will not be linked with your 
data. Only researchers directly involved in the study have access to the data. All data 
will be collected and stored in accordance with the Data Protection Act (1998). 
  
Whom can I contact for further information? 
If you have any further questions please contact: 
Gráinne Schäfer  [email] 
Dr. Amanda C de C Williams  [email] 
 
You do not have to take part in this study if you do not want to. If you decide to 
take part, you may withdraw at any time without having to give a reason. 
  
  
Factors affecting decisions of doctors and medical students in the treatment of 
Chronic Pain 
  
All research projects are reviewed by an ethics committee. This study has been 
approved by the Ethics Chair of the UCL Research Committee as Project ID 
Number 4714/001 
  
Volunteer consent form 
 
Confidential 
 
Investigators: Gráinne Schäfer, Dr. Amanda C de C Williams 
  
Participant’s Statement 
 
I agree that I have (please tick each statement to which you agree): 
 
 Read the information sheet 
 Had the opportunity to ask questions and discuss the study via email and  
 Received satisfactory answers to all of my questions or have been advised 
of an individual to contact for answers to pertinent questions about the 
research and of my rights as a participant and of whom to contact in the 
event of a research-related injury. 
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 I understand that I am free to withdraw from the study without penalty if I so 
wish, and I consent to the processing of my personal information for the 
purposes of this study only and that it will not be used for any other purpose.  
 I understand that such information will be treated as strictly confidential and 
handled in accordance with the provisions of the Data Protection Act 1998. 
 
By clicking the 'next' button, you agree to take part in the study. 
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Appendix 6: Donation to Médecins Sans Frontièrs UK 
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Appendix 7: Method for obtaining ratings of trustworthiness/selecting stimuli 
 
Participants and setting 
A convenience sample of fifty-five (14 male) trainee clinical psychologists 
took part in the trustworthiness rating task prior to the main study. 
 
Materials 
Stimuli from the UNBC-McMaster Shoulder Pain Expression Archive 
Database (Lucey, Cohn, Prkacin, Solomon, & Matthews, 2011) were used in both 
parts of the current study. The database contains 130 videos showing faces of 
patients with shoulder pain while they were undergoing a series of painful 
physiotherapeutic manoeuvres (for a full description of patient characteristics, tests 
and videotape characteristics see Lucey et al., 2011). For the first part of the study, 
still images of the patients carrying a neutral expression were used as stimuli, 
following the methods of Oosterhof and Todorov (2008). Stimuli were chosen for 
trustworthiness ratings if the patient expressed a moderate intensity of pain 
expression in their respective video and if their ethnicity was Caucasian. As a result, 
51 (28 male, age range 20 – 67 years) patient stimuli were selected for 
trustworthiness ratings.  
 
Measures 
Estimations of trustworthiness were made on a scale of 1 to 9 (Appendix), the 
same method as that of Oosterhof and Todorov (2008). The scales were anchored at 
either end with the words “Not trustworthy at all” and “Extremely trustworthy”.  
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Procedure 
The study was set up on the survey platform Limesurvey, and participants 
accessed it online. Participants were emailed invitations to take part in the study and 
upon entering the website, they were asked to provide informed consent. They 
reported their gender and year of training. They were then presented with each of the 
51 patient stimuli in a random order and were asked to rate the trustworthiness of 
each patient, relying on their ‘gut feeling’. Each presentation lasted as long as it took 
participants to select a rating of trustworthiness and click through to the next 
presentation. It was not possible for participants to go back and change previous 
ratings.  
 
Results 
The mean rating of trustworthiness was 5.14 (SD = .85, range = 1-9). There 
was a difference in mean ratings of female and male chronic pain patients, with 
female chronic pain patients (M = 5.49, SD = .61) rated higher in trustworthiness 
than males (M = 4.85, SD = .80, t(49) = -3.14, p = 0.003). The videos of male and 
female patients with the three lowest and highest ratings in trustworthiness were 
selected for the second part of the study (Table 1) in order to maximise effects due to 
trustworthiness.  
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Appendix 8: Table with characteristics of patients in each video 
 
Table. Characteristics, FACs ratings and mean trustworthiness ratings of patients in 
each video. 
 Mean (SD) 
trustworthiness rating 
Trustworthiness 
classification 
Gender 
 
Video 1 
 
 
6.42 (1.60) 
 
High 
 
Female 
Video 2 6.36 (1.46) High Female 
Video 3 6.51 (1.61) High Female 
Video 4 6.24 (1.45) High Male 
Video 5 6.25 (1.31) High Male 
Video 6  6.06 (1.80) High Male 
Video 7 4.76 (1.47) Low Female 
Video 8 3.96 (1.35) Low Female 
Video 9 4.91 (1.48) Low Female 
Video 10 3.95 (1.79) Low Male 
Video 11 3.60 (1.67) Low Male 
Video 12 3.60 (1.47) Low Male 
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Appendix 9: Study instructions 
  
You will be shown a series of vignettes that are followed by videos of patients 
with CP. You will then be asked questions relating to the corresponding 
vignettes and videos. 
  
Please ensure that your mobile phone and sound on the computer are switched 
to silent to minimise distractions while you are doing the study (the videos you 
will be watching have no sound so you don't need speakers for this study).  
  
Please press the F11 button on your keyboard. This will change your browser to 
fullscreen view. You can change it back to normal view by pressing F11 again 
after completing the study. 
 
If you have to leave the survey and come back again, your progress will be saved 
as long as you access the survey from the same browser. 
By clicking the 'next' button, you agree to take part in the study. 
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Appendix 10: Response bars 
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   How trustworthy is this patient? 
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Appendix 11: Vignettes 
Vignette 1 
Dear Doctor, 
 
Re: Ms Wilson, Hospital number: 4816752 
 
I would be grateful if you could see this patient, who says that she has experienced pain in 
her right shoulder for about 1 year. She reports that she is finding it difficult to drive due to 
the pain and she lives in a rural area with limited public transport so finds it difficult to leave 
her house for daily errands. She said that she has no other health conditions, apart from 
asthma. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 2 
Dear Doctor, 
 
Re: Ms Walker, Hospital number: 7494018 
 
I would be grateful if you could see this patient, who says that she has experienced pain in 
her right shoulder for about 1 year. She reports that she is finding it difficult to look after her 
two young grandchildren because of the pain. She reports that she has been depressed for 
about 3 years, but does not currently take medication or have psychological treatment for it.  
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 3 
Dear Doctor, 
 
Re: Ms Harris, Hospital number: 4185247 
 
I would be grateful if you could see this patient, who says that she has experienced pain in 
her right shoulder for about 1 year. She reports that she is finding it difficult to continue full 
time work because of the pain. She reports that she began to feel depressed about 6 months 
ago, but does not currently take medication or have psychological treatment for it. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
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Vignette 4 
Dear Doctor, 
 
Re: Mr Anderson, Hospital number: 9187282 
 
I would be grateful if you could see this patient, who presents with shoulder pain and says 
that the pain started about 1 year ago. He reports that he is finding it difficult to drive due to 
the pain and he lives in a rural area with limited public transport so finds it difficult to leave 
his house for daily errands. He said that he has no other health conditions, apart from 
asthma.  
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 5 
Dear Doctor, 
 
Re: Mr Brown, Hospital number: 0234052 
 
I would be grateful if you could see this patient, who presents with shoulder pain and says 
that the pain started about 1 year ago. He reports that he is finding it difficult to continue full 
time work because of the pain. He has been depressed for about 3 years, but does not 
currently take medication or have psychological treatment for it. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 6 
Dear Doctor, 
 
Re: Mr Davis, Hospital number: 1475482 
 
I would be grateful if you could see this patient, who reports pain in his right shoulder for 
about 1 year. He said that he is a carer for his elderly father and that he has been finding it 
more difficult to care for him due to the pain. He reports that he began to feel depressed 
about 9 months ago, but does not currently take medication or have psychological treatment 
for it. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 7 
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Dear Doctor, 
 
Re: Ms Moore, Hospital number: 4815751 
 
I would be grateful if you could see this patient, who presents with shoulder pain and says 
that the pain started about 1 year ago. She reports that she is finding it difficult to continue 
full time work because of the pain. She is asthmatic but said that she does not have any other 
problems with her health.  
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 8 
Dear Doctor,  
 
Re: Ms Thomas, Hospital number: 4815729 
 
The patient presents with shoulder pain and reports that the pain started about 1 year ago. 
She reports that the pain is interfering with her ability to carry out her studies. She has been 
depressed for about 2 years, but does not currently take medication or have psychological 
treatment for it.  
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 9 
Dear Doctor, 
 
Re: Ms White, Hospital number: 4816752 
 
I would be grateful if you could see this patient, who presents with shoulder pain and says 
that the pain started about 1 year ago. She reports that she is finding it difficult to look after 
her young child because of the pain. She reports that she began to feel depressed about 9 
months ago, but does not currently take medication or have psychological treatment for it. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 10 
  184 
Dear Doctor, 
 
Re: Mr Taylor, Hospital number: 4815495 
 
I would be grateful if you could see this patient, who reports pain in his right shoulder for 
about 1 year. He reports that the pain is interfering with his ability to carry out his studies. 
He is asthmatic but said that he does not have any other problems with his health. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
Vignette 11 
Dear Doctor, 
 
Re: Mr Smith, Hospital number: 0434023 
 
I would be grateful if you could see this patient, who reports pain in his right shoulder and 
says that the pain started about 1 year ago. He said that he is a carer for his elderly uncle and 
that he has been finding it more difficult to care for his uncle due to the pain. He reports that 
he has been depressed for 2 years, but does not currently take medication or have 
psychological treatment for it. 
 
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson  
 
Vignette 12 
Dear Doctor, 
 
Re: Mr Jones, Hospital number: 5861679 
 
I would be grateful if you could see this patient, who presents with shoulder pain and says 
that the pain started about 1 year ago. He reports that he is self-employed and is finding it 
difficult to keep up with his work duties because of the pain. He says that he began to feel 
depressed about 6 months ago, but does not currently take medication or have psychological 
treatment for it.  
I am requesting your opinion regarding the appropriate treatment of this patient. Thank you 
for your help. 
 
Yours sincerely, 
 
Dr. Watson 
 
 
 
  185 
 
 
 
Appendix 13: Further results 
Interactions with p > .01 and post-hoc test results for interactions that were p < 
.05. 
 
Table 21.  Interactions between training level, history of depression, trustworthiness 
and gender for pain management decisions with p > .01 
 
Patient gender x history of depression 
There was a significant interaction between patient gender and history of 
depression (Table 10). Post hoc tests indicated that the previously mentioned main 
effect for gender remained, with participants estimating males as in more pain than 
 Trustworthiness x 
training level 
Trustworthiness x 
gender x training 
level 
Gender x history of 
depression x 
training level 
 F 
(1,61) p  η𝑝 
2  
F 
(1,61) p  η𝑝 
2  
F 
(2,60) p η𝑝 
2  
 
Pain estimates 2.49 .120 .04 2.87 .061 .05 2.36 .099 .04 
 
Exaggerating pain 0.19 .666 <.01 0.03 .857 <.01 1.74 .180 .03 
 
Minimising pain 0.94 .336 .02 0.02 .89 <.01 4.21 .017 .07 
 
Hiding pain 
 
5.91 .018 
 
.09 0.19 .662 <.01 0.86 .427 .01 
 
Opioids 4.03 .049 .06 4.28 .043 .07 1.91 .153 .03 
 
Analgesics 1.18 .283 .02 0.15 .699 <.01 3.88 .02 .04 
 
Antidepressants 0.72 .400 .01 1.41 .240 .02 2.00 .14 .03 
 
Pain management 
programme 2.61 .111 .04 5.77 .019 .09 0.51 .602 .01 
 
Mental health 
specialist 2.84 .097 .04 0.20 .659 <.01 2.21 .114 .04 
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females, regardless of history of depression (Female, no history of depression: M = 
4.74, SE = 0.17; Male, no history of depression: M = 5.43, SE = 0.14; t(62) = 5.35, p 
< .001; Female, depression before CP: M = 4.63, SE = 0.17; Male, depression before 
CP: M = 5.82, SE = 0.16; t(62) = 7.63, p < .001; Female, depression after CP: M = 
4.56, SE = 0.16; Male, depression after CP: M = 5.33, SE = 0.18; t(62) = 4.74, p < 
.001). Pain estimates for male patients were similar across all histories of depression 
(p > .050), while female patients with no history of depression and who developed 
depression after CP were more likely to be given higher estimates of pain than 
female patients who developed depression before CP (t(62) = 3.00, p = .01; t(62) = 
3.43, p = .003). 
 
There was also an interaction between patient gender and history of 
depression for likelihood of referring to a mental health specialist. Post hoc tests 
revealed that for patients with no history of depression, females were more likely 
than males to be referred to a mental health specialist (M = 2.10, SE = 0.23; M=1.64, 
SE = 0.19; t(62) = 3.11, p = .003). There were no differences between males and 
females in the other two conditions.  
 
Patient trustworthiness x gender 
There was an interaction between patient trustworthiness and gender for 
likelihood of prescribing analgesics. Post hoc tests indicated that the previously 
mentioned main effect for trustworthiness only occurred in female, but not male 
patients (HT female: M = 6.39, SE = 0.22; LT female: M = 5.87, SE = 0.20; t(62) = 
3.37, p = .001; HT male: M = 6.77, SE = 0.20; LT male: M = 6.77, SE = 0.22; t(62) 
= 0, p = .998). This interaction indicates that participants were more likely to 
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prescribe analgesics to HT females than LT females, but participants gave similar 
ratings of prescription of analgesics to males, regardless of their level of 
trustworthiness. The main effect for patient gender also only occurred in LT patients, 
with LT males more likely to be prescribed opioids than LT females (t(62) = 6.15, p 
< .001). There was no difference for HT females compared to HT males (p > .05). . 
The main effect for patient gender remained, with males more likely to be prescribed 
analgesics than females for both levels of trustworthiness (t(62) = 2.79, p = .007; 
t(62) = 5.56, p < .001). 
 
Patient trustworthiness x gender x history of depression 
There was also a significant interaction between trustworthiness, patient 
gender and history of depression for likelihood of prescribing analgesics (Figure 1). 
Post hoc tests showed that the HT male who developed depression after CP was 
more likely to be prescribed analgesics than the LT male in the same condition  
(t(62) = 2.51, p = .015). For females who had no history of depression and who 
developed depression before CP, HT females were more likely than LT females to be 
prescribed analgesics (t(62) = 2.24, p = .029; t(62) = 2.63, p = .011).  
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Figure 1. Mean likelihood of prescribing analgesics across trust, gender and history 
of depression. Error bars represent standard errors. 
 
Note: *p < .05, ** p < .01, *** p < .001 
 
 
There was an interaction between trustworthiness, patient gender and history 
of depression for likelihood of referring to pain management,. Post hoc tests 
indicated that the HT male who developed depression after CP was more likely to be 
referred to pain management than the HT female in the same condition (M = 4.60, SE 
= 0.32; M = 3.56, SE = 0.33; t(62) = 3.62, p = .001). There were no differences 
between HT males and females for patients who developed depression before CP and 
patients with no history of depression. The LT male who developed depression 
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before CP was more likely than the LT female to be referred to pain management (M 
= 5.06, SE = 0.34; M = 3.90, SE = 0.36; t(62) = 3.37, p = .001). There was a similar 
trend for patients who developed depression after CP (M = 4.21, SE = 0.36; M = 
3.78, SE = 0.33; t(62) = 1.88, p = .065) and there was no difference between males 
and females who had no history of depression.  
 
Patient trustworthiness x training level 
There was an interaction between patient trustworthiness and training level 
for likelihood of prescribing opioids (21). Post hoc tests indicated that students were 
more likely to prescribe opioids to HT patients than LT patients (M = 3.15, SE = 
0.30; M = 2.87, SE = 0.30; t(62) = 2.50, p = .015), while clinicians were not affected 
by patient trustworthiness (M = 1.79, SE = 0.28;  M = 1.82, SE = 0.28; t(62) = 0.24, 
p = .808). 
 
Patient gender x training level 
There was a significant interaction between patient gender and training level 
for likelihood of prescribing analgesics. Post hoc tests indicated that medical students 
gave a higher likelihood of prescribing analgesics to male patients than pain 
clinicians, but that there was no difference between groups in female patients (male 
patients: M = 7.30, SE = 0.30; M = 6.24, SE = 0.27; t(62) = 2.65, p = .010; female 
patients: M = 6.40, SE = 0.32;  M = 5.84, SE = 0.27; t(62) = 1.30, p = .199). The 
main effect for patient gender remained, with both groups more likely to prescribe 
analgesics for males than females (t(62) = 5.28, p < .001; t(62) = 2.51, p = .015).  
 
History of depression x training level 
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There was a significant interaction between history of depression and training 
level for likelihood of prescribing analgesics. Post hoc tests indicated that clinicians’ 
likelihood of prescribing analgesics were not affected by the history of depression of 
patients (p > .05), but that medical students were more likely to prescribe analgesics 
for patients who had no history of depression than patients who developed 
depression before CP, and patients who developed depression after CP (no history of 
depression: M = 7.12, SE = 0.29; depression before CP: M = 6.76, SE = 0.31; 
depression after CP: M = 6.66, SE = 0.31; t(62) = 2.66, p = .029; t(62) = 3.46, p = 
.003).  
  
Patient gender x history of depression x training level 
There was a significant interaction between patient gender, history of 
depression and training level for likelihood of prescribing analgesics (Figure 2). Post 
hoc tests found that students were more likely to prescribe analgesics for males than 
females, regardless of their history of depression (control: t(62) = 2.22, p = .03; 
depression before CP: t(62) = 5.10, p < .001; depression after CP: t(62) = 3.15, p = 
.003). There was no significant difference for clinicians between males and females, 
except for patients with no history of depression, where clinicians were more likely 
to prescribe analgesics for males than females, t(62) = 3.01, p = .004. The history of 
depression x training level interaction was found to only occur for female patients, 
with students more likely to prescribe analgesics for female patients who had no 
history of depression than female patients who developed depression before CP, and 
female patients who developed depression after CP (t(62) = 4.66, p < .001; t(62) = 
3.61, p = .002). 
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Figure 2. Mean likelihood of prescribing analgesics across gender, history of 
depression and training level. Error bars represent standard errors. 
 
 
Note: *p < .05, ** p < .01, *** p < .001 
 
Patient trust x gender x training level 
There was an interaction between trust, gender and training level for 
likelihood of prescribing opioids (Figure 3). Post-hoc tests indicated that the patient 
gender x training level interaction remained, but that the trustworthiness x training 
level interaction only occurred for female patients. This interaction indicates that 
students were more likely to prescribe opioids for HT females than LT females (t(62) 
= 4.86, p < .001), but there were no differences in students’ ratings between HT 
males and LT males (p > .05).  
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Figure 3. Mean likelihood of prescribing opioids across trust, gender and training 
level. Error bars represent standard errors. 
 
Note: *p < .05, ** p < .01, *** p < .001 
 
There was an interaction between trust, patient gender and training level, for 
likelihood of referring to pain management. Post hoc tests revealed that students 
were more likely to refer LT males than LT females to pain management (M = 5.20, 
SE = 0.45; M = 4.25, SE = 0.43; t(62) = 4.43, p < .001). There were no differences 
between HT males and females. Clinicians were just as likely to refer males to pain 
management as females regardless as to whether they were high or low in 
trustworthiness.  
 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
High
trustworthiness
Low
trustworthiness
High
trustworthiness
Low
trustworthiness
Clinician Student
L
ik
e
li
h
o
o
d
 o
f 
p
re
s
c
ri
b
in
g
 o
p
io
id
s
Female
Male
* *** 
*** 
